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Thesis Abstract 
 
Regenerative medicine is a rapidly expanding field of science with an exhaustive 
volume of literature published on the different strategies used to repair diseased 
or injured tissue. Recently, stem cells have emerged as a promising candidate in 
this regard owing to their involvement in embryogenesis, homeostatic turnover 
and normal tissue repair. Despite this potential, stem cell-based therapies have 
yet to be fully established in a clinical setting owing to complications associated 
with their limited numbers, immunogenicity, tumour formation and the ethical 
considerations surrounding their usage. Furthermore, the mechanisms underlying 
stem cell differentiation are complex and not fully understood, thus expanding 
stem cell numbers and predictably directing their commitment toward a desired 
lineage, represent a major challenge for tissue regeneration strategies. 
 
In an attempt to circumvent these problems there is currently a rising interest in 
biomimetic materials that aim to reproduce the physical architecture, chemical 
composition and plasticity of the in vivo extracellular environment in an in vitro 
setting. Furthermore, the need to expand stem cells while maintaining the stem 
cell phenotype has prompted many to look to the stem cell niche for answers. At 
the centre of most cellular responses to the physical cues embedded within the 
ECM are integrins. Integrins are mechanosensitive membrane spanning receptors 
that link the ECM to the cytoskeleton and thus transmit information from outside 
the cell into the nucleus, affecting gene transcription via a series of intracellular 
signalling cascades. To that end, many biomimetic systems incorporate integrin-
binding ligands such as the tripeptide RGD. 
 
In this work glass surfaces functionalised with RGD were used to study changes in 
mesenchymal stem cell (MSC) responses to increased integrin binding by using an 
enzymatic ‘switch’ to reveal surface-bound RGD peptides that have been masked 
by a large chemical cap (Fmoc). The results of this work demonstrated that RGD-
functionalised substrates can support MSC growth and influence them to commit 
to a particular fate. MSCs on surfaces where integrin-ligand binding was blocked 
developed a fibroblast-like phenotype whereas MSC grown on surfaces that were 
later enzymatically digested to reveal the underlying RGD ligands developed an 
osteoblast phenotype similar to RGD controls. 
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1.1 Introduction 
 
The primary objective of regenerative medicine is to restore natural function to 
diseased or injured tissue in the absence of self-mediated repair (Mironov et al., 
2004; Haseltine, 2001). Current tissue regeneration therapies rely on three main 
strategies to achieve this ideal: stem cells as an alternative source of specialised 
cells, biomaterials as instructive matrices to support cell anchorage and guided 
tissue growth, and the delivery of biomolecules e.g. growth factors etc to target 
areas (Rice et al., 2012; Naderi et al., 2011; Olson et al., 2011; Smith and Ma, 
2010). Stem cells in particular are expected to play a pivotal role in many future 
applications owing to their involvement in normal tissue repair. Yet despite their 
potential, stem cell-based therapies remain largely in their infancy.  
 
The success of stem cells in a clinical environment hinges on our ability to obtain 
a sufficient number of viable cells and direct these cells along a desired lineage; 
something that is difficult to achieve in culture. Standard culture methods fail to 
meet the requirements necessary to maintain stem cell ‘stemness’ (Siddappa et 
al., 2007; Fehrer and Lepperdinger, 2005) as they lack the complexity of the in 
vivo stem cell niche. The niche dictates quiescence, renewal and commitment 
through physical and biochemical signals (Li and Clevers, 2010; Scadden, 2006); 
thus recreating these cues is not only key to developing in vitro niches conducive 
to stem cell growth and differentiation, but also invaluable to our understanding 
of the niche environment. Mimetic materials designed with niche-like properties 
are already beginning to make progress in this regard (Patterson et al., 2010). 
 
 
Figure 1-1 Stem cells in tissue regeneration: Along with biomaterials and small biomolecules, stem cells 
are promising tools in regenerative medicine. Figure shows three possible methods of using stem cells to 
repair damaged tissue. Arrows indicate that stem cells can be allogeneic (from a donor) or autologous (from 
the patient); the dashed arrow indicates that SSCs can be either autologous but are mostly allogeneic while 
ESCs are always allogeneic and iPSCs are usually derived from the patient’s own cells.  
Induced pluripotent stem 
cells 
Somatic stem cells 
Embryonic stem cells 
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1.2 Stem Cells 
 
It is generally accepted that the capacity for long-term self-renewal and ability 
to commit to one or more lineages, sets stem cells apart from other cell types 
(Biswas and Hutchins, 2007; Young and Black, 2004; Verfaillie, 2002; Pittenger et 
al., 1999). As a rule, stem cells can be grouped into three categories depending 
on their origin. Embryonic stem cells (ESCs) are derived from the inner cell mass 
of a blastocyst-stage embryo. They were first isolated from mice by Martin Evans 
and Matthew Kaufman, and independently by Gail R. Martin in the early eighties 
(Evans and Kaufman, 1981; Martin, 1981) while human ESCs were isolated more 
than a decade later by James Thomson and co-workers (Thomson et al., 1998). 
In comparison to ESCs, somatic stem cells (SSCs in this thesis) exist in specialised 
niches within particular subsets of adult tissues including bone marrow, adipose 
tissue, dental pulp and brain tissue (Steinhoff et al., 2013; Mendez-Ferrer et al., 
2010; Alvarez-Buylla et al., 2002; Zuk et al., 2002; Gronthos et al., 2000). They 
normally serve to replenish tissue during normal tissue remodelling. 
 
SSCs are divided into tissue-specific types e.g. mesenchymal stem cells (MSCs), a 
population of SSCs first identified in bone marrow (Becker et al., 1963) and since 
found in adipose tissue, the umbilical cord (Wharton’s jelly), and in dental pulp 
(Nombela-Arrieta et al., 2011; Lu et al., 2006; Zuk et al., 2002; Gronthos et al., 
2000). Morphologically MSCs are large, flat adherent cells that are fibroblast-like 
when packed closely together, but adopt a well-spread polygonal appearance in 
areas of low cell density (Figure 1-2). Of all the SSCs they are perhaps one of the 
better characterised owing to their popularity in cell-based experiments, which 
has risen substantially in the last decade due to ease of use and the discovery of 
a number of advantageous characteristics. For instance, while the use of ESCs in 
stem cell research is complicated by ethical dispute surrounding the destruction 
of fertilised human embryos (Wert and Mummery, 2003), MSCs can be obtained 
relatively easily without causing harm to the donor, thus they are not subject to 
the same constraints. MSCs are also known to exhibit a stable phenotype in vitro 
whereas ESCs are prone to spontaneous differentiation resulting in the formation 
of teratomas (Wakitani et al., 2003). One interesting characteristic attributed to 
MSCs is that they may posses the ability to regulate certain aspects of the innate 
immune response and evade rejection issues typically associated with allogeneic 
transplants (comprehensively discussed in (English and Mahon, 2011)).  
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Figure 1-2: Mesenchymal Stem Cells. MSCs are large flat fibroblast-like cells that adopt a polygonal shape 
at low density, but appear spindle-like at high density. Panels are immuno-fluorescence images of a single 
MSC (left hand panel) and multiple MSCs (right hand panel). Colours are red (actin), green (vinculin in left 
panel and tubulin in right panel) and blue (nuclei). Scale bar= 25!m (Roberts, unpublished work). 
 
 
Induced-pluripotent stem cells (iPSCs) are artificially derived from differentiated 
somatic cells that have been reprogrammed to exhibit ESC-like qualities. In 2006 
Shinya Yamanaka and co-workers engineered the first generation of iPSCs using a 
retroviral vector to insert four key transcription factors into the nuclei of mouse 
fibroblasts (Takahashi and Yamanaka, 2006). Shortly afterwards, the same group 
and others published additional work on mouse iPSCs (Okita et al., 2007; Wernig 
et al., 2007) and human iPSCs (Yu et al., 2009; Takahashi et al., 2007; Yu et al., 
2007). IPSCs have received much interest as a source of pluripotent stem cells 
that have a greater level of plasticity than SSCs, but are not subject to the same 
controversies as ESCs. As iPSCs are obtained from somatic cells they also have 
the potential to be used in patient-tailored therapies by generating autologous 
stem cells (Christoph, 2012; Barrilleaux and Knoepfler, 2011). A major drawback 
in iPSC-based therapy centres on their propensity to form tumours. A number of 
the transcription factors used in iPSC reprogramming are oncogenes or known to 
be involved in tumorigenesis (Kooreman and Wu, 2010; Knoepfler, 2009). 
 
 
1.2.1 Stem Cell Differentiation 
 
The capacity to commit to specialised cell types is a unique feature inherent to 
stem cells. The number of cells and the types of cells they can differentiate into 
depends on their origin. During embryogenesis, ESCs of the inner cell mass would 
ordinarily give rise to the embryo proper resulting in the formation of all cells of 
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the three primary germ layers (Nichols and Smith, 2012); ESCs are therefore said 
to be pluripotent. As their name implies, iPSCs are also pluripotent due to their 
ESC-like characteristics (Stadtfeld and Hochedlinger, 2010). Tissue-specific SSCs 
on the other hand are limited to a smaller number of cell types and are referred 
to as multipotent. MSCs derived from mesenchymal connective tissue, have been 
shown to differentiate into osteogenic (bone), adipogenic (fat) and chondrogenic 
(cartilage) cells, while haematopoietic stem cells in bone marrow are limited to 
myeloid and lymphoid lineages, and neural stem cells from the sub-ventricular 
and sub-granular zones of the brain specialise into neurons and other glial cells 
(Young and Black, 2004). The mechanisms regulating the switch from renewal to 
commitment are poorly understood however the mitogen-activate protein kinase 
(MAPK) and other intracellular signalling pathways are likely involved (Oeztuerk-
Winder and Ventura, 2012; Ables et al., 2010; Nusse, 2008; Jaiswal et al., 2000). 
 
 
Figure 1-3: Stem cell differentiation. The differentiation capacity of stem cells depends on their origin. 
ESCs and iPSCs can differentiate into cells of all germ layers but SSCs are limited to cells of the tissue they 
reside in. Figure is a cartoon representation of the stem cell ability to either renew or commit to a specific 
lineage such as an osteoblast during osteogenic commitment. 
Chondrocytes 
Osteoblasts 
Adipocytes 
Myoblasts 
Neurons 
Stem cells 
Epithelia 
Blood cells 
Gut epithelia 
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1.2.2 The MAPK Signalling Pathway  
 
Collectively, the MAPK signalling pathways are fundamental mediators of signal 
transduction responsible for propagating a diverse range of extracellular stimuli 
into the cell. Classical MAPK pathways include the extracellular signal-regulated 
kinases 1 and 2 (ERK1/2), c-Jun N-terminal kinases 1-3 (JNK1-3), p38 (!, ", # and 
$) and ERK5. Atypical MAPKs such as ERK3/4, ERK7/8 and Nemo-like kinase (NLK) 
are distinct from the other MAPKs and very little is known about their activation 
or function (Cargnello and Roux, 2011). MAPK signalling operates via a system of 
sequential kinase activations starting with the MAP3Ks (Figure 1-4). MAP3Ks can 
be activated by multiple stress stimuli such as hyperosmosis, oxidative stress and 
inflammatory mechanisms (Xu et al., 2012; Xi et al., 2000; Aikawa et al., 1997), 
growth factors e.g. epidermal growth factor, platelet-derived growth factor and 
nerve growth factor etc (von Kriegsheim et al., 2009; Kao et al., 2001), integrins 
(Fincham et al., 2000; Aplin and Juliano, 1999), and G protein-coupled receptors 
(Crespo et al., 1994; Koch et al., 1994). MAP3Ks phosphorylate and activate the 
MAP2Ks, which in turn activate MAPKs (Humphreys et al., 2013; Plotnikov et al., 
2011). MAPKs translocate directly into the nucleus or activate additional kinases 
in the cytoplasm (Roux et al., 2007).  
(Urushihara and Kinoshita, 2011) 
 
Figure 1-4: The MAPK signalling cascades. Classical MAPK signalling pathways can be subdivided into four 
cascades (ERK1/2, p38, JNK and ERK5) operating through a system of sequentially activated kinases. The 
MAP3Ks are activated in response to numerous extracellular stimuli and propagate this stimulus via MAP2Ks 
and MAPKs. MAPKs can engage with target transcription factors within the nucleus altering gene expression 
and functional output (redrawn and adapted from Urushihara and Kinoshita, 2011).  
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Although MAP3K activation is somewhat complex, subsequent activation of MAP2 
and MAP kinases is relatively linear due to a high degree of specificity between 
MAP3Ks and MAP2Ks, and the MAP2Ks and MAPKs (Cargnello and Roux, 2011). The 
principle route of ERK1/2 for example is via the Raf-MEK-ERK cascade, which is 
initiated by receptor-mediated phosphorylation of the guanosine triphosphatase 
(GTPase) Ras. Ras is first activated at the plasma membrane by son-of-sevenless 
(SOS), a guanine nucleotide exchange factor (Boriack-Sjodin et al., 1998; Buday 
and Downward, 1993), which is itself recruited to the membrane by the growth 
factor receptor-bound protein GRB2 (Lowenstein et al., 1992). Ras activates Raf, 
which activates MEK1/2 that then activate ERK1/2 (Morrison, 2012; Kolch, 2000; 
Zheng and Guan, 1994; Vojtek et al., 1993; Zheng and Guan, 1993). Downstream 
substrates of ERK1/2 and other MAP3Ks in the cytoplasm are known as MAPKAPK 
while MAPK substrates in the nucleus are transcription factors (Figure 1-5). 
 
As previously indicated, MAP3Ks and MAP2Ks are resident in the cytoplasm only 
whereas MAPKs can activate additional downstream kinases or translocate to the 
nucleus and interact with transcription factors (Kanno et al., 2007; Roux et al., 
2007; Brunet et al., 1999). Although the core canonical pathways consists of only 
a handful of components, the number of proteins and kinases that feed into the 
network from other pathways, and extend out from MAPK, is considerably larger. 
Using a computational approach to look for physical interactions between MAPK 
proteins and the rest of the proteome, Bandyopadhyay et al. assembled a list of 
2000 protein interactions broadly related to MAPK, while Kriegsheim et al. used 
a stable isotope labelling by amino acids (SILAC)-based approach to identify 284 
proteins relating to the ERK1/2 pathway alone (Bandyopadhyay et al., 2010; von 
Kriegsheim et al., 2009). 
 
Given the substantial number of molecules that interact with ERK1/2 and indeed 
MAPKs as a whole, it is likely that these pathways are able to affect many other 
cell functions through these extended cascades. In fact, the MAPK family plays a 
fundamental role in stem cell renewal and differentiation at multiple levels and 
as such they are extensively described in literature (Colello et al., 2012; Kanno 
et al., 2007; Meloche and Pouysségur, 2007; Yamamoto et al., 2006; Fincham et 
al., 2000; Jaiswal et al., 2000). Some of the other signalling pathways that MAPK 
can cross-communicate (crosstalk) with are described in Appendix I.  
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Figure 1-5: The ERK1/2 signalling pathway. MAPK cascades can be activated by growth factors, integrins, 
G protein-coupled receptors and stress stimuli. The primary route of ERK-mediated signalling is via the Raf-
MEK-ERK pathway initiated by the activation of Ras at the plasma membrane. ERK1/2 activate additional 
downstream kinases and also interact with transcription factors within the nucleus (image courtesy of Cell 
Signaling Technology®). 
 
 
1.2.3 MAPK Regulates the Cell Cycle 
 
The cell cycle is divided into four main sections starting with G1 (Gap1) followed 
by S phase (Synthesis), G2 phase (Gap2) and finally M phase (Mitosis); cells which 
are not dividing e.g. either quiescent or senescent, exist outside the cycle in G0 
(Tyson et al., 2002). Progression through the cell cycle is tightly controlled by a 
series of activators and inhibitors at several positions (checkpoints) in the cycle 
that dictate cycle transition or arrest; dysregulation of these components often 
leads to uninhibited proliferation typical of most cancers (Maddika et al., 2007). 
In order to progress from G1 to S phase the cell cycle must first pass through the 
restriction point that separates two functionally different parts of G1. This part 
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of the cycle is activated by mitogenic signals e.g. growth factors and integrins; a 
loss of these signals results in the cell returning to G0 (Blagosklonny and Pardee, 
2002; Zetterberg et al., 1995).  
 
Mitogenic activation initiates the expression of cyclin D, which binds to a cyclin-
dependent kinase (Cdk). The cyclin-Cdk complex essentially drives the cell cycle 
and enables the phosphorylation of the retinoblastoma tumour suppressor Rb. In 
its hypo-phosphorylated form Rb is bound to E2F transcription factors preventing 
the transcription of E2F genes including cyclin E. Phosphorylation by cyclin D and 
Cdk4/6 causes Rb to dissociate from E2F leading to cyclin E expression (Ezhevsky 
et al., 1997; Ohtani et al., 1995). Cyclin E binds to Cdk2 resulting in the hyper-
phosphorylation of Rb maintaining it in a deactivate state; this marks a point in 
the cycle where mitogenic signals are no longer required to maintain progression 
and, once cyclin E and Cdk2 have reached threshold levels, the cells are able to 
enter S phase (Johnson and Walker, 1999). Cyclin A complexes with Cdk2 in early 
S phase then Cdk1 driving the cycle through G2 and into M phase which is mainly 
controlled by cyclin B (Lindqvist et al., 2007). M phase ends when cyclin A and B 
are degraded leading to a resetting of the cycle (Sudakin et al., 1995). 
 
 
Figure 1-6: The cell cycle. The cell cycle is divided into four main sections of growth not including G0 
where cells reside outside of the cycle in a quiescent or senescent state. Upon stimulation, cells enter into 
the G1 stage of the cycle where the cells grow in size and synthesise mRNA in preparation of DNA synthesis. 
Progression through the R point occurs only in the presence of mitogen activated cyclin D in complex with 
cdks4/6. Phosphorylation of the Rb protein enables cyclin E transcription and progression past the G1/S.  
 
 
ERK1/2 is vital to G0/G1 and G1/S progression as the absence of active signalling 
inhibits growth (Meloche and Pouysségur, 2007; Yamamoto et al., 2006; Pagès et 
al., 1993). Several studies have established that growth factor-mediated ERK1/2 
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controls the cell cycle by inducing high levels of cyclin D1 and typically proceeds 
in a biphasic manner with an initial high-level transient phase followed by a low-
level sustained phase (Jones and Kazlauskas, 2001; Meloche et al., 1992). Weber 
et al. observed a 10-16 fold increase in ERK1 activity roughly 15-30 minutes after 
IIC9 hamster embryonic fibroblasts were stimulated with platelet-derived growth 
factor; this was followed by a period of extended ERK activity at lower levels for 
15 hours. At the same time, cyclin D1 mRNA was seen to increase 5 fold around 4 
hours after stimulation and hold at 3-4 fold above quiescent levels for 24 hours; 
this trend was similarly seen at the protein level. Inhibiting ERK1 throughout G1 
led to a significant decrease in cyclin D1 and induced cell cycle arrest (Weber et 
al., 1997). Moreover, Yamamoto et al. identified a number of anti-proliferative 
genes suppressed in response to active ERK1/2 signalling. This down-regulation is 
essential for the transition through G1/S as failure to incite and maintain ERK1/2 
during G1 blocked S phase entry in mouse NIH3T3 cells (Yamamoto et al., 2006).  
 
Growth factor signalling alone however, is insufficient to induce ERK activity and 
requires concomitant signalling through the integrin-adhesion assembly. Similar 
to growth factors, integrin-mediated activation of ERK1/2 also regulates the cell 
cycle by up-regulating cyclin D1 expression and suppressing cell cycle inhibitors 
(Assoian and Schwartz, 2001; Huang et al., 1998). Integrins are linked to ERK1/2 
through the adhesion plaque, which contain many structural proteins and kinases 
including focal adhesion kinase (FAK). FAK forms a complex with Fyn, SOS, GRB2 
and Ras (Schlaepfer et al., 1998; Schlaepfer et al., 1994) where Ras initiates the 
activation of the MAP3 kinase Raf (Figure 1-5). Evidence that growth factors and 
integrin signalling are both required to achieve successful entry into S phase can 
be seen in Renshaw et al. Firstly, growth factor stimulation of suspended NIH3T3 
cells only weakly activated ERK2 whereas it was strongly activated in cells that 
were allowed to adhere, and secondly ERK2 activity recovered in suspended cells 
that were replated up to 24 hours after detachment (Renshaw et al., 1997). 
 
 
1.2.4 MAPK Directs Stem Cell Differentiation 
 
In addition to controlling the cell cycle, MAPK signalling also plays an important 
role in cell phenotype commitment. Studies using rat PC12 cell lines have shown 
that growth factors that induce the transient phase of ERK1/2 expression but not 
the sustained phase fail to initiate differentiation, whereas growth factors that 
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induce both the transient and sustained expression do (Mullenbrock et al., 2011; 
von Kriegsheim et al., 2009). Whether this extends to other cell types has yet to 
be established however, growth factor-induced ERK1/2 activity is also essential 
to ESC differentiation into mesodermal and especially neural lineages (Kunath et 
al., 2007; Stavridis et al., 2007).  
 
Since integrins are involved in cell-substrate anchorage and cytoskeletal tension 
(Bhadriraju et al., 2007), integrin-induced activation of ERK1/2 has been largely 
studied in relation to mechanical stress (Zhang et al., 2012; Kanno et al., 2007; 
Ward Jr et al., 2007). In fact, integrin signalling and subsequent ERK activation 
as a result of externally applied tension, supports tension-specific differentiation 
(Yim and Sheetz, 2012; Kilian et al., 2010; Engler et al., 2006). Integrin-induced 
activation of ERK1/2 is particularly linked to osteogenic differentiation (Kilian et 
al., 2010; Khatiwala et al., 2009; Jaiswal et al., 2000) as ERK1/2 stimulates the 
core binding factor alpha1 (CBFA1) transcription factor while also simultaneously 
suppressing the nuclear peroxisome proliferator-activated receptor PPAR! (Ge et 
al., 2009; Kanno et al., 2007; Adams et al., 1997; Hu et al., 1996). 
 
CBFA1, also known as runt-related transcription factor 2 (RUNX2), is essential to 
proper bone growth as demonstrated by Komari et al using CBFA1-mutated mice. 
In this work, CBFA1+/- pups developed a number of skeletal abnormalities while 
CBFA1-/- pups died shortly after birth due to a complete lack of bone ossification 
throughout most of the body (Komori et al., 1997). Similar work and results were 
reported in Otto et al. (Otto et al., 1997). An explanation for this can be found 
in Ducy et al. wherein the authors identified CBFA1 binding sites in the promoter 
region of most osteoblast-related genes including osteopontin (OPN), osteocalcin 
(OCN), bone sialoprotein (BSP) and collagen (COL) type I. Rat osteosarcoma cells 
transfected with CBFA1 antisense oligonucleotides led to a loss of COL type I and 
a marked reduction of OPN and OCN expression (Ducy et al., 1997).  
 
Several studies have shown that specifically targeting ERK or integrin signalling 
with inhibitors results in the loss of CBFA1 activity. Salasznyk et al. for instance 
confirmed that the knockdown of FAK using small interfering RNA (siRNA) inhibits 
ERK activity and subsequent phosphorylation of CBFA1. The transcription factor 
Osterix, alkaline phosphatase expression and calcium deposits in these samples 
were also inhibited (Salasznyk et al., 2007). Similarly, Shi et al. established that 
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FAK and ERK expression was greatest on stiff matrices compared to soft matrices 
but suppression of FAK or ERK resulted in a reduction in the down-regulation of 
both COL type I and OCN, while the loss of FAK similarly reduced ERK expression.  
 
Moreover, by inhibiting the Rho-associated kinase (ROCK); COL type I, OCN, FAK 
and ERK were all reduced suggesting ROCK is required to activate FAK and FAK is 
necessary to activate ERK (Shih et al., 2011). Finally, using a dominant negative 
ERK1 protein to inhibit the activity of ERK1, Lai et al. reported that cell growth 
was arrested and differentiation inhibited as confirmed by the reduction of COL 
type I, OPN and BSP compared. Interestingly, in addition to these observations, 
inhibiting ERK activity also impeded cell adhesion, spreading, migration and the 
expression of several integrins (Lai et al., 2001). In these examples osteogenesis 
was disrupted by a loss of FAK or ERK thus ERK signalling and the integrin/Rho/ 
ROCK pathway may synergistically coordinate osteogenesis. Furthermore, while 
cell adhesion, spreading and the generation of contractile forces activates MAPK 
via integrins in a process of outside-in signalling, Lai et al. showed that MAPK is 
also able to regulate these processes through inside-out signalling. Other signals 
that feed into MAPK can hence affect integrin and cytoskeletal dynamics through 
MAPK and influence cell growth and differentiation.  
 
Although CBFA1 is considered critical to osteogenesis, silencing PPAR! is equally 
important in establishing the osteogenic phenotype. As per CBFA1, PPAR! in the 
context of differentiation is a critical cell fate decider but unlike CBFA1 PPAR! is 
a regulator of adipogenesis (Tontonoz et al., 1994). In bone marrow MSCs, PPAR! 
inhibits osteogenesis by both up-regulating genes associated with adipogenesis, 
and down-regulating genes associated with osteogenesis (Shockley et al., 2009); 
it is also thought to contribute to a loss of stem cell stemness and induce ageing 
in these cells (Shockley et al., 2007). Thus by activating CBFA1 and suppressing 
PPAR!, ERK 1/2 acts to support osteogenic stem cell differentiation. 
 
 
1.2.5 The Stem Cell Niche 
 
The concept of a somatic stem cell niche was first introduced in 1978 to account 
for inconsistencies in stem cell immortality versus their limited self-replicating 
capacity in culture (Schofield, 1978). Niches are specialised microenvironments 
that maintain stem cells in a quiescent state and which also participate in their 
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activation. Examples of stem cell niches include bone marrow, intestinal crypts, 
hair follicle bulge and both the subventricular and subgranular zones of the brain 
(Fuchs et al., 2004). Niches act to maintain the stem cell population throughout 
the course of a person’s lifetime, and supply progenitor cells during tissue injury 
response through a process of symmetrical and asymmetrical division. While the 
former produces two identical daughter stem cells, the latter method produces 
one stem cell and a progenitor cell (Walker et al., 2009; Morrison and Spradling, 
2008; Morrison and Kimble, 2006).  
 
In order to effect this level of regulation, the niche environment must be able to 
provide certain stimuli through both physical and biochemical means to mediate 
these cues. Predictably, one of the markers of a stem cell niche is a high density 
of integrins (Jones and Wagers, 2008). It is presumed that integrins act to anchor 
the residing cells to the niche architecture, facilitate their movement between 
different regions of the niche, and provide mechanical information regarding the 
local environment (Jones and Wagers, 2008; O'Reilly et al., 2008; Tanentzapf et 
al., 2007). Integrins also determine the orientation of the mitotic spindles during 
mitosis dictating symmetrical or asymmetrical division (Toyoshima and Nishida, 
2007; Thery et al., 2005). Intrinsic signals from within the niche e.g. direct cell-
cell contact and secreted signalling molecules, and also extrinsic signalling from 
outside the niche e.g. inflammatory cytokines, also contribute to niche dynamics 
(Scadden, 2006; Li and Xie, 2005).  
 
 
Figure 1-7: Niche dynamics. Niches represent specialised microenvironments responsible for maintaining 
the residing stem cells in a quiescent state while also preparing them for differentiation and mobilisation in 
response to tissue remodelling and repair. In order to carry out this function it is proposed that the niche 
requires both localised and extrinsic signals such as a physical interaction between the niche architecture 
as well as certain paracrine, autocrine and neural signals (Scadden, 2006). 
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1.3 The Cytoskeletal Assembly and Integrins 
 
The eukaryotic cytoskeleton is essentially made up from three main components: 
microfilaments, microtubules and intermediate filaments (Fletcher and Mullins, 
2010; Janmey, 1998). Microfilaments are filamentous actin (f-actin) composed of 
two helical strands of polymerised globular actin measuring approximately 7 nm 
in diameter (Bremer and Aebi, 1992). In comparison, microtubules are composed 
of heterodimeric " and #-tubulin that polymerise end to end into protofilaments 
with around 13 protofilaments making up a hollow cylinder. Microtubules are the 
largest cytoskeletal filament with a diameter of 25 nm depending on the number 
of protofilaments within the tubule (Murphy et al., 2001; Burton et al., 1975).  
 
 
Figure 1-8: Cytoskeletal components. Upper panels display cartoon representations of the three types of 
cytoskeletal components. These are microtubules (left-hand panel), intermediate filaments (centre panel) 
and microfilaments (right-hand panel). In this image the intermediate filaments represent neurofilaments 
which are specific to neural cells (Fletcher and Mullins, 2010). Lower panels display immuno-fluorescence 
images of MSCs labelled for #-tubulin (left-hand panel), the intermediate filament vimentin (centre panel) 
and f-actin (right-hand panel). Fluorescence images are Roberts unpublished work and scale bar is 50 !m. 
 
 
While microfilaments and microtubules only contain one type of protein, several 
different types of proteins make up the intermediate filaments such as keratins, 
neurofilaments, desmin, vimentin, glial fibrillary acidic protein and the nuclear 
lamins (Fuchs and Weber, 1994). Intermediate filaments are approximately 10 
nm in diameter and, in contrast to both microfilaments and microtubules, they 
are not composed of individual globular monomers, but rather they are formed 
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from fibrous proteins (Kirmse et al., 2007; Herrmann and Aebi, 2004). Whereas 
most of the intermediate filaments exist within the cytoplasm, lamins form part 
of the nuclear lamina supporting the nuclear envelope, thus they are exclusively 
restricted to the cell nucleus (Stuurman et al., 1998). Together, the cytoskeletal 
filaments serve to maintain cell shape and stability, transmit mechanical forces 
into the nucleus, facilitate migration and coordinate the trafficking of organelles 
within the cell body.  
 
Cell shape is governed by the principles of tensional integrity (tensegrity). While 
tensegrity in an architectural sense was first described by R. Buckminster Fuller, 
it has also recently been used to explain cytoskeletal behaviour on the basis that 
the filamentous elements of the cytoskeletal scaffold exhibit cellular tensegrity 
(Ingber, 2008). The tensegrity model proposes that a cell mechanically stabilises 
its structure through tensile prestress where tensional forces generated by actin 
microfilaments and the intermediate filaments, are balanced by the microtubule 
network and cell-extracellular matrix (ECM) adhesions, which resist compression 
(Ingber, 1993). Because the cytoskeleton is coupled to the nucleus via the linker 
of nucleoskeleton and cytoskeleton (LINC) complex, changes in cell shape impact 
the nucleus and by extension, affects gene expression (Mellad et al., 2011). This 
continuous complex of fibres also coordinates the relocation of intracellular and 
membrane-bound organelles. Motor proteins such as myosin, dynein and kinesin 
use microfilaments and microtubules as tracks, which they walk along or tether 
organelles to (Vale, 2003).  
 
To carry out these functions the cytoskeleton must reorganise itself according to 
the specific needs of the cell. The formation, extension and dissociation of all of 
the cytoskeletal filaments enables cell spreading and mobility along a substrate. 
Monomeric components of microfilaments and microtubules (globular actin or g-
actin and tubulin respectively) polymerise in a unidirectional manner resulting in 
the filaments themselves having a polarised structure. G-actin monomers attach 
to microfilaments at the barbed (+) end and dissociate from the pointed (-) end 
(Holmes, 2009; Oda et al., 2009; Wegner, 1976). At the leading edge of the cell, 
microfilament growth and dissociation along with the assembly and disassembly 
of adhesion contacts creates a retrograde treadmilling of the microfilaments and 
promotes forward movement (Gardel et al., 2008; Ponti et al., 2004).  
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1.3.1 Stress Fibres 
 
In order to generate the tractional forces necessary for spreading and migration, 
multiple actin microfilaments are bundled together into stable structures known 
as stress fibres. Stress fibres are composed of 10-30 actin filaments cross-linked 
by actin binding proteins including myosin (Pellegrin and Mellor, 2007; Cramer et 
al., 1997). Several recent reviews have divided stress fibres into ventral, dorsal, 
transverse arc and perinuclear cap (Burridge and Wittchen, 2013; Tojkander et 
al., 2012). Ventral stress fibres are composed of highly contractile actomyosin 
bundles that lie along the base of the cell and are tethered at both ends by focal 
adhesions. Dorsal stress fibres on the other hand do not contain myosin (thus are 
not contractile), are anchored at one end to a focal adhesion, and attached to a 
transverse arc at the opposite end. Transverse arcs themselves are curved actin 
bundles that contain myosin but are not fixed at any point to adhesion contacts 
(Hotulainen and Lappalainen, 2006; Small et al., 1998). Perinuclear stress fibres 
are situated above the nucleus maintaining its shape and position within the cell 
with respect to overall cell shape (Khatau et al., 2009).  
 
 
Figure 1-9: Stress Fibres. Stress fibres are composed of actin filaments and can be grouped into 4 subtypes 
e.g. dorsal, transverse arc, ventral and perinuclear stress fibres (Tojkander et al., 2012). Right hand panel 
is an immuno-labelled MSC annotated with coloured lines depicting examples of dorsal (3x dark blue lines), 
transverse arc (1x light blue lines) and ventral (3x white lines) stress fibres. Other colours are red (actin), 
green (vinculin) and blue oval (nucleus). Image is Roberts unpublished work; scale bar is 25 !m. 
 
 
The contractile properties of the actomyosin assembly induce contractile forces 
in the cell body generating propulsive forces at the leading edge of the cell and 
retraction forces at the rear edge (Vicente-Manzanares et al., 2007). Moreover, 
stress fibres act as viscoelastic cables to structurally reinforce the cell body and 
balance these forces across the whole cell (Kumar et al., 2006). Because stress 
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fibres are attached to the ECM through integrins, they dynamically reorganise in 
response to mechanical changes in the surrounding ECM. Therefore, in addition 
to promoting tractional forces and stabilising cell shape, stress fibres along with 
ECM adhesions, form part of the mechanotransduction machinery responsible for 
modulating cell function (Guolla et al., 2012). 
 
 
1.3.2 The Extracellular Environment  
 
Contact between cells and the ECM is paramount to their survival since without 
it cells suffer from anoikis (homelessness) a form of programmed cell death. The 
in vivo matrix is a complex and hierarchical microenvironment largely composed 
of an interlocking meshwork of glycoproteins, proteoglycans and soluble growth 
factors that define the physiochemical properties of the ECM, and also provides 
structural support to neighbouring cells (Hynes, 2009; Daley et al., 2008; Bosman 
and Stamenkovic, 2003). Far from being inert, extensive research has shown that 
communication between cells and their matrix modulates key cellular processes 
(Frantz et al., 2010; Reilly and Engler, 2010).  
 
As well as binding growth factors, many of the fibril proteins (collagens, laminins 
and fibronectin etc) contain recognition sequences known as matrikines that are 
involved in cell adhesion and migration, fibril assembly and signal transduction 
(Hynes and Naba, 2012; Kim et al., 2011; Ricard-Blum and Ballut, 2011; Schultz 
et al., 2011; Davis, 2010; Wierzbicka-Patynowski and Schwarzbauer, 2003). Fibril 
matrikines are exposed via cell–mediated events thus the reciprocal relationship 
between cells and the ECM can result in localised and large-scale changes to the 
ECM architecture and composition that in turn affects cell behaviour (Hynes and 
Naba, 2012; Silva et al., 2012; Mwenifumbo and Stevens, 2007). This perception 
of the ECM state is mediated by force-dependent mechanotransduction. 
 
Mechanotransduction is the conversion of physical forces into biochemical signals 
resulting in changes to gene expression (Ingber, 2006; Chen et al., 2004). Output 
responses are elicited by two types of mechanotransduction involving integrins. 
In direct mechanotransduction, changes in the mechanical properties of the ECM 
alter gene expression through tension-specific reorganisation of the cytoskeleton 
and nucleoskeleton leading to a redistribution of chromosomal DNA (Dahl et al., 
2008). In indirect mechanotransduction, integrins initiate intracellular signalling 
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cascades such as MAPK thereby altering gene expression by specific transcription 
factors (Hoffman et al., 2011; Schwartz, 2010; Wang et al., 2009).  
 
 
1.3.3 Integrins 
 
Integrins are heterodimeric transmembrane receptors containing non-covalently 
bound "# subunits. In humans there are 18 " subunits and 8 # subunits that can 
combine to form 24 "# combinations. Each dimer consists of an extracellular 
domain, single-spanning transmembrane domain and a short cytoplasmic domain 
linking the cytoskeleton to the ECM (Ivanska, 2012; Hynes, 2002). Two seperate 
subfamilies can be distinguished between by differences in their " subunits. Nine 
of the " subunits ("* in Figure 1-10) contain an extra structure incorporating an 
inserted "I domain, which forms the primary ligand-binding site for all of the "I 
integrins. In "I-less integrins ligand binding is solely replaced by the #I domain 
within the # subunit (Schwartz, 2010; Xie et al., 2010; Luo and Springer, 2006).  
 
Integrins bind external ligands within the ECM establishing a direct link between 
cells and their extracellular surroundings (Kanchanawong et al., 2010; Delon and 
Brown, 2007; Humphries, 2000). It is through these transmembrane contacts that 
integrins can transfer extracellular signals across the cell membrane (Hanein and 
Horwitz, 2012; Bershadsky et al., 2006). In doing so integrins are fundamental to 
many biological functions including those already discussed in previous sections 
(Colello et al., 2012; Gardel et al., 2010; Streuli, 2009; LaFlamme et al., 2008). 
 
 
Figure 1-10: Integrin classification. Integrin " and # subunits combine to form 24 distinct heterodimers 
that can be divided into subfamilies by differences in their primary ligand binding sites ("I versus #I) and 
ligand affinity e.g. collagen, laminin and fibronectin (RGD receptors). Left hand panel shows "# pairings 
divided by ligand affinity; pairings with "* refer to "I containing " subunits (Hynes, 2002). Right hand panel 
shows a cartoon representation of integrins of "I containing subunits (left) and "I-less subunits (right). 
Domain labels are as described in Figure 1-11, adapted from (Luo and Springer, 2006). 
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1.3.4 Integrin-Ligand Binding 
 
Integrin-ligand binding is universally regulated by divalent metal cations (Raborn 
et al., 2011; Valdramidou et al., 2008). Crystallography and electron microscopy 
studies of "I-less # subunits have localised these cations (Mg2+, Mn2+ and Ca2+) to 
three neighbouring metal ion sites within the #I binding domain. These sites are 
referred to as the metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS 
(ADMIDAS) and the synergistic metal ion binding site (SyMBS, formerly the ligand-
induced metal bind site LiMBS) (Dong et al., 2012; Zhang and Chen, 2012; Zhu et 
al., 2008). Cation occupancy coordinates the pairing of "# subunits, directs the 
intracellular trafficking of integrins and the folding/unfolding of integrins during 
the transition from inactive to ligand-bound (Raborn and Luo, 2012).  
 
 
Figure 1-11: Integrin conformational states. In their low-affinity state integrins adopt a bent position with 
the head domain toward to the membrane surface concealing the ligand-binding site (closed headpiece, 
bent). Extension of the subunits exposes the ligand-binding domain resulting in a ‘primed’ state allowing 
interaction with extrinsic ligands but not full binding (closed headpiece, extended). Structural changes to 
the ligand-binding domain of the #1 sub-domain and overall integrin structure enable ligand binding (open 
headpiece, extended). Figure shows the low-affinity, high-affinity and ligand-bound structures for "I-less 
integrins (Luo and Springer, 2006). 
 
 
Investigations into integrin structure have revealed three distinct conformations 
related to their activation state (Figure 1-11). In the low affinity state, integrins 
exist in a bent configuration, which can extend and adopt an open conformation 
when bound to a ligand (Campbell and Humphries, 2011; Wang and Luo, 2010; 
Luo and Springer, 2006). For "1-less integrins, this rearrangement occurs as a 
consequence of tertiary and quaternary changes to the global integrin structure 
induced by alterations to the MIDAS, ADMIDAS and SyMBS domains. For example, 
studies involving the binding of RGD revealed the arginine residue positions into 
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a cleft within the integrin " subunit while the aspartic acid residue coordinates 
to the Mg2+ cation of the MIDAS core within the # subunit. This causes localised 
displacement of the MIDAS core and destabilisation of ADMIDAS resulting in steric 
changes to the # hybrid domain and subsequent separation of the "# subunits to 
the extended-open configuration (Nagae et al., 2012; Wang et al., 2010; Takagi, 
2007; Xiong et al., 2002). Dissociation of the "# leg domains during extension is 
necessary for establishing integrin activation and the propagation of intracellular 
signalling processes. Mutations that prevent "# detachment maintain integrins in 
an inactive state resulting in poor adhesion formation, cell spreading and stress-
fibre formation (Askari et al., 2010; Zhu et al., 2007; Lu et al., 2001). 
 
 
1.3.5 The Adhesion Assembly 
 
Ligand binding triggers integrin clustering and the formation of adhesion plaques 
– large multimolecular structures connecting the integrin cytoplasmic domains to 
the actin cytoskeleton (Wehrle-Haller, 2012; Geiger and Yamada, 2011; Barczyk 
et al., 2010). Adhesion formation serves to both anchor cells to their surrounding 
matrix, and to transmit regulatory signals between the cell and ECM. During the 
initial stages of attachment transient focal complexes (<1 !m in length) develop 
at the leading edge of the cell lamellipodia (Alexandrova et al., 2008; Nobes and 
Hall, 1995) allowing cells to spread and migrate. Focal complexes rapidly form 
and dissociate as the leading edge advances however a small percentage mature 
into larger adhesions (1-5 !m in length) at the lamellipodium-lamellum interface 
(Ciobanasu et al., 2012; Vicente-Manzanares et al., 2009; Ridley and Hall, 1992). 
Maturation of focal complexes into fully developed focal adhesions corresponds 
with their localisation to the periphery of actin stress fibres and the recruitment 
of additional proteins to the adhesion plaque particularly the GTPases RhoA and 
"-actinin during myosin II dependent contractility and f-actin cross-linking (Choi 
et al., 2008; Chrzanowska-Wodnicka and Burridge, 1996; Ridley and Hall, 1992; 
Bershadsky et al., 1985). Focal adhesions in turn, can also mature into "5#1-rich 
fibrillar adhesions, which attach to fibronectin fibrils via the synergy binding site 
and are important in ECM remodelling (Friedland et al., 2009; Faucheux et al., 
2006). The transfer of physical and chemical information through adhesion sites 
relies primarily on the molecular make-up of the adhesion assembly owing to the 
fact integrins themselves lack any intrinsic enzymatic activity.  
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Figure 1-12: Adhesion formation. Focal complexes develop at the leading edge of cells lamellipodia where 
they either disassemble during normal adhesion turnover or mature into focal adhesions at the lamellum 
interface. Left hand panel depicts newly formed focal complexes (nascent adhesions) and f-actin organised 
into large bundles at the interface and terminating in focal adhesions; adapted from Vincente-Manzanares 
et al., 2009. Right hand panel shows an enlarged section of a MSC immuno-stained for f-actin (red) and 
vinculin (green). Vinculin staining of adhesions clearly shows small focal complexes at the leading edge 
with larger adhesions further back. Roberts unpublished work; Scale bar is 10 !m. 
 
 
The adhesion assembly itself is extensive, consisting of actin and integrin binding 
proteins in addition to a diverse range of interconnecting adaptor and signalling 
proteins (Wolfenson et al., 2013; Geiger and Zaidel-Bar, 2012; Zamir and Geiger, 
2001). While the complete ‘integrin adhesome’ is still being constructed, current 
research by the Geiger and Iyengar laboratories estimates there to be as many as 
180 intrinsic and associated components forming 742 intermolecular connections 
(Zaidel-Bar and Geiger, 2010; Zaidel-Bar et al., 2007; Zaidel-Bar et al., 2004; 
Zaidel-Bar et al., 2003). The number of combinations is such that recruitment to 
the adhesion plaque is likely dependent on feedback mechanisms that determine 
activation of individual components in a spatiotemporal manner relative to the 
signalling pathways involved (Geiger and Zaidel-Bar, 2012; Hanein and Horwitz, 
2012; Zaidel-Bar and Geiger, 2010; Zaidel-Bar et al., 2007).  
 
The exact molecular events following integrin activation are as yet unresolved 
leaving the order in which these proteins assemble open to debate. Nonetheless, 
it is largely accepted that the structural proteins talin, vinculin and paxillin, and 
signalling kinases such as integrin-linked kinase and FAK are some of the earliest 
proteins to localise to focal complexes, while zyxin and tensin are incorporated 
later (Lawson et al., 2012; Critchley and Gingras, 2008; Campbell and Ginsberg, 
2004; Kim et al., 2003; Zaidel-Bar et al., 2003; Nikolopoulos and Turner, 2001). 
Talin particularly appears to be essential for early adhesion dynamics. Activated 
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and recruited to the plasma membrane by the phospholipid PIP2, talin binds to 
both distal and proximal regions of the # membrane domain thereby maintaining 
separation of the "# subunits (Gingras et al., 2010; del Rio et al., 2009; Goksoy 
et al., 2008; Wegener et al., 2007; Gingras et al., 2005; Garcia-Alvarez et al., 
2003). As talin also contains binding domains for f-actin in addition to vinculin 
and FAK, it is one of few proteins able to directly link with both integrins and 
the actin cytoskeleton. Cross-linking is further stabilised by its interaction with 
vinculin, which is also able to bind actin and "-actinin (Scales and Parsons, 2011; 
Ziegler et al., 2006).  
 
 
Figure 1-13: The adhesome network. The network depicts 156 intrinsic and associated components of the 
integrin adhesome assembly, which include both cytoskeletal and actin-binding proteins and a large number 
of adaptor proteins. Each individual component is capable of connecting to several other members of the 
adhesion complex with a high level of complexity suggesting the adhesome operates in a switchable manner 
depending on the pathways being triggered. Data was correct at time of publishing however the number of 
components now stands at 180 with 742 individual interactions. Red arrows refer to directional activation 
and blue arrows directional inhibition while black lines indicate binding partners. See original reference for 
colour -coded key (Zaidel-Bar et al., 2007). 
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Deciphering the entire adhesion architecture appears unlikely given its complex 
and fluidic nature though certainly many of the major pathways will no doubt be 
extensively characterised. Using super-resolution microscopy, Kanchanawong et 
al. were able to postulate the existence of a number of protein-specific strata 
vertically separating integrins from the actin cytoskeleton by approximately 40 
nm. Of note was an integrin-signalling layer containing FAK and paxillin, a force- 
transduction layer incorporating talin and vinculin, and an actin-regulatory layer 
that included zyxin (Kanchanawong et al., 2010). These protein-specific strata 
elegantly support studies that have used protein-protein interactions to infer the 
molecular structure of the adhesion assembly (Legg, 2010). 
 
 
Figure 1-14: Focal adhesion architecture. Schematic depicts experimentally determined protein position 
within the adhesion assembly identifying several protein-specific strata. FAK and paxillin form a membrane 
proximal layer involved in signal transduction while talin and vinculin are activated by force-dependent 
mechanisms and are involved in force transduction. Adapted from Kanchanawong et al., 2010. 
 
 
1.3.6 Integrins in Cytoskeletal Contractility 
 
As indicated in section 1.3.2, integrins are central to mechanotransduction by 
propagating physical forces through the cytoskeleton, and by initiating specific 
signalling pathways (Hoffman et al., 2011; Schwartz, 2010). During cytoskeletal 
contraction, attachment of integrins to the ECM leads to a reorganisation of the 
cytoskeletal assembly and activation of the GTP binding proteins Rac and Cdc42 
involved in the shaping of lamellipodia, filopodia and focal complexes (Price et 
al., 1998; Nobes and Hall, 1995). Forces generated in the actin network provoke 
resistive forces in the ECM at adhesion contacts, which loop back into the actin 
cytoskeleton. This feedback is responsible for inducing additional tension in the 
cell body by recruiting guanine exchange factors and up-regulating RhoA and the 
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Rho-associated kinase ROCK (Guilluy et al., 2011; Ridley and Hall, 1992); ROCK 
in turn regulates myosin II activation (Amano et al., 1996). Non-muscle myosin II 
(NM II) is a hexomeric motor protein containing two heavy chains, two essential 
light chains and two regulatory light chains (Sellers, 2000). In its inactive form, 
NM II exists in an auto-inhibited conformation preventing myosin-actin binding. 
Phosphorylation of the regulatory light chains (MRLC) releases the auto-inhibited 
form allowing the hexomer to extend and assemble into bipolar microfilaments, 
which can then interact with actin filaments (Vicente-Manzanares et al., 2009; 
Craig et al., 1983). Phosphorylation and activation of NM II is critical to tension-
specific reorganisation of the cytoskeleton through NM II’s association with actin 
(actomyosin complex). The contractile forces of NM II promote the bundling of f-
actin into stress fibres and the elongation of focal complexes to focal adhesions 
(Bhadriraju et al., 2007; Polte et al., 2004).  
 
 
 
 
Figure 1-15: Cytoskeletal tension. NM II exists as an auto-inhibited dimer unable to associate with other 
myosin filaments (10S NM II). Phosphorylation of the MRLC triggers extension (6S NM II) allowing multiple 
myosin-dimers to bind to actin (upper panel, Vincente-Manzanares et al., 2009). Lower panels show an MSC 
immuno-labelled for actin (red) and phosphomyosin (green). Right-hand panel is a composite of actin and 
phosphomyosin with nucleus in blue. Higher expressions of phosphomyosin coincide with tightly bundled 
stress fibres at sites of increased tension (yellow). Roberts unpublished work; scale bar is 50!m. 
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1.4 Biomaterials 
 
Biomaterials are described as substrates intended to be used to treat, augment 
or even replace damaged tissues (Williams, 2009). Since their initial conception, 
the types of material used in their design, their function and level of complexity 
have all evolved. Modern biomaterials have been used in a therapeutic capacity 
for more than 50 years; but while prosthetic implants have been invaluable in 
substituting damaged tissues since the 1960s, their biological inertness restricts 
their use in alternative areas of restorative medicine. In 1998, Professor Hench 
proposed biomaterial research should concentrate on tissue regeneration rather 
than tissue replacement (Hench, 1998; Hench, 1980) hence there became a need 
for biomaterials to move away being bioinert and toward being bioactive. Today, 
biomaterials underpin most tissue regeneration strategies, and while prosthetics 
implants are still necessary to replace damaged joints, resorbable scaffolds, and 
materials engineered to direct stem cell fate are now part of the repertoire (Cha 
et al., 2012; Chen et al., 2012; Hench and Thompson, 2010; Shoichet, 2009; 
Navarro et al., 2008; Nair and Laurencin, 2007). 
 
 
1.4.1 Surface Modification of Biomaterials 
 
The success of any implant is fundamentally dependent on how well endogenous 
proteins and cells communicate with the substratum interface, a process largely 
governed by the chemical composition of the material itself (Jeong and Kohane, 
2011; Nath et al., 2004; Dee et al., 2003). Surface functionality in particular has 
a prominent role in determining the extent to which a material integrates with a 
biological system. Immediately after implantation, proteins adsorb onto exposed 
surfaces in a manner directed by the underlying properties of the material (Rabe 
et al., 2011; Nath et al., 2004). Wettability for example, affects protein folding, 
orientation and electrostatic state, which consequently influences cell adhesion 
and subsequent responses (Oliveira et al., 2012; Wilson et al., 2005; Keselowsky 
et al., 2003; Webb et al., 1998).  
 
The composition of this proteinaceous film is subject to change over time due to 
the competitive displacement of early-adsorbed proteins, typically those of low 
molecular weight and those in high abundance, by proteins adsorbed later with a 
stronger binding affinity for the surface- the Vroman effect (Vroman and Adams, 
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1969a; Vroman and Adams, 1969b). The process by which one protein exchanges 
another at the surface is still debated however Hirsh et al. used a combination 
of quartz crystal microbalance-dissipation, atomic force spectroscopy and mass 
spectrometry to determine that a transient complex forms between proteins on 
a mildly hydrophobic polystyrene substrate (Hirsh et al., 2013). In this process, a 
protein embeds itself within the latticework of a protein already adsorbed to the 
surface, this complex then turns and the first protein layer is displaced (Heinrich 
et al., 1996). The type of protein adsorbed to the surface is important, as some 
proteins are known to promote cell attachment whereas others are anti-adhesive 
(Curtis and Forrester, 1984). More importantly, the properties of the biomaterial 
itself and of the adsorbed protein layer, affect the compatibility of an implanted 
device with the surrounding host tissue so both must be carefully controlled. 
 
Modifying the surface properties of a material is an effective means of altering 
substrate functionality without undermining the bulk properties of the material. 
Combining concepts from nanotechnology, cell biology and surface science; third 
generation materials are both biocompatible (able to elicit a desirable biological 
response without resulting in toxicity (Williams, 2008; Williams, 2003)), and also 
biologically functional (Hench and Thompson, 2010; Hench and Polak, 2002). The 
recent emergence of biomimetic modifications has seen a shift in the design of 
biomaterials toward materials that mimic particular aspects of the ECM e.g. its 
composition, architecture and dynamic nature (Kim et al., 2012; de la Rica and 
Matsui, 2010; Roy et al., 2010; von der Mark et al., 2010; Shin et al., 2003).  
 
 
1.4.2 Incorporating Biomimetic Properties into Biomaterials  
 
Incorporating one or more ECM-like features into the design of mimetic materials 
is an established approach for furnishing otherwise inert surfaces with biological 
functionality similar to that of the cell matrix. Examples of mimetic modification 
include the addition of micro- and nanoscale topographies to substrates in order 
to mimic topographical features present within the ECM (McMurray et al., 2011; 
Biggs et al., 2010; Dalby et al., 2007a), replicating the viscoelastic properties of 
specific tissue matrices (Tse and Engler, 2011; Pek et al., 2010; Engler et al., 
2006), controlling growth factor release from hydrogels and resorbable scaffolds 
(Park et al., 2011; Sun et al., 2011; Wylie et al., 2011; Yamamoto et al., 2001), 
and selectively targeting cell surface receptors with mimetic ligands (Rahmany 
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and Van Dyke, 2012; Kammerer et al., 2011; Shekaran and García, 2011). Stimuli 
responsive materials (SRMs) also simulate ECM plasticity by altering the physical 
or chemical properties of a system using an externally applied stimulus. Systems 
that change size, shape and cell adhesiveness have all recently been reported in 
literature using triggers ranging from light and temperature to ionic strength, pH 
and enzymes to initiate these changes (Qin et al., 2013; Chen et al., 2011; Chan 
et al., 2008; Todd et al., 2007; Auernheimer et al., 2005; Ebara et al., 2004). 
 
 
1.4.3 Mimetic Ligands to Control Cell Behaviour 
 
While there are many ways of introducing mimetic features into the design of a 
material, targeting cell surface receptors with ECM ligands satisfies the demand 
for materials that are biomimetic, and the need for molecular-level control over 
their intended function. Such materials not only allow us to examine cell-surface 
events, but also enable us to improve current surface modification strategies. As 
most cell-matrix contacts are mediated by integrin receptors, much of the work 
carried out to date has involved mimetic peptides that represent integrin ligands 
such as RGD, GFOGER and DGEA (Liu et al., 2011; Sànchez-Cortes and Mrksich, 
2011; Yoon and Mofrad, 2011; Sànchez-Cortes et al., 2010; Harbers and Healy, 
2005). Immobilising these ligands onto a non-fouling support prevents proteins 
adsorbing to the surface so that cell-substrate interactions are fostered only by 
the ligand and target receptor (Werner and Garcia, 2006).  
 
The rationale behind functionalising surfaces with oligopeptides rather than full-
length ECM proteins has been widely debated. Although peptide ligands tend to 
be limited to a single function e.g. adhesion, both the amino acids and peptides 
used in the design of these ligands can be commercially obtained at high purity 
yields, are chemically well-defined, and easily modified with protecting groups 
for use in peptide synthesis (Barker, 2011; Bellis, 2011; Collier and Segura, 2011; 
Williams, 2011). Full-length proteins on the other hand are not as easily defined. 
Proteins contain multiple functional domains and the availability of these ligands 
at the surface interface is often inconsistent due to random folding and variable 
adsorption (Rabe et al., 2011; Mrksich, 2000). 
 
The ability to control ligand type and spatial distribution is essential to peptide-
presenting surfaces. Surface receptors are specialised proteins that fulfil unique 
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and specific functions governing all basic cell processes (Deller and Jones, 2000); 
the presented ligand therefore determines functional response depending on its 
corresponding receptor. Ligand spacing is particularly important in cell adhesion 
and spreading, a number of investigations have shown spacing is critical to the 
formation of stable adhesions, spreading, migration and cell stiffness. Members 
of the Spatz group for example have identified a critical ligand spacing of 53-75 
nm beyond which adhesion formation and cell spreading is reduced in REF52 rat 
fibroblast cells (Cavalcanti-Adam et al., 2007; Cavalcanti-Adam et al., 2006). In 
contrast, Massia and Hubbell found that a ligand spacing of 140 nm was required 
to induce focal adhesion formation and the organisation of stress fibres in human 
foreskin fibroblasts. A spacing of 440 nm was required to mediate cell spreading 
(Massia and Hubbell, 1991). Wang et al. also suggest ligand spacing is important 
in deciding osteogenic and adipogenic commitment of MSCs (Wang et al., 2013). 
By using self assembled monolayers (SAMs), both ligand type and distribution can 
be controlled to a relatively high degree (Mrksich and Whitesides, 1996).  
 
 
Figure 1-16: Biomimetic ligands. Peptide ligands designed to affect specific cell surface receptors can be 
immobilised to the material surface using bioinert linkers that prevent protein adsorption. Cell interactions 
are maintained by the specificity of the ligand, thus cells are able to adhere to biomaterial substrates in a 
controlled manner. Figure depicts a cartoon representation of a cell adhesion ligand (purple circle) grafted 
to a solid support via a bioinert linker (black lines). Adhesion receptors on the cell surface (green arches) 
are able to bind to these ligands and facilitate cell attachment and spreading.  
 
 
1.4.4 Self Assembled Monolayers 
 
SAMs form when bifunctional molecules adsorb to the surface of a material. The 
SAM head-group dictates substrate affinity while the alkyl backbone determines 
molecular packing, and the end-groups establish functionality. As such, SAMs are 
highly ordered monolayers chemically and spatially defined by the properties of 
the individual adsorbates (Gooding and Ciampi, 2011; Vericat et al., 2010). Thiol 
and siloxane-based SAMs are the two most commonly used monolayers in surface 
Chapter 1: General Introduction 
30 
modification strategies. Thiols readily adsorb to gold and other metals materials 
through the sulphur head-group whereas siloxane SAMs adsorb to mica, glass and 
metal oxides via the methoxy group (Haensch et al., 2010; Love et al., 2005). 
 
 
Figure 1-17: Self-assembled monolayers. Alkanethiol SAMs on gold and alkylsiloxane SAMs on silica/glass 
are two main types of SAMs. Thiol SAMs (left) adsorb to gold substrates via the thiol (SH) head group while 
the alkyl chains extend outwards away from the surface. Siloxane SAMs (right) are typically prepared with 
trimethoxysilanes, which covalently attach to hydroxyl groups on silica and silica-like substrates. The Si-O 
bond can also form between adjacent molecules forming a network of cross-linked siloxane chains. End 
groups (X) can be tailored with different chemical moieties and serve as anchor points for other molecules. 
 
 
SAMs are widely used to control the surface chemical properties of a material, 
and as such have become an important tool for investigating interfacial dynamics 
(Pulsipher and Yousaf, 2010; Mrksich, 2009). Using SAMs with two different end-
groups, Li et al. were able to manipulate protein adsorption and cell adhesion. 
Similarly, Faucheux et al. also demonstrated the impact of different end-group 
chemistries on cell adhesion, spreading and viability concluding that, while some 
chemical moieties encourage cell adhesion and growth, others are less favoured 
(Li et al., 2013; Faucheux et al., 2004). SAMs containing bioinert backbones are 
routinely used to covalently attach peptides, enzymes and other biomolecules to 
a surface thereby extending their range of functionality and application (Hudalla 
and Murphy, 2009; Wittmann et al., 2005; Patel et al., 1997).  
 
 
1.4.5 Solid Phase Peptide Synthesis 
 
Functionalising SAMS with peptides can be carried out by building the chain one 
amino acid at a time directly onto the monolayer, or by synthesising the whole 
peptide separately and attaching it to the monolayer when completed. The basic 
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principles of peptide synthesis involve the formation of an amide bond between 
the amine group of one amino acid monomer and the carboxyl group of a second 
amino acid to build up the peptide chain (Bodanszky, 1984). Assembling peptides 
directly onto a solid support can be carried out using solid-phase synthesis. 
 
 
Figure 1-18: Principles of peptide synthesis. Peptides are formed via a series of dehydration reactions 
(loss of water) between the amine group of one amino acid and the carboxyl group of another (blue). Figure 
demonstrates the reaction of two amino acids to form a dipeptide resulting in the loss of a water molecule. 
R stands for R-groups signifying amino acid side chains.  
 
 
The success of solid-phase peptide synthesis (SPPS) is largely credited to Robert 
B. Merrifield whose 1964 paper transformed peptide synthesis (Merrifield, 1964). 
Since its initial conception SPPS has undergone several refinements, however the 
major principles remain much the same. N-protected amino acids are covalently 
attached to a solid support via an amine-functionalised linker which enables the 
peptide chain to be built up through repeated cycles of amino acid coupling and 
removal (deprotection) of the protecting group (Amblard et al., 2006; Merrifield, 
2006). During synthesis, n-terminal protecting groups such as t-butyloxycarbonyl 
(Boc) and 9-fluorenylmethoxycarbonyl (Fmoc), prevent amino acids polymerising 
with each other in situ, since the peptide bond cannot be formed while they are 
conjugated to the protecting groups. Functional groups present on the side chain 
are also often conjugated to protecting groups to prevent unwanted non-specific 
reactions (Orain et al., 2002; Fields et al., 1992).  
 
 
Figure 1-19: N-terminal protecting groups. N-protecting groups such as Boc and Fmoc are routinely used 
in SPPS to prevent the random polymerisation of amino acids in solution. Boc and Fmoc represent the two 
main protecting groups while Cbz is now often restricted to side chain protection. Black chemical groups 
and bond lines refer to the core amino acid structure while coloured bonds belong to the protecting group. 
!
HOH 
+ 
! !
Butyloxycarbonyl (Boc)   Fluorenylmethoxycarbonyl (Fmoc)   Benzyloxycarbonyl (Cbz) 
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SPPS can be carried out using either Boc or Fmoc n-protecting groups. Boc is acid 
sensitive so it is removed using trifluoroacetic acid while side chain protecting 
groups are cleaved with hydrogen fluoride and other hydrohalides (Anderson and 
McGregor, 1957; McKay and Albertson, 1957). Fmoc is base-labile which enables 
milder deprotection stages without the need for harsh acids and neutralisation 
steps as per Boc synthesis (Carpino and Han, 1972; Carpino and Han, 1970). The 
combination of base- and acid-labile protecting groups in Fmoc SPPS enables an 
orthogonal approach to deprotection strategies that allows the Fmoc group to be 
removed but does not affect side chain protecting groups. This also works in the 
opposite direction where Fmoc is stable under the acidic conditions required to 
remove side chain protectors (Merrifield, 2006).   
 
 
Figure 1-20: Solid phase peptide synthesis. N-protected (Fmoc) amino acids can be covalently coupled to 
surface tethered amine groups in the presence of activating groups such as DIC and Oxyma. Removal of the 
Fmoc moiety during deprotection stages is carried out under basic conditions using 20% piperidine (diagram 
shows the resulting cleavage of the Fmoc group as a dibenzofulvene adduct). This enables additional amino 
acids to be couple to the free amine terminus. Repeated cycles of coupling and deprotection stages permit 
the stepwise building up of long-chained oligopeptides. 
!
Fmoc protected 
amino acid 
Cleaved Fmoc 
group 
Coupling 
Deprotection 
Surface-tethered 
amine functionalised 
linker 
Fmoc terminating 
chain 
DIC / Oxyma 
20% Piperidine 
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1.5 Project Rational and Aims 
 
The absence of predictable stem cell differentiation in vitro currently presents a 
major challenge for stem cell-based therapeutics. Stem cells are regulated by an 
elaborate network of intracellular signalling pathways and environmental cues. 
Hence there is an exhaustive volume of literature dedicated to identifying these 
pathways. One of the mechanisms identified as a potential driving force behind 
stem cell differentiation is cytoskeletal tension. In two separate studies McBeath 
et al. and Killian et al. determined cell shape and cytoskeletal tension induced 
MSC differentiation by effecting changes in RhoA and ROCK expression (McBeath 
et al., 2004) and MAPK and Wnt signalling pathways (Kilian et al., 2010). In both 
examples MSCs that exhibited a well spread morphology with pronounced stress 
fibres expressed phenotypic markers consistent with an osteogenic commitment, 
whereas cells that were poorly spread underwent adipogenesis. Osteogenic cells 
were found to have increased levels of RhoA and ROCK, MAPK and wingless type 
(Wnt)-related genes correlating with lower levels in MSCs that were adipogenic. 
Similarly, Ward et al., observed an up-regulation of the osteo-specific markers 
OCN and BSPII, and a down-regulation of other lineage-specific markers in MSCs 
subjected to a mechanical strain (Ward Jr et al., 2007). Thus higher contractile 
forces in the cytoskeleton influence MSC differentiation along an osteogenic line 
while very low levels result in adipogenesis.  
 
Further evidence for this is seen in studies relating to matrix elasticity, integrins 
and the adhesion assembly. As discussed in section 1.3.6, cytoskeletal tension is 
intimately linked to the formation of adhesion plaques, feedback from the ECM, 
phosphorylation of the MLRC and formation of actin stress fibres (Chrzanowska-
Wodnicka and Burridge, 1996; Burridge and Chrzanowska-Wodnicka, 1996). The 
bidirectional transduction of mechanical forces through integrins means internal 
and external forces can engender changes in integrin clustering and the adhesion 
composition. Matrices with relatively inelastic compositions exert greater forces 
than those that are softer; this force is then applied to the cytoskeletal network 
increasing contractile tension in the cell body. Unsurprisingly, MSCs cultured on 
stiff matrices similar to that of collagenous bone have been shown to prefer an 
osteogenic lineage while those on softer matrices prefer neuronal and myogenic 
lineages (Engler et al., 2006). Altering adhesion formation through topographical 
influences has also been shown to affect the differential capacity of MSCs. Dalby 
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and co-workers have reported on several occasions that MSCs cultured on certain 
nano-patterned polymers develop large fibril-like adhesions, and that these cells 
express genes associated with MAPK and Wnt-mediated osteogenesis (Biggs et 
al., 2009a; Biggs et al., 2009b), and osteo-specific proteins e.g. OPN and OCN 
(McMurray et al., 2011; Dalby et al., 2007b).  
 
The focus of this thesis is to examine the relationship between MSC morphology, 
tension and adhesion formation in relation to changes in ligand availability and 
their impact on MSC differentiation. This will be achieved by culturing MSCs on a 
peptide functionalised glass surface presenting a surface-bound integrin ligand. 
This system is as described in Todd et al., whereby the ligand is initially formed 
as a precursor peptide sterically inactivated with a large chemical group (Fmoc), 
and activated by enzymatically cleaving the Fmoc blocking group to reveal the 
underlying ligand (Todd et al., 2009). In the inactive ‘off’ state, it is expected 
that cell attachment and the degree of spreading will be limited due to a lack of 
ligand availability. In the ‘on’ state, cell spreading is expected to increase as the 
underlying ligands are exposed. The aims of this thesis include the synthesis and 
characterisation of the enzyme-responsive peptide substrate as described above, 
optimisation of Fmoc digestion in situ (rather than ex situ as per Todd et al.), 
and characterisation of MSC viability, size, shape and adhesion formation. The 
last chapter will be dedicated to determining if changes elicited in response to 
ligand availability initiate MSC differentiation.  
 
 
Figure 1-22: Enzyme-responsive substrates. The Figure depicts a cartoon representation of the enzyme-
responsive substrate used within this thesis. The amine-functionalised polyethylene glycol monolayer (black 
wavy lines) acts a linker onto which the integrin ligand RGD (purple oval) is attached. The ligand is masked 
by an Fmoc-protected alanine dipeptide (Fmoc is pink hexagon and alanine dipeptide is orange squares) 
preventing cells from interacting with the RGD. The terminal alanine and Fmoc are enzymatically removed 
with elastase (green pacman) to reveal the ligand during culture. 
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2.1 Introduction 
 
Controlling interfacial dynamics between materials and the cellular environment 
is essential for the development of new biomaterials. The advent of biomimetic 
modifications (materials intended to emulate a specific biological function) has 
generated a wave of materials endowed with tuneable surface chemistries that 
have dramatically advanced our understanding of the molecular mechanism that 
drive cell-substrata interactions. As the major mediators of these interactions, 
integrins have a prominent role in these events. Integrin transduction pathways 
feed into a myriad of other intracellular cascades, thus these same signals are 
likewise responsible for other cellular processes governing survival, proliferation 
and lineage commitment. In order to recreate this level of complexity in vitro, it 
is necessary to engineer materials that are able to promote cell attachment, and 
also effect changes in cell function. One way this can be achieved is by targeting 
integrins with specific ligands. In fact, surfaces modified with the integrin-active 
ligand RGD have shown improved adhesion, growth and differentiation compared 
to non-functionalised surfaces (Wang et al., 2013; Sànchez-Cortes et al., 2010). 
 
Historically, RGD was first identified as a tetrapeptide (RGDS) in the 9th and 10th 
type III domains of the matrix protein fibronectin (Pierschbacher and Ruoslahti, 
1984a; Pierschbacher and Ruoslahti, 1984b), and since found in other adhesion-
promoting proteins including vitronectin, collagen and fibrinogen (Davis, 1992; 
Smith and Cheresh, 1990; Hawiger et al., 1989). Although the advantages of RGD 
and other bioactive peptides are well established, it is becoming evident there is 
also a need to control certain spatial and temporal parameters. While Spatz and 
colleagues have identified a specific ligand spacing beyond which the benefits of 
RGD are abrogated (Cavalcanti-Adam et al., 2007), Mrksich and co-workers have 
recently reported that ligand affinity is similarly important (Kilian and Mrksich, 
2012). In vivo these features are both dynamic and tightly regulated, thus there 
is a need to be able to adapt these properties on demand and in situ. 
 
Accordingly, the physiochemical properties of SRMs can be manipulated by using 
an externally applied stimulus (Qin et al., 2013; Chen et al., 2011; Cole et al., 
2009; Chan et al., 2008; Petersen et al., 2008; Todd et al., 2007). For example, 
Ebara et al. developed a system of mechanically disrupting cell-ECM contacts by 
functionalising a temperature responsive polymer with RGD peptides. Above the 
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lower critical solution temperature, human umbilical vein endothelial cells were 
able to adhere and spread because the polymer chains were in a collapsed state 
exposing the adhesive peptides. Lowering the temperature caused the polymer 
chains to soften and swell physically covering the peptides and inducing the cells 
to become rounded before eventually detaching (Ebara et al., 2004). Wirkner et 
al. described the use of a light-sensitive system with similar properties to that of 
Ebara and colleagues. Cyclic RGD peptides were covalently attached to surfaces 
treated with a peg-based SAM. In its inactive state, a large photolabile chemical 
group masked the RGD peptides. Exposing the system to light led to the blocking 
group being photolytically cleaved from the surface exposing the underlying RGD 
to the cells (Wirkner et al., 2011). In both examples the stimulus was used to 
control the adhesive properties of the substrate in situ. 
 
While the work described by Ebara, Wirkner and other groups, demonstrates the 
ability to induce on-demand changes to the surrounding cell microenvironment, 
translating many of these systems into a viable in vivo application, is limited by 
the practicalities of generating localised changes in temperature, light intensity, 
ionic strength and pH etc, and also in engineering materials capable of switching 
under physiological conditions. In comparison, systems that employ enzymes as a 
trigger (enzyme responsive materials or ERMs) do not suffer from these problems 
(Zelzer et al., 2013; Ulijn, 2006). Enzymes are fundamental to many biological 
processes from ECM turnover and zymogen activation, to wound repair and signal 
transduction (Parks et al., 2011; Hunter, 1995; Neurath and Walsh, 1976). Their 
diverse application and highly selective behaviour therefore makes them ideally 
suited as SRM triggers.  
 
Combining both the dynamic properties of ERMs and the functionality of mimetic 
peptides answers the demand for molecular-level control over material surfaces 
comparable to the complex, highly organised and multifunctional nature of many 
biological systems. This chapter describes the synthesis and characterisation of a 
peptide-functionalised surface combining several mimetic features including: (I), 
surface modification using SAMs as a foundation for the attachment of a bioinert 
monolayer. (II), the use of a mimetic peptide to control cell adhesion, and (III), 
dynamic control over ligand availability by incorporating a short cleavable linker 
sensitive to enzyme-mediated digestion.  
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2.2 Materials and Methodology 
 
 
2.2.1 Materials 
 
List of Reagents 
 
 
Surface modification reagents .......................................................... 
Hydrogen peroxide (30%) ................................................. Sigma-Aldrich 
Sulphuric acid (concentrated) ........................................... Sigma-Aldrich 
Absolute ethanol .....................................................................Sigma 
Acetone................................................................................Sigma 
Methanol ..............................................................................Sigma 
Piperidine .............................................................................Sigma 
Trifluoroacetic acid .................................................................Sigma 
Poly-(ethylene glycol)...............................................................Sigma 
N,N’-Diisopropylcarbodiimide......................................................Sigma 
Anhydrous N,N-Dimethylformamide ..............................................Sigma 
Ethyl (hydroxyimino) cyanoacetate ...............................................Sigma 
(3-glycodyloxypropyl) trimethoxysilane ..........................................Sigma 
 
Fmoc amino acids.......................................................................... 
Alanine (Ala-OH) ........................................................... Sigma-Aldrich 
Glycine (Gly-OH) ........................................................... Sigma-Aldrich 
Arginine (Arg-(Pbf)-OH) ................................................... Sigma-Aldrich 
Aspartic acid (Asp-(OtBu)-OH) ........................................... Sigma-Aldrich 
Glutamic acid (Glu-(OtBU)-OH).......................................... Novabiochem 
 
Other reagents .............................................................................. 
Porcine pancreatic elastase (4.61 U/mgP)............... Worthington Biochemical 
1X Phosphate buffered saline ......................................................Sigma 
 
 
 
2.2.2 Surface Modification 
 
 
2.2.2.1 Surface Preparation and Amine Functionalisation 
 
Substrates were synthesised as described in Todd et al., 2009. Glass coverslips 
were sonicated in acetone, ethanol, methanol then deionised water (20 minutes 
each). Afterwards coverslips were chemically cleaned using a 3:7 solution of 30% 
hydrogen peroxide (H2O2) and concentrated sulphuric acid (H2SO4) for 1 hour to 
remove organic contaminants; then individually washed in copious amounts of 
deionised water, dried under nitrogen and stored at 75°C. Once completely dry, 
surfaces were functionalised with amine groups as per Piehler et al. to facilitate 
direct attachment of amino acids during SPPS (Piehler et al., 2000). To achieve 
this, surfaces were immersed in (3-Glycidyloxypropyl) trimethoxysilane (GOPTS) 
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at 37°C for 1 hour, then washed with acetone and dried under nitrogen. A poly-
(ethylene glycol) diamine powder (PEG; n=18) was melted onto the coverslips at 
75°C for 48 hours to provide amine-functionality. Surfaces were then cleaned in 
distilled water until excess PEG was removed, and then dried under nitrogen. 
 
 
2.2.2.2 Solid Phase Peptide Synthesis 
 
To build up the peptide chain using SPPS, a three-step procedure was applied. In 
step 1, the first Fmoc protected amino acid (0.2 mmol) was coupled to the PEG 
monolayer in a solution of ethyl-(hydroxyimino) cyanoacetate (oxyma, 0.4 mmol) 
and N,N’-diisopropylcarbodiimide (DIC, 0.4 mmol) per 10 ml of anhydrous N,N-
dimethylformamide (DMF). Samples were submerged in solution for 2 hours and 
gently agitated on a rotating platform to allow continued mixing of reagents and 
removal of by-products from the sample surface. After this time samples were 
then rinsed in DMF, ethanol, methanol and DMF (5 minutes each using agitation). 
A fresh amino acid solution was prepared and samples were left overnight under 
the same conditions described above, followed by washing stages.  
 
For the second step, Fmoc groups were removed (deprotected) using piperidine 
(20% in DMF) for 2 hours under agitation, followed by washing steps. Subsequent 
additions of Fmoc protected amino acids were carried out using repeated stages 
of steps 1 and 2 until the desired peptide chain was established. The terminating 
Fmoc groups were left in place. The final step (step 3) was to remove side chain 
protecting groups on the aspartic acid and glutamic acid residues (O-tert. Butyl; 
OtBu) and arginine (pentamethyldihydrobenzofuran-5-sulfonyl; Pbf) with a 90% 
solution of aqueous trifluoroacetic acid (TFA) for 4 hours. Samples were washed 
and dried then either stored under vacuum in a desiccator or used straight away.  
 
 
2.2.2.3 Enzymatic Cleaving of the Fmoc Protecting Groups 
 
The terminal Fmoc groups were enzymatically cleaved using porcine pancreatic 
elastase reconstituted in phosphate buffered saline (PBS). Throughout this work 
the same bottle was used and recorded as having an enzymatic activity of 4.61 
units/mg where 1 unit converts 1 µmole of N-succinyl-trialynyl-p-nitroanilide per 
minute at 25°C. For proof of concept, substrates were incubated in a 1.0 mg/ml 
solution overnight at 37°C and then washed with ethanol, methanol and distilled 
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water (10 minutes each), and dried under nitrogen. For in situ Fmoc cleaving see 
chapter 3 section 3.2.5. 
 
 
2.2.3 Stepwise Monitoring of Solid-Phase Peptide Synthesis 
 
 
2.2.3.1 Water Contact Angle  
 
Water contact angle (WCA) was carried out using the sessile drop technique with 
a KSV CAM 100 contact angle goniometer (KSV Instruments, USA). High contrast 
images of static water droplets were recorded and CAM 100 software was used 
to apply a circular fit to the droplet outline to determine contact angles across a 
series of measurements. Three different sets of data using three samples were 
recorded from each stage of synthesis and averages were pooled (total n=225). 
 
 
Figure 2-1: WCA experimental set-up. Contact angles were measured using the sessile drop technique and 
fitted with a circular line to determine angles. Measurements were recorded in series using 25 frames per 
droplet at 100 millisecond intervals.  
 
 
2.2.3.2 Solid State Fluorescence Spectroscopy 
 
After each coupling and deprotection stage, samples were taken from the bulk 
batch after the methanol washing stage and rinsed in distilled water followed by 
drying under nitrogen. Samples were analysed using fluorescence spectroscopy 
(FS) to confirm the attachment of the Fmoc-protected amino acids, and removal 
of the Fmoc group during coupling and deprotection stages. This technique is as 
described in literature by Zelzer et al. (Zelzer et al., 2012) taking advantage of 
the fluorescent properties of the Fmoc group.  
 
Fluorescence spectra were measured at room temperature using a JASCO FP-
6500 spectrophotometer (JASCO, JPN) with spectra manager™ software. Samples 
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were attached to a glass microscope slide inserted into a custom-made rotatable 
holder within the spectrophotometer chamber. Samples were orientated at 30 
degrees to the incident light to limit the amount of reflected excitation light 
hitting the detector. Excitation of the surface-tethered Fmoc groups was carried 
out using an excitation wavelength of 270 nm with a slit width of 20 nm. Three 
spectra were recorded at each stage of synthesis using three different samples. 
 
Figure 2-2 Set-up of sample holder for solid-state fluorescence. Images show the sample holder for solid-
state FS as described in Zelzer et al., 2012. Right-hand panel shows samples attached to a glass microscope 
slide inserted into a rotatable holder. Centre and left-hand panel show samples orientated at 30 degrees to 
the incident light within the spectrophotometer chamber.  
 
 
2.3 Results 
 
 
2.3.1 Nomenclature  
 
A total of eight different substrates were used for experimental purposes. These 
substrates are represented in Figure 2-3 as skeletal structures, and throughout 
this thesis using the following format. Chemically cleaned glass coverslips were 
used as “plain” controls without surface modification, while pegylated samples 
were used to validate PEG diamine as a bioinert background. These samples are 
referred to as PLAIN and PEG (Figure 2-3; A and C). Substrates containing surface 
-tethered peptides are referred to by peptide sequence (using the single letter 
code; Figure 1-12) and in short form e.g. aspartic acid is written as D or Asp.  
 
Two different peptides were synthesised using SPPS; AARGD and AARGE where 
RGD represents the bioactive integrin binding ligand, RGE represents a non-
functional variant of RGD, and AA is the enzymatically cleavable dipeptide. The 
full-length structures Fmoc-AARGD and Fmoc-AARGE are referred to collectively 
as FMOC substrates and individually as FMOC-D and FMOC-E where the letters D 
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and E denote the aspartic acid (D) and glutamic acid (E) residues that distinguish 
the sequences from each other (Figure 2-3; D). Similarly, enzymatically digested 
samples are referred to as DIGE samples and individually as DIGE-D and DIGE-E 
(Figure 2-3; E). DIGE-D and DIGE-E substrates start out with the same structure 
as FMOC-D and FMOC-E prior to digestion. Digestion results in the removal of the 
terminating Fmoc group and adjacent alanine (Fmoc-A!ARGD and Fmoc-A!ARGE; 
! refers to point of cleavage). Positive and negative controls reflect truncated 
forms of the full-length structure, and are analogous to digested substrates with 
peptide sequences of ARGD and ARGE respectively (also Figure 2-3; E).  
 
 
Substrate 
 
 
Peptide Sequence 
 
  
PLAIN .........................................................................................  
PEG............................................................................................  
FMOC (FMOC-D) ............................................................. Fmoc-AARGD 
FMOC (FMOC-E).............................................................. Fmoc-AARGE 
DIGE (DIGE-D)..................................................... Fmoc-AARGD " ARGD 
DIGE (DIGE-E)..................................................... Fmoc-AARGE " ARGE 
Positive controls (ARGD) ........................................................... ARGD 
Negative controls (ARGE) .......................................................... ARGE 
  
Table 2-1: Substrate nomenclature. Substrates are identified by their peptide sequences (using the single 
letter code) and by the presence or absence of the Fmoc group.  
 
2.3.2 Substrate Characterisation 
 
Attachment of amino acids and chemical deprotection of the Fmoc groups during 
SPPS was confirmed using solid-state FS and WCA. The results of both techniques 
confirm that the protocol for building up peptides on a solid support using Fmoc-
amino acids is both robust and reproducible. Additional Time-of-Flight Secondary 
Ion Mass Spectrometry (ToF-SIMS), X-ray Photoelectron Spectroscopy (XPS) and 
High-Performance Liquid Chromatography (HPLC) data can be found in Todd et 
al. (Todd et al., 2009) and Zelzer et al. (Zelzer et al., 2012). FS and WCA were 
also used to confirm removal of Fmoc after treatment with elastase.  
 
WCA measurements (Figure 2-4) were observed to change between the different 
stages of synthesis depending on the terminating functional group. The covalent 
attachment of epoxide groups after substrate silanization resulted in an increase 
in hydrophobicity from 20.5 ±1.02 to 49.7 ±0.95 degrees followed by a decrease 
(32.5 ±0.72) after coupling of the amine-terminating PEG chains. Attachment of 
Fmoc amino acids resulted in contact angles of 43.0 ±0.66 to 45.1 ±0.76 degrees, 
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while deprotected surfaces displayed angles of 32.5 ±0.72 to 40.5 ±0.92 degrees 
(Table 2-2). WCA measurements appeared to be affected by the chemistry of the 
side-chain protecting groups. Removal of the Fmoc group from aspartic acid and 
glycine residues lowered the contact angle (36.8 ±0.74 and 34.3 ±0.83) to values 
similar to that of PEG surfaces (NH2 32.5 ±0.72) however, after the coupling of 
arginine, contact angles of the deprotected surfaces remained much higher (40.5 
±0.92 for RGD and 39.5 ±0.87 for ARGD). 
 
Surface-bound Fmoc groups were identified by the presence of an emission peak 
at 315 nm (excitation wavelength of 270 nm). After deprotection, the successful 
removal of Fmoc was confirmed by the absence of this peak. Figure 2-5 confirms 
the presence and absence of Fmoc fluorescence during successive coupling and 
deprotection stages from Fmoc-D to Fmoc-A!ARGD (digested sample). PLAIN and 
PEG spectra display only background fluorescence similar to deprotected spectra 
confirming that the fluorescence signal is intrinsic to Fmoc. Interestingly, the 
signal intensity obtained for arginine was consistently lower than that obtained 
for any of the other amino acids while the signal intensity of spectra obtained 
for glycine were always higher.  
 
Similar to WCA, FS appeared to be affected by the side-chain protecting group 
as the fluorescence intensity signal was weakened after the coupling of arginine. 
Whereas aspartic acid and alanine contain simple OtBu and methyl (CH3) groups 
respectively, and glycine does not have a protecting group, the protecting group 
of the arginine side-chain contains a large aromatic compound (Pbf). Zelzer et 
al. demonstrated the quenching effect of the Pbf group by substituting the Pbf 
protected arginine for an unprotected version. Samples that were coupled with 
an unprotected arginine displayed a fluorescence intensity signal similar to that 
of the other amino acids (Zelzer et al., 2012).  
 
At 1.0 mg/ml (46.1 units total), elastase was shown to cleave the terminal Fmoc 
group as shown in Figures 2-4 and 2-5 (labelled as Fmoc-A!ARGD). In Figure 2-4, 
loss of the Fmoc group is seen as a change in contact angle similar to chemically 
deprotected surfaces (40.9 ±1.52 versus 32.5 ±0.72 to 40.5 ±0.92). In Figure 2-5, 
cleavage of the Fmoc group is represented by a negative fluorescence spectrum 
lacking the typical 315 nm Fmoc peak. Thus, at this concentration it was shown 
that surface-tethered Fmoc could be cleaved from the rest of the peptide. 
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Figure 2-3: Preparation of enzyme-responsive peptide-mimetic substrates. Chemically cleaned glass 
coverslips (A) were modified with GOPTS solution (B). Addition of a PEG diamine provided the surface with 
amine functionality to enable subsequent coupling of amino acids (C). The complete surface structure was 
built up through stepwise coupling of amino acids and Fmoc deprotection stages. As the amino acids were 
Fmoc-protected the surface chains naturally terminated in the Fmoc blocking group (D). The structure also 
contains an ala-ala dipeptide that formed the designated enzyme-cleavable site. Digestion resulted in the 
removal of the Fmoc capping group and one of the alanine residues (E). R groups are (R1) Asp: CH2COOH / 
Glu: CH2CH2COOH and (R
2) Arg: (CH2)2C(NH)2NH2 
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Figure 2-4: Water contact angle. There was a significant increase in contact angle after silanization of the 
substrates, which then dropped after introducing the PEG diamine monolayer. Contact angle was seen to be 
greater when Fmoc protecting groups were in place compared with surfaces that were deprotected. Data 
points and error bars refer to Table 2-2, red markers refer to substrates used for cell culture experiments 
 
 
Substrate 
 
WCA (°) 
 
  
PLAIN ..........................................................................  20.5 ± 1.02 
GOPTS .........................................................................  49.7 ± 0.95 
PEG.............................................................................  32.5 ± 0.72 
Fmoc-D-PEG...................................................................  43.0 ± 0.66 
D-PEG ..........................................................................  36.8 ± 0.74 
Fmoc-GD-PEG.................................................................  43.2 ± 0.83 
GD-PEG ........................................................................  34.3 ± 0.79 
Fmoc-RGD-PEG ...............................................................  44.9 ± 0.82 
RGD-PEG.......................................................................  40.5 ± 0.92 
Fmoc-ARGD-PEG .............................................................  45.1 ± 0.76 
ARGD-PEG .....................................................................  39.5 ± 0.87 
Fmoc-AARGD-PEG............................................................  43.7 ± 0.84 
Fmoc-A!ARGD-PEG ..........................................................  40.9 ± 1.52  
  
Table 2-2: Tabular figures of WCA measurements. Values and standard deviation were calculated using 25 
images per dataset with 9 datasets taken across 3 substrates (total n=225 images per set).    
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Figure 2-5: Stepwise monitoring of peptide synthesis using solid-state fluorescence spectroscopy. The 
emission spectra show the stepwise synthesis of the peptide chain from FMOC-D to FMOC-AARGD and FMOC-
A!ARGD. The presence of surface-tethered Fmoc groups is identified by the presence of a 315 nm emission 
peak (when excited at 270 nm) indicating successful amino acid coupling. The absence of this peak after 
Fmoc-deprotection stages and enzymatic digestion indicates successful removal of the Fmoc groups. PLAIN 
and PEG references show that the 315 nm peak is intrinsic to the Fmoc group. 
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2.4 Discussion and Conclusion 
 
The intention of this chapter was to outline the synthesis and characterisation of 
the enzyme-responsive substrate described in chapter 1 (section 1.5). In order to 
do so, a multistep strategy was applied to synthesise the substrates in separate 
stages using several well-known surface-modifying techniques. The first step was 
to introduce epoxide groups to the surface of glass coverslips using a silane-type 
SAM. As discussed in chapter 1, SAMs form highly organised monolayers that act 
as anchor points for the attachment of other chemical moieties or biomolecules. 
Here, GOPTS was used to covalently attach a PEG diamine spacer to introduce a 
bioinert monolayer. PEG is known to inhibit non-specific protein adsorption but 
the exact mechanisms of its anti-fouling properties are still unclear.  
 
A commonly held theory is that extensive hydration of the monolayer owing to a 
particular conformational arrangement coupled with high chain mobility, leads 
to entropic and steric repulsion at the surface interface (Wattendorf and Merkle, 
2008; Zheng et al., 2005; Kingshott et al., 2002). PEG is commonly incorporated 
into biomimetic systems as a way of maintaining long-term functionality specific 
to the ligand of choice. Without PEG, protein adsorption at the material surface 
would result in a loss of ligand specificity due to the introduction of additional 
ligands present within native ECM and culture medium proteins (George et al., 
2009; Lee and Voros, 2005; Sharma et al., 2004; Hern and Hubbell, 1998).  
 
Fmoc SPPS was used to build up the peptide ligand and enzyme cleavable linker 
by covalent attachment of individual protected amino acids. In this system, RGD 
and its non-functional variant RGE, along with the alanine dipeptide linker were 
synthesised in a stepwise fashion using the terminal Fmoc as a blocking group to 
prevent cells from interacting with the peptide sequence. A major question with 
regards to our system, is the extent to which the surface is functionalised with 
RGD; a variable defined by both the availability of the amine groups on the PEG 
monolayer and the steric restrictions imposed by neighbouring RGD units, as well 
as the efficiency of the chemistry used to build up the peptide sequence. Due to 
the bifunctional nature of the PEG diamine (H2N-PEG-NH2), there is potential for 
the linear chains to form loops preventing conjugation of the amino acids during 
SPPS. Although we were unable to determine the exact number of amine groups 
at the surface, previous experiments by Todd et al. (Todd et al., 2009) suggest 
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the number of PEG chains bound to the surface closely resembles a monolayer so 
if loops do form they must be small in number. As per section 1.4.3, whether or 
not the PEG chains formed loops does not affect the overall aim of the study. If 
the availability of RGD ligands had been reduced during synthesis due to looping 
of the PEG chains, the cells would have failed to properly adhere and spread. 
 
In addition to the RGD ligand, a second component of this system is the ‘off-on’ 
enzyme-mediated means by which the substrate is triggered to change from one 
state to the other. In the ‘off’ state the surface-bound ligands exist as inactive 
precursor peptides that corresponding cell receptors are unable to respond to. In 
the ‘on’ state cells are freely able to interact with the ligands. By enzymatically 
exposing RGD in DIGE samples the system is comparable to the unmasking of 
matrikines by cells (section 1.3.2) during normal matrix remodelling. Controlling 
this switch in function was achieved by adding an alanine dipeptide to the free 
end of RGD during SPPS, and by utilising the in-built steric properties of Fmoc, 
which was left attached to the terminal alanine. The dipeptide operated as a 
recognition site for elastase, a serine protease known to preferentially cleave 
between small amino acids including alanine and valine (Hedstrom, 2001; Powers 
et al., 1977; Kasafirek et al., 1976). Elastase was used based on its relevance in 
wound repair and remodelling (Young and McNaught, 2011; Eming et al., 2007; 
Fleck and Chakravarthy, 2007).  
 
Surface characterisation was carried out in this work using WCA and solid-state 
FS. WCA was used throughout each stage of synthesis by measuring changes in 
surface wettability, while solid-state FS was specifically used for monitoring the 
amino acid coupling and deprotection stages. Although these techniques lack the 
sensitivity of other surface analysis methods they are relatively inexpensive and 
were available in-house. Furthermore, Zelzer et al. have shown solid-state FS is 
a reliable method of monitoring Fmoc peptide synthesis that compliments WCA 
(Zelzer et al., 2012). ToF-SIMS and XPS were used in previous works to establish 
proof-of-principle concepts by confirming elemental and molecular fingerprints 
distinct to each stage of synthesis (Zelzer et al., 2012 and Todd et al., 2009). 
The combined data of this work and others, suggest that surface modification, as 
described in this chapter, is an effective and robust method for functionalising 
glass surfaces with short-chained peptides for receptor-targeted cell adhesion. 
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3.1 Introduction 
 
Successfully employing stem cells in regenerative medicine demands a high level 
of control over their renewal and commitment similar to that exerted by the in 
vivo microenvironment. Instructive features present within the matrix regulate a 
number of cellular processes hence materials modelled on certain aspects of the 
ECM now form a large part of biomaterial science and regenerative strategies. As 
the major mediators of cell-substratum contact, integrins have long been known 
to play a pivotal role in the transduction of mechanical forces across the plasma 
membrane (Ross et al., 2013; Giancotti and Ruoslahti, 1999). Evidence in favour 
of this has come from numerous studies into cell adhesions and their impact on 
cell survival, growth, migration and differentiation (Wang et al., 2013; Schwartz 
and Ginsberg, 2002; Giancotti and Ruoslahti, 1999; Mettouchi et al., 2001). The 
conclusion of these studies is that integrins and adhesions form an integral part 
of the regulatory mechanisms responsible for controlling cell fate through force 
transduction, cell spreading and the induction of cytoskeletal tension. 
 
The relationship between adhesion formation, the extent of spreading (cell size 
or shape) and contractile forces in the cytoskeleton, has been well documented 
(Kilian et al., 2010; McBeath et al., 2004; Huang et al., 1998; Chen et al., 1997). 
The level of overlap between these mechanisms is such that changes to one can 
result in changes in the other two. For example, applying external forces at the 
site of focal adhesions has been shown to induce adhesion growth and activate 
signalling cascades involved in cytoskeletal tension (Guilluy et al., 2011; Riveline 
et al., 2001). Furthermore, inhibiting actin polymerisation or pathways involved 
in myosin activation, reduces the cells ability to spread decreasing cell adhesion 
numbers and size (Arnsdorf et al., 2009; Bhadriraju et al., 2007). Reshaping the 
cell morphology by manipulating cell shape, tension and adhesion formation has 
been associated with changes to functional output including the development of 
lineage-specific characteristics and differentiation (McBeath et al., 2004). Under 
normal circumstances cell spreading and the accumulation of contractile forces 
is initiated and regulated by focal adhesions (Geiger and Yamada, 2011; Zaidel-
Bar et al., 2004) hence their development is a critical determinant in cell fate. 
 
First identified by electron microscopy (Abercrombie et al., 1971), adhesions can 
be divided into distinct types based on their morphology, molecular composition, 
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and function (Zamir and Geiger, 2001). The first adhesions to form are the small 
dot-like focal complexes (FXs) that develop at the leading edge of motile cells in 
response to the small GTPases Rac and Cdc42 (Zaidel-Bar et al., 2004; Nobes and 
Hall, 1995). FXs are followed by focal adhesions (FAs) that contain high levels of 
paxillin, vinculin and phosphotyrosine-containing proteins, and develop from FXs 
through previously described Rho-mediated mechanisms (Zaidel-Bar et al., 2004; 
Zamir et al., 1999; Ridley and Hall, 1992). The third type of adhesion, are known 
as fibrillar adhesions (FBs). FBs are mainly composed of !5"I integrins, have high 
levels of tensin (and corresponding low levels of FA proteins), and are associated 
with fibronectin (Pankov et al., 2000). Additionally, they are independent of the 
actomyosin complex and involved in the reorganisation of fibronectin into fibrils 
(Yamada et al., 2003; Katz et al., 2000). Supermature focal adhesions (SMAs) are 
a type of adhesion similar to FAs and FBs. Morphologically SMAs are closer to FBs 
but molecularly closer to FAs (Biggs et al., 2009a; Biggs et al., 2009b).  
 
The intension of the work in this chapter was to characterise MSC responses to 
the substrates described in chapter 2. Of particular interest were differences in 
response to surfaces with the active cell adhesion promoting RGD ligand (ARGD) 
compared with substrates with the inactive RGE peptide (ARGE), and differences 
between substrates in a low adhesive ‘off’ state (FMOC) compared with surfaces 
switched in situ from the ‘off’ state to an adhesion promoting ‘on’ state (DIGE). 
As RGD plays a fundamental role in cell adhesion, and adhesion itself is central 
to cell size and function, MSCs were investigated for variations in size, adhesion 
subtype and tension. Criteria for distinguishing between adhesion subtypes is as 
described in Biggs et al. (Biggs et al., 2009a; Biggs et al., 2009b) e.g. FXs were 
identified as being less than 1 !m in length, FAs 1-5 !m and SMAs greater than 5 
!m in length. FBs were not recorded as they are mostly associated with a pliable 
3D fibronectin matrix similar to in vivo conditions and thus not expected to be 
present in monolayer conditions (Pompe et al., 2003). For optimisation studies, 
these same criteria were used as indicators of favourable conditions.  
 
The aims of this chapter were to: (I), develop a means of enzymatically cleaving 
the Fmoc groups in situ to expose underlying RGD ligands in culture (II), optimise 
cell culture conditions to maximise MSC responses and (III), identify differences 
in MSC responses with respect to substrate chemistry. 
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3.2 Materials and Methodology 
 
 
3.2.1 Materials 
 
List of Reagents 
 
 
Cell culture reagents...................................................................... 
Mesencult® -XF Basal medium ............................... STEMCELL Technologies 
Mesencult® - XF Supplement ................................. STEMCELL Technologies 
MEM-Alpha culture medium ..........................................PAA Laboratories 
Antibiotic mix .................................................................... In-house 
L-glutamine (200 mM)...............................................................Sigma 
Penicillin streptomycin .............................................................Sigma 
Ampotericin B (250 !g/ml) ................................................... Invitrogen 
Foetal bovine serum.................................................................Sigma 
Trypsin.................................................................................Sigma 
Versine............................................................................. In-house 
Sodium chloride ......................................................................Sigma 
Potassium chloride...................................................................Sigma 
Glucose ................................................................................Sigma 
Phenol red indicator.................................................................Sigma 
Ethylenediaminetetraacetic acid..................................................Sigma 
4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid.............. Sigma-Aldrich 
 
Immunocytochemistry reagents ........................................................ 
1X Phosphate buffer saline ............................................... Sigma-Aldrich 
Formaldehyde .............................................................. Sigma-Aldrich 
Permeabilisation buffer......................................................... In-house 
Sucrose ...................................................................... Sigma-Aldrich 
Triton® X 100 ............................................................... Sigma-Aldrich 
Magnesium chloride hexahydrate ....................................... Sigma-Aldrich 
Bovine serum albumin..................................................... Sigma-Aldrich 
Tween 20® .................................................................. Sigma-Aldrich 
Rhodamine phalloidin ................................... Invitrogen, Molecular Probes 
Fluorescein streptavidin ...........................................Vector Laboratories 
Horse-biotinylated anti mouse IgG...............................Vector Laboratories 
Vectashield mounting media with DAPI .........................Vector Laboratories 
Mouse monoclonal anti-vinculin IgG ..............................................Sigma 
Mouse monoclonal anti-phosphomyosin IgG ............Cell Signalling Technology 
 
Cell staining reagents ..................................................................... 
Coomassie brilliant blue R-250 .......................................... BDH Biochem 
Acetic acid ............................................................................Sigma 
Methanol ..............................................................................Sigma 
 
Other reagents ............................................................................. 
Porcine pancreatic elastase (4.61 U/mgP)............... Worthington Biochemical 
Lymphoprep gradient solution ...................................... Robbins Scientific 
MACS buffer solution .................................................... Miltenyi Biotec 
Ethanol ................................................................................Sigma 
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3.2.2 Cell Models 
 
 
3.2.2.1 PromoCell® MSCs 
 
Bone marrow MSCs purchased from PromoCell® (#C-12975, Germany) were frozen 
shortly after isolation in serum free freezing media before use. For proliferating 
cells, MSCs are thawed from stock, maintained in MSC growth medium for 3 days 
and tested for viability, morphology and adherence. The cells are characterised 
by flow-cytometry using specific surface antigens: CD31 (PECAM), CD44 (HCAM), 
CD45 (PTPRC) and CD105 (Endoglin), and tested for their ability to differentiate 
using osteogenic, adipogenic and chondrogenic induction medium. Flasks of live 
proliferating MSCs are shipped at passage 2. On arrival, MSCs were equilibrated 
for 2 hours at 37°C (5% CO2) then maintained in alpha-minimal essential medium 
(!-MEM) as per section 3.2.3. 
 
 
3.2.2.1 STRO-1 Selected MSCs 
 
STRO-1+ MSCs (courtesy of Prof Oreffo, University of Southampton) were derived 
from bone marrow obtained from haematologically normal patients undergoing 
routine total hip replacement surgery with the approval of Southampton General 
Hospital Ethics Committee (and informed patient consent); using only tissue that 
would normally be discarded. Cells were aspirated from trabecular bone marrow 
(courtesy of Dr Murawski) and centrifuged at 250 g for 4 minutes at 4°C. The cell 
pellet was resuspended in !-MEMs and filtered through a 70 !m pore nylon mesh 
(BD Biosciences). Red blood cells were removed by centrifuging with lymphoprep 
gradient solution and cells in the buffy layer were resuspended in 10 ml of 4-(2-
hydroxyethyl)-1-piperazine-ethanesulphonic acid (HEPES) saline solution with 5% 
v/v foetal calf serum, 5% v/v human serum and 1% w/v bovine serum albumin 
(BSA). Afterwards the cells were incubated with a STRO-1 antibody in hybridoma 
supernatant (hybridoma courtesy of Dr Beresford, University of Bath) and flushed 
with magnetic cell separation (MACS) buffer to remove any excess antibody. The 
cells were incubated with human anti-IgM magnetic microbeads (Miltenyi Biotec, 
UK) then added to a magnetic column; the eluent was collected as the STRO-1- 
fraction. After washing with MACs buffer without the magnetic field, the eluted 
cell population was collected as the STRO-1+ fraction. STRO-1+ selected MSCs are 
referred to as Stro1 MSCs throughout the rest of this thesis. 
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3.2.3 MSC Maintenance and Experiment Preparation  
 
MSCs were maintained at 37°C and 5% CO2 in !-MEM supplemented with 10% v/v 
foetal bovine serum (FBS) and 2% v/v antibiotic mix (60% v/v L-Glutamine, 35% 
v/v penicillin streptomysin and 5% v/v Ampotericin B). For all experiments cells 
were rinsed in HEPES saline solution (150 mM NaCl, 5 mM KCl, 5 mM Glucose, 10 
mM HEPES and 0.5% v/v phenol red indicator adjusted to pH 7.5), followed by 4 
ml of trypsin-versene solution (0.5% v/v trypsin and versene: 150 mM NaCl, 5 mM 
KCl, 5 mM Glucose, 10 mM HEPES, 1 mM ethylenediaminetetraacetic acid (EDTA) 
and 0.5% v/v phenol red indicator adjusted to pH 7.5) until cells were detached 
from the tissue culture flask. Detached cells were transferred to a sterile falcon 
tube and centrifuged at 376 g for 4 minutes. The supernatant was discarded and 
the cell pellet resuspended in 5 ml of fresh !-MEMs. Cell numbers were counted 
using a Neubaur haemocytometer and seeded as per experimental setup.  
 
Unless otherwise stated, cells were cultured on all substrates at a density of 75 
cells/mm2 for a period of 7 days with media changes carried out every 48 hours; 
all experiments were carried out in triplicate. For FBS studies, PromoCell® MSCs 
were seeded using !-MEM containing 10% v/v FBS (standard serum media; SSM), 
2% v/v FBS (low serum media; LSM) or serum free media (Mesencult™; SFM). For 
seeding density studies, Stro1 MSCs were seeded at 75 cells/mm2, 39 cells/mm2 
and 7 cells/mm2. In all experiments elastase was added to DIGE samples in place 
of ordinary media as per section 3.2.4 at 48 hours post seeding and removed 96 
hours post seeding. Prior to use, coverslips were sterilised with 70% ethanol (3x5 
minutes) then washed with HEPES saline solution and basal !-MEM.  
 
 
3.2.4 Elastase Tolerance 
 
Cells were seeded onto plain coverslips and left to adhere for 48 hours. Porcine 
pancreatic elastase was dissolved in !-MEMs at 37°C as a stock solution and then 
sterilised through a 0.24 !m syringe filter. The stock solution was diluted across 
a concentration range of 1.0–0.1 mg/ml (4.61-0.461 units) and added to samples 
in place of !-MEMs (controls were maintained in !-MEMs). MSCs were incubated 
for a further 24 hours then examined for detachment with a Zeiss Axiovert light 
inverted microscope at 10X magnification (0.25 NA). Images were captured with 
a Qimaging digital CCD camera (Qimaging, Canada) and QcaptureTM software. 
Chapter 3: Cell Culture Optimisation and MSC Characterisation 
58 
3.2.5 Coomassie Blue Staining 
 
MSCs were fixed as in section 3.2.6 and stained with coomassie blue protein dye 
(0.5% w/v coomassie brilliant blue R-250 dissolved in 4:1 methanol:acetic acid 
filtered with Whatman filter paper) for 15 minutes at room temperature. Excess 
stain was removed by washing samples with water and images were taken using 
a Zeiss Axiovert light microscope as per section 3.2.4. 
 
 
3.2.6 Immunocytochemistry  
 
Samples were washed with PBS and fixed with 10% v/v formaldehyde/PBS for 15 
minutes at 37°C. Cells were permeabilised at 4°C for 5 minutes (30 mM sucrose, 
50 mM NaCl, 3 mM MgCl2.6H2O, 20 mM HEPES and 0.5% v/v Triton® X-100 in PBS 
adjusted to pH 7.2) and non-specific binding epitopes were blocked with 1% w/v 
BSA/PBS for 15 minutes at 37°C. Primary antibodies were made up in BSA/PBS 
containing rhodamine-phalloidin (1:500) with mouse monoclonal anti-vinculin IgG 
(1:150) for adhesion quantification or mouse monoclonal anti-phosphomyosin IgG 
(1:200) for phosphomyosin studies. Samples were incubated for 1 hour at 37°C 
then washed with 0.5% v/v Tween20/PBS (PBST; 3x5 minutes under agitation) to 
minimise background labelling. Horse biotinylated anti-mouse IgG (1:15) in BSA/ 
PBS was added to samples and incubated for 1 hour at 37°C. After washing steps, 
samples were incubated for 30 minutes at 4°C with fluorescein isothyiocyanate 
streptavidin (FITC; 1:150) in BSA/PBS followed by washing stages. Samples were 
placed on glass slides in 4’6-diamidino-2-phenylindole (DAPI) mountant and cells 
visualised using a Zeiss Axiophot fluorescence microscope at 20X magnification 
(0.40 NA). Images were captured using an Evolution QEi digital monochromatic 
CCD camera (Media Cybernetics, USA) with QcaptureTM imaging software.  
 
 
3.2.7 Image Analysis 
 
Using the threshold tool, actin images were exported to ImageJ to calculate cell 
size (Figure 3-1). For adhesion quantification studies, vinculin images were first 
exported to Adobe Photoshop® and the individual adhesions traced with a 1-pixel 
width line to create an adhesion mask superimposed over the background image. 
ImageJ was then used to determine total adhesion numbers and lengths per cell. 
Phosphomyosin expression was quantified using the method described in Burgess 
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et al. (Burgess, 2011; Burgess et al., 2010). Images were exported to ImageJ and 
cells selected using the polygon tool. Expression was calculated using integrated 
density (ID) values where ID = (area x mean grey value). Values were corrected 
for background fluorescence using ID – (cell area x background fluorescence ID). 
All data was analysed by one-way analysis of variance (ANOVA) with Dunn’s post-
hoc test to identify significant differences (P<0.5) between groups.  
 
 
 
 
 
 
 
 
 
Figure 3-1: Image analysis. For size quantification fluorescence images (top left) were exported to ImageJ 
to measure total cell area (top right). These same fluorescence images were also used to calculate adhesion 
numbers and subtypes (middle row). Greyscale images of vinculin immuno-labelled adhesions (centre panel) 
were exported into Photoshop® to create an adhesion mask (middle right). Adhesions were then analysed in 
ImageJ. Using the polygon selection tool, ImageJ was also used to quantify phosphomyosin expression by 
calculating total fluorescence intensity (bottom row) as per Burgess et al., 2011. Scale bars are 50 !m.  
Chapter 3: Cell Culture Optimisation and MSC Characterisation 
60 
 3.3 Results 
 
For results, discussion and conclusion purposes, comparisons are drawn between 
substrates in relation to their surface chemistry. Based on previous data, it was 
expected that RGD positive controls (ARGD) would elicit a maximal response due 
to the nature of the integrin-binding RGD ligand, and that DIGE-D surfaces would 
follow a similar trend. Conversely, ARGE and DIGE-E substrates were expected to 
elicit a minimal response given that RGE is non-integrin binding. As such, ARGD 
and DIGE-D are compared alongside each other and contrasted against ARGE and 
DIGE-E. Since the main objective of this work was to identify differences in MSC 
response to surfaces in a low adhesive ‘off’ state and surfaces in a high adhesive 
‘on’ state, ARGD and particularly DIGE-D are contrasted against FMOC surfaces. 
PLAIN and PEG are contrasted with each other as glass is known to support cell 
attachment and growth and PEG is known to inhibit cell adhesion. It is important 
to note that, although PLAIN substrates are also compared alongside ARGD and 
DIGE-D, it is only for ease of writing. PLAIN surfaces are subject to uncontrolled 
adsorption of serum proteins, which contain numerous and randomly distributed 
bioactive ligands. As such, functional response cannot be attributed to any one 
ligand. A reminder of substrate nomenclature can be seen below in Table 3-1.  
 
Substrate                                                              Peptide sequence 
 
  
PLAIN .........................................................................................  
PEG............................................................................................  
FMOC (FMOC-D) ............................................................. Fmoc-AARGD 
FMOC (FMOC-E).............................................................. Fmoc-AARGE 
DIGE (DIGE-D)..................................................... Fmoc-AARGD # ARGD 
DIGE (DIGE-E)..................................................... Fmoc-AARGE # ARGE 
Positive controls (ARGD) ........................................................... ARGD 
Negative controls (ARGE) .......................................................... ARGE 
  
Table 3-1: Substrate nomenclature. Substrates are identified by their peptide sequences (using the single 
letter code) and by the presence or absence of the Fmoc group.  
 
 
3.3.1 MSC Attachment and Characterisation 
 
To see if cells would adhere to these substrates, PromoCell® MSCs were cultured 
using standard conditions (section 3.2.3) on all surfaces including DIGE surfaces 
that had been cleaved prior to culture as per section 2.2.2.3. Cells were allowed 
to adhere and monitored at regular intervals over 3 days. MSCs were observed to 
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have attached and spread on PLAIN, ARGD and DIGE-D substrates after 4 hours, 
while those cultured on ARGE, FMOC and DIGE-E substrates, had made only weak 
attachments and were mostly rounded. Cells seeded onto PEG surfaces remained 
detached even at 24 hours, and some cells had clearly died. At day 3, cells were 
fixed and stained with coomassie blue as described in sections 3.2.6 and 3.2.5. 
Cells seeded onto PLAIN, ARGD, FMOC-D and DIGE-D substrates displayed typical 
MSC morphology appearing flat and well spread with prominent bundles of actin 
stress fibres. In comparison, cells cultured on ARGE, FMOC-E and DIGE-E surfaces 
tended to be smaller (quantified in section 3.3.3), with a preference for forming 
multiple islands of overlapping cells rather than being more evenly distributed. 
Very few cells adhered to PEG at this time point and those that did were mainly 
confined to the islands of overlapping cells. MSCs separated from these masses 
appeared small and square-like or elongate and spindly. 
 
 
Figure 3-2: MSC attachment and spreading. PromoCell® MSCs were cultured for a period of 3 days on all of 
the surfaces including pre-treated DIGE surfaces then fixed and stained with coomassie blue. Cells attached 
to most of the substrates with varying degrees of spread depending on substrate chemistry. MSCs on PLAIN, 
ARGD and DIGE-D tended to be larger than those on ARGE, FMOC and DIGE-E surfaces, and developed strong 
stress fibres. Cells seeded on PEG substrates had a tendency to clump into islands of overlapping cells while 
cells that were separated from these islands were small and poorly spread. This clumping was also observed 
on ARGE, FMOC and DIGE-E but to a lesser extent (MSCs in both FMOC-D and FMOC-E images represent both 
clumped and spread cells characteristic of these surfaces). Scale bar is 100 !m (n=3 per substrate). 
 
 
3.3.2 Elastase Tolerance and Fmoc Cleaving 
 
Compared with the original system in Todd et al. (Todd et al., 2009), enzymatic 
cleaving of the Fmoc group and subsequent switching of FMOC surfaces from the 
‘off’ to the ‘on’ state, is intended to be conducted in situ thereby exposing the 
underlying RGD ligands at a specified point during culture rather than exposing 
the cells directly to RGD as in ARGD substrates. Given the trypsin-like nature of 
elastase it was first necessary to identify the maximum concentration of enzyme 
tolerated by the cells without cleaving them from the surface. PromoCell® MSCs 
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were cultured using standard media conditions as per section 3.2.3. At 48 hours, 
MSCs had adhered and spread as per previous observations. After incubating with 
elastase for 24 hours, all cells became rounded and detached between 1.0 and 
0.4 mg/ml while some cells remained attached but poorly spread at 0.2 mg/ml. 
At 0.1 mg/ml cells were indistinct from control cells incubated in basic !-MEM.  
 
 
Figure 3-3: Elastase tolerance. MSCs were cultured on plain glass coverslips for 48 hours then treated with 
different concentrations of elastase between 1.0 to 0.1 mg/ml (4.60 U to 0.460 U) in !-MEMs. Control MSCs 
incubated with basic medium only, displayed typical MSC morphology (A) while MSCs treated with 1.0 to 0.4 
mg/ml elastase detached (B-E respectively). The majority of cells treated with 0.2 mg/ml also detached (F) 
however a few small cells remained attached (G). At 0.1 mg/ml MSCs were indistinguishable from controls 
(H). Spread cells were stained with coomassie blue; scale bar is 100 !m (n=3 per condition). 
 
 
Solid-state FS was used to ascertain if adding 0.1 mg/ml elastase to cultures was 
sufficient to remove surface-bound Fmoc groups. DIGE surfaces were incubated 
for 48 hours with the relevant concentration and analysed as per section 2.2.3.2. 
At this time point the 315 nm fluorescence peak typically associated with Fmoc 
was absent from the spectra (Figure 3-4) indicating successful removal. As such, 
all further studies were carried out using 0.1 mg/ml elastase. 
 
   
In
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ity
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a.
u.
) 
Wavelength (nm) 
Figure 3-4: Solid-state fluorescence spectra of Fmoc digestion using 0.1 mg/ml elastase. Left hand panel 
displays a typical Fmoc positive spectrum with a fluorescence peak at 315 nm, while the central panel 
displays a negative spectrum after chemical deprotection. The right hand panel indicates the Fmoc group is 
removed when digested with 0.1 mg/ml of elastase. Method is as in Zelzer et al., 2011 (n=3 per substrate). 
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3.3.3 Optimising Cell Culture Conditions 
 
 
3.3.3.1 FBS Concentration Affects Cell Spreading and MSC Size 
 
In addition to optimising the enzyme switch, cell culture conditions also required 
optimising. A common additive to cell culture media is FBS, which contains large 
amounts of the globular protein BSA. In order to perform proteomic techniques 
such as 2D gel electrophoresis and SILAC it is often necessary to standardise the 
serum proteins that are added to the system or reduce them. This is because FBS 
can be variable in content and mask subtle changes in proteomic output. Serum 
proteins were reduced by lowering the FBS concentration in one lot of cultures, 
and removed from a second batch of cultures using a serum free alternative. The 
intention was to see if the FBS content could be lowered or eliminated without 
compromising overall cell viability. PromoCell® MSCs were seeded as per section 
3.2.3 at a density of 75 cells/mm2 in 10% v/v FBS (standard serum media; SSM), 
2% v/v FBS (low serum media; LSM) or serum free media (Mesencult™; SFM). At 7 
days, cells were treated as described in section 3.2.6 then analysed as per 3.2.7. 
Image analysis identified several differences in MSC development both between 
the substrates and between culture conditions. 
 
Consistent with attachment studies (section 3.3.1), cells grown on PLAIN, ARGD, 
FMOC-D and DIGE-D were all well spread with large bundles of actin stress fibres 
and prominent adhesions while cells seeded on ARGE, FMOC-E and DIGE-E tended 
to be smaller with a reduced number of visible adhesions. At day 7, some of the 
cells that had adhered to PEG substrates had formed stronger contacts and were 
more spread than 3 day cultures, but still to a lesser extent than MSCs on other 
substrates. This trend was observed in both SSM and LSM cultures, however MSCs 
across all substrates in SFM cultures were elongated with membrane ruffles and 
few visible adhesions (Figures 3-6 to 3-8). Interestingly, although differences in 
size between the surfaces in SSM were not significant, and despite being smaller 
in general, there was a marked difference in cell size between surfaces in SFM. 
For example, MSCs cultured on PLAIN substrates were 1.4 times larger than MSCs 
on PEG. Similarly, MSCs cultured on ARGD surfaces were 2.4 times larger than 
MSCs on ARGE, and cells on DIGE-D were 1.6 times larger than cells on DIGE-E 
surfaces. MSCs seeded onto FMOC substrates were similar to PLAIN, PEG, ARGE 
and DIGE-E cultures in that they were much smaller in size than cells seeded on 
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ARGD and DIGE-D. As a comparison between ‘off’ and ‘on’ states, MSCs cultured 
on DIGE-D were twice as large as MSCs on FMOC-D (Figure 3-10 and Table 3-2). 
 
Substrate  
 
 
Average cell size (µm2) 
 
       SSM            LSM            SFM 
 
  
PLAIN ..................................  18180 ± 1433 14560 ± 6845 1206 ± 71.7 
PEG.....................................  11560 ± 1094 08916 ± 4628 0867 ± 70.3 
ARGE ...................................  13680 ± 1929 12320 ± 4245 1065 ± 86.5 
ARGD...................................  17820 ± 1663 12990 ± 5314 2520 ± 157. 
FMOC-E ................................  15940 ± 1489 13090 ± 5581 0790 ± 50.1 
FMOC-D ................................  18060 ± 1509 15260 ± 5611 1354 ± 72.3 
DIGE-E .................................  15570 ± 1844 08659 ± 4872 1641 ± 94.8 
DIGE-D .................................  16920 ± 1716 09949 ± 5600 2683 ± 147. 
  
Table 3-2: Quantification of PromoCell® MSC size. MSC size was affected by both substrate chemistry and 
serum concentration with cells tending to be much larger in SSM cultures. In most cases cells also exhibited 
a greater degree of spread on PLAIN, ARGD, FMOC-D and DIGE-D surfaces. Table data shows the average cell 
size of MSCs cultured for 7 days at a density of 75 cells/mm2 using SSM, LSM and SFM. Values correlate with 
Figures 3-9 to 3-10; error values are standard error (n=40 per substrate except SFM PEG where n=15). 
 
 
Differences in cell size were also observed between the three culture conditions. 
In LSM cultures where FBS had been reduced from 10% to 2% v/v, cell sizes were 
reduced between comparable samples but only significantly so on DIGE surfaces. 
In contrast, MSCs were 15 times smaller on PLAIN substrates in SFM cultures than 
MSCs cultured on PLAIN in SSM. Likewise, cells cultured on ARGD surfaces in SFM 
were 7 times smaller than cells on ARGD cultured using SSM, 13 times smaller on 
FMOC-D in SFM than FMOC-D in SSM, and 6 times smaller on DIGE-D substrates in 
SFM compared to DIGE-D MSCs in SSM (Figures 3-9 and 3-10). Cell numbers were 
also noticeably less on all surfaces compared to SSM and LSM (observation only). 
As a result of reduced cell size in LSM conditions, and poor cell numbers in SFM 
conditions, all other studies were carried out using SSM.  
 
 
Figure 3-5: Immuno-fluorescence images of MSCs cultured in different media conditions. Image depicts 
MSCs cultured at a density of 75 cells/mm2 for 7 days on ARGD substrates using SSM (left hand panel), LSM 
(centre panel) and SFM (right hand panel). Colours are red (actin), green (vinculin) and blue (nuclei); scale 
bar is 100 !m SSM and LSM, and 50 !m SFM. 
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Figure 3-6: Immuno-fluorescence images of PromoCell® MSCs seeded at 75 cells/mm2 in SSM conditions. 
Over 7 days, MSCs attached to all surfaces but were morphologically different depending on the substrate. 
Stress fibres and adhesions were clearly seen in all cultures, however cells seeded on PLAIN, ARGD, FMOC-D 
and DIGE-D tended to be larger with more adhesions than cells cultured on PEG, ARGE, FMOC-E and DIGE-E. 
For ARGD, ARGE, DIGE-D and DIGE-E this is consistent with the difference in ligand activity between RGD 
and the non-functional RGE. Colours are red (actin), green (vinculin) and blue (nuclei); scale bar is 100 µm. 
PLAIN                                                        PEG 
 
 
 
 
 
 
 
 
 
 
 
ARGD                                                          ARGE 
 
 
 
 
 
 
 
 
 
 
 
FMOC-D                                                      FMOC-E 
 
 
 
 
 
 
 
 
 
 
 
DIGE-D                                                       DIGE-E 
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Figure 3-7: Immuno-fluorescence images of PromoCell® MSCs seeded at 75 cells/mm2 in LSM conditions. 
Similar to MSCs cultured in SSM, MSCs adhered to all substrates displaying the same pattern observed in SSM 
cultures with cells tending to be slightly larger on PLAIN, ARGD, FMOC-D and DIGE-D, and smaller on PEG, 
ARGE, FMOC-E and DIGE-E. Stress fibres and adhesions were mainly unaffected by LSM conditions, however 
adhesions tended to be located toward the cell edge rather than throughout the cell body, and overall cell 
sizes were smaller than SSM. Colours are red (actin), green (green) and blue (nuclei); scale bar is 100 µm. 
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Figure 3-8: Immuno-fluorescence images of PromoCell® MSCs seeded at 75 cells/mm2 in SFM conditions. In 
contrast to MSCs cultured in SSM and LSM, MSCs cultured in SFM were morphologically different on all substrates 
regardless of chemistry. After 7 days there were fewer cells per substrate compared to equivalent surfaces in SSM 
and LSM. Cells that had adhered were small and elongate with membrane ruffles and much fewer adhesions. The 
adhesions themselves were very small and predominantly located toward the edges of the cells. Colours are red 
(actin), green (vinculin) and blue (nuclei); scale bar is 50µm. nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
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Figure 3-10: Quantification of PromoCell® MSC size seeded at 75 cells/mm2 in different conditions. Each 
graph depicts average cell size of PromoCell® MSCs after 7 days in standard serum media (SSM), low serum 
media (LSM) or serum free media (SFM). Stars indicate significant differences between groups as 
determined by one-way ANOVA and Dunns post hoc test where *P<0.5 **P<0.1 and ***P<0.001. Numerical 
values can be found in Table 3-2 and a list of all significant differences can be found in Table A-2. Error 
bars represent standard error (n=40 per substrate except SFM PEG n=15). 
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3.3.3.2 Adhesion Characterisation using SSM Conditions 
 
The role of cell-ECM adhesions in cell behaviour and function has been discussed 
in depth elsewhere (section 1.3.5). By characterising the number and subtype of 
adhesions expressed by MSCs in this work, the intension is to see if MSCs develop 
different adhesion ‘profiles’ when cultured on surfaces functionalised with RGD, 
compared with MSCs cultured on the other substrates. Adhesion characterisation 
refers to PromoCell® MSCs cultured using SSM (same cultures as section 3.3.3.1). 
In order to quantify each adhesion subtype, the average number of all adhesions 
per cell was recorded for each of the substrates. The subtypes (FX, FA and SMA) 
were then expressed as a percentage of this value (Table 3-3). Despite the total 
average number of adhesions per cell being similar across the different surfaces, 
there was an obvious difference in the distribution of these adhesions between 
the subtypes. The majority of the adhesions fell into the FA category regardless 
of substrate chemistry meaning that FXs and SMAs contributed to a much smaller 
percentage of the overall number. Individual percentages of the three subtypes 
thus varied depending on the substrate (Figure 3-11).  
 
 
Figure 3-11: Adhesion analysis. Regardless of surface chemistry, most of the adhesions analysed were FAs 
with FXs and SMAs forming a much smaller percentage however the relative percentages of these two types 
of adhesion differed depending on the substrate. As a rule MSCs cultured on PEG (not shown), ARGE, FMOC 
and DIGE-E substrates tended to develop more FXs than PLAIN (not shown), ARGD and DIGE-D. Conversely, 
MSCs that were cultured on PLAIN, ARGD and DIGE-D tended to develop more of the SMAs than PEG, FMOC 
and DIGE-E. To see images of MSCs on all substrates refer to Figure 3-6; scale bar is 100 !m. 
ARGD                                    ARGE                                   FMOC-D 
 
 
 
 
 
 
 
 
 
 
FMOC-E                                DIGE-D                                 DIGE-E 
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Analysis of the adhesion numbers and types revealed that approximately 11% of 
the total number of adhesions recorded for cells seeded on PEG surfaces were 
FXs while FXs expressed on ARGE and DIGE-E substrates accounted for 5% and 7% 
of adhesions respectively. In contrast, only 2% of adhesions on PLAIN and ARGD, 
and 4% on DIGE-D substrates were FXs. This trend was reversed for SMAs where 
SMAs constituted 41% of adhesions expressed by MSCs seeded on PLAIN surfaces, 
39% on ARGD surfaces, and 35% of the total number of adhesions recorded for 
cells cultured on DIGE-D surfaces. Conversely, only 24% of adhesions on PEG, 22% 
of adhesions on ARGE and 25% of adhesions on DIGE-E surfaces were SMAs. MSCs 
seeded on FMOC-D typically developed more FXs (6%) and fewer SMAs (23%) than 
cells cultured on PLAIN, ARGD or DIGE-D (Table 3-3).  
 
Substrate     
 
Average 
 
(Total) 
 
 
FX 
 
(%) 
 
 
FA 
 
(%) 
 
 
SMA 
 
(%) 
 
    
PLAIN .................... 195 ± 12.2 1.87 ± 0.448 57.2 ± 1.91 40.9 ± 1.99 
PEG....................... 131 ± 12.3 10.6 ± 1.460 65.8 ± 1.91 23.6 ± 2.34 
ARGE ..................... 221 ± 23.4 4.78 ± 0.580 73.1 ± 1.67 22.1 ± 1.74 
ARGD..................... 232 ± 23.5 2.03 ± 0.351 59.0 ± 2.06 39.0 ± 2.08 
FMOC-E .................. 227 ± 17.4 3.41 ± 0.489 71.2 ± 1.80 25.4 ± 1.93 
FMOC-D .................. 213 ± 16.8 5.69 ± 0.563 71.6 ± 1.42 22.7 ± 1.42 
DIGE-E ................... 197 ± 21.1 7.44 ± 0.808 67.4 ± 1.91 25.1 ± 1.89 
DIGE-D ................... 188 ± 16.9 3.52 ± 0.552 61.5 ± 1.72 35.0 ± 1.81 
    
Table 3-3: Quantification of PromoCell® MSC adhesions. For adhesion characterisation, the average total 
number of adhesions per cell was recorded and the subtypes expressed as a percentage of this value. Table 
data shows the total average number of adhesions per cell and corresponding percentages of each subtype 
for MSCs cultured at a density of 75 cells/mm2 for 7 days in SSM conditions. Values correlate with Figures 3-
12 and 3-13; error values are standard error (n=40 per substrate). 
 
 
The results of adhesion characterisation suggest that cells seeded on PEG, ARGE, 
FMOC and DIGE-E surfaces develop more FXs than those seeded on PLAIN, ARGD 
and DIGE-D while cells cultured on PLAIN, ARGD and DIGE-D substrates develop 
more SMAs. In this data, MSCs cultured on PEG coated substrates developed 5.5 
times more FXs than PLAIN and ARGD while those on ARGE had roughly 2.5 times 
more FXs than ARGD and those seeded on FMOC-D developed 1.6 times more FXs 
than DIGE-D. MSCs seeded on DIGE-E surfaces developed 1.8 times more FXs than 
DIGE-D. Conversely, MSCs cultured on PLAIN substrates expressed 1.7 times more 
SMAs than those that were seeded on PEG. MSCs seeded on ARGD 1.8 times more 
SMAs than ARGE, and DIGE-D MSCs had 1.4 times more SMAs than DIGE-E and 1.5 
times more SMAs that FMOC-D (Figures 3-12 and 3-13).  
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Figure 3-13: Quantification of the average percentage of adhesion subtypes expressed by PromoCell® 
MSCs cultured at 75 cells/mm2 in SSM conditions. After 7 days, the average total number of adhesions per 
cell was recorded and the adhesion subtypes plotted as a percentage of this value. Stars indicate significant 
differences between groups as determined by one-way ANOVA and Dunn’s post hoc test *P<0.5, **P<0.1 and 
***P<0.001. Numerical values can be found in Table 3-3 and a list of all significant differences in Table A-3. 
Error bars are standard error (n=40 per substrate).  
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3.3.3.3 Seeding Density Affects Cell Spreading and MSC Size 
 
Cell seeding density has previously been shown to be an important regulator of 
MSC behaviour, affecting proliferation rate and size (Sekiya et al., 2002). Taking 
this into consideration, stro1 MSCs were seeded at a set number of cells (10,000 
per sample) on substrates with different surface areas. Circular coverslips with 
diameters of 13 and 18 mm, and rectangular coverslips with dimensions of 22x64 
mm were used (total surface areas of 133, 255 and 1408 mm2) resulting in initial 
cell seeding densities of 75, 39 and 7 cells/mm2. Cultures plated at 75 cells/mm2 
are comparable to the PromoCell® studies using SSM. As in section 3.3.3.1, stro1 
MSCs were fixed and immuno-labelled at day 7 then analysed to determine their 
average size. Both sets of cells were morphologically indistinguishable from each 
other in terms of size, and behaviour. However, stro1 MSCs exhibited a greater 
degree of size difference between the substrates even at comparable densities.  
 
Compared to PromoCell® MSCs, stro1 cells were larger on PLAIN, ARGD and DIGE-
D substrates and smaller on PEG, FMOC and DIGE-E, creating a pronounced size 
divide between the substrates. This pattern persisted in all three densities, and 
became more pronounced as the density decreased. Unexpectedly, at the lowest 
density cells reacted differently to the substrates compared with the other two 
densities and PromoCell® cultures. Although cells attached and spread on PLAIN 
and ARGD surfaces within hours, those seeded on PEG, ARGE, FMOC, DIGE-D and 
DIGE-E remained detached for longer. By 24 hours, cells adhered to FMOC-D and 
DIGE-D but were still detached in PEG, ARGE, FMOC-E and DIGE-E cultures. Note, 
at this time point DIGE-D and DIGE-E substrates have not yet been digested, and 
therefore have the same surface chemistry as FMOC-D and FMOC-E. A significant 
number of cells were lost from PEG, ARGE and DIGE-E cultures at 48 hours during 
media changes while cells that had attached were poorly spread (Figure 3-14).  
 
At day 7, cells cultured on PLAIN, ARGD and DIGE-D surfaces were clearly much 
larger than those seeded on the other substrates. In fact, size analysis confirmed 
that MSCs cultured on PLAIN substrates were 3.2 times larger than cells on PEG, 
while MSCs cultured on ARGD were 4 times larger than MSCs on ARGE substrates. 
Furthermore, cells that were plated on DIGE-D substrates were approximately 5 
times larger than cells seeded on DIGE-E and almost twice as big as those seeded 
on FMOC-D substrates (Figures 3-15 to 3-17 and Table 3-4). Lowering the seeding 
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density diminished the ability of the cells to adhere to substrates functionalised 
with PEG, Fmoc and the non-integrin-binding peptide RGE. All other experiments 
were therefore carried out using a seeding of 7 cells/mm2. 
 
 
Figure 3-14: Stro1 MSCs seeded at 7 cells/mm2 in SSM conditions. Upper two rows refer to PLAIN, ARGD, 
FMOC-D and DIGE-D where the labelled row is at 24 hours and the unlabelled row is 7 days. Lower two rows 
are PEG, ARGE, FMOC-E and DIGE-E with labelled row at 24 hours and unlabelled row at 7 days. Note at 24 
hours DIGE-D and DIGE-E surfaces are undigested and therefore are the same as FMOC-D and FMOC-E. MSCs 
took longer to attach to PEG, ARGE, FMOC and DIGE-E at this density and were much smaller. Cells in upper 
and lower panels of the same samples do not correspond with each other; scale bar is 100 !m. 
 
 
Substrate  
 
 
Average cell size (µm2) 
 
        75               39                 7 
 
  
PLAIN .................................... 19880 ± 726 16080 ± 666 15790 ± 695 
PEG....................................... 06833 ± 632 02936 ± 134 04975 ± 276 
ARGE ..................................... 09228 ± 530 04615 ± 181 05690 ± 332 
ARGD..................................... 21560 ± 921 18040 ± 755 022700 ± 974. 
FMOC-E .................................. 09884 ± 571 05838 ± 281 04295 ± 246 
FMOC-D .................................. 14590 ± 787 08240 ± 243 07806 ± 441 
DIGE-E ................................... 10810 ± 754 06728 ± 209 03757 ± 167 
DIGE-D ................................... 17900 ± 638 16310 ± 485 018060 ± 981. 
  
Table 3-4: Quantification of stro1 MSC size. Stro1 MSCs were morphologically indistinct from PromoCell® 
MSCs with the exception that stro1 cells spread to a greater degree on PLAIN, ARGD and DIGE-D substrates 
and to a lesser degree on PEG, FMOC and DIGE-E. Table shows the average cell size of MSCs cultured for 7 
days at a seeding density of 75, 39 and 7 cells/mm2 in SSM conditions. Values correlate with Figures 3-15 to 
3-17; error values are standard error (n=40 per substrate). 
Chapter 3: Cell Culture Optimisation and MSC Characterisation 
76 
 
Figure 3-15: Immuno-fluorescence images of Stro1 MSCs seeded at 7 cells/mm2 in SSM conditions. After 
7 days of culture, Stro1 cells were morphologically indistinguishable from PromoCell® MSCs, however these 
cells spread to a greater degree on PLAIN ARGD FMOC-D and DIGE-D substrates, and to a smaller degree on 
PEG, ARGE, FMOC-E and DIGE-E creating a pronounced size difference between the substrates. Colours are 
red (actin), green (vinculin) and blue (nuclei); scale bar is 100 !m.  
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Figure 3-17:Quantification of Stro1 MSC size using different seeding densities in SSM conditions. Graphs 
depict average cell size after 7 days of culture at initial seeding densities of 75, 39 or 7 cells/mm2. Stars 
indicate significant differences between groups as determined by one-way ANOVA and Dunn’s post hoc test 
where *P<0.5 **P<0.1 and ***P<0.001. Numerical values can be found in Table 3-4 and a list of all significant 
differences can be found in Table A-5. Error bars represent standard error (n=40 per substrate). 
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3.3.3.4 Adhesion Characterisation at 7 cells/mm2 
 
As per PromoCell® cultures, most of the adhesions were FAs and in fact, for stro1 
cells over 80% of adhesions were FAs resulting in an even smaller percentage of 
FXs and SMAs. Regardless, the general trend observed in PromoCell® studies was 
also observed in stro1 cultures. MSCs cultured on PEG, ARGE and DIGE-E tended 
to express more FXs compared to those on PLAIN, ARGD and DIGE-D substrates. 
MSCs cultured on PLAIN, ARGD and DIGE-D substrates typically developed more 
SMAs compared to PEG, ARGE and DIGE-E. FXs were greatest on both DIGE-E and 
FMOC-D accounting for nearly 6% of all adhesions, while roughly 4% of adhesions 
on PEG and 5% of adhesions on ARGE substrates were also FXs. In terms of SMAs, 
13% of adhesions expressed by cells on ARGD, 9% of adhesions on DIGE-D and 4% 
on FMOC-D were SMAs. Interestingly, MSCs on PLAIN surfaces previously followed 
the same pattern as ARGD and DIGE-D in that they express fewer FXs and more 
SMAs compared to the other surfaces. However, approximately 5% of adhesions 
on these cells were FXs and 7% were SMAs indicating that MSCs seeded on PLAIN 
substrates had more FXs and fewer SMAs than ARGD and DIGE-D (Table 3-5).  
 
Substrate     
 
Average 
 
(Total) 
 
 
FX 
 
(%) 
 
 
FA 
 
(%) 
 
 
SMA 
 
(%) 
 
    
PLAIN .................... 434 ± 25.3 5.39 ± 0.540 88.0 ± 0.564 6.64 ± 0.401 
PEG....................... 162 ± 11.0 4.48 ± 0.418 93.5 ± 0.496 2.01 ± 0.287 
ARGE ..................... 186 ± 8.77 5.19 ± 0.634 93.1 ± 0.592 1.75 ± 0.217 
ARGD..................... 411 ± 24.7 2.86 ± 0.732 83.8 ± 1.110 13.4 ± 0.877 
FMOC-E .................. 167 ± 11.5 3.01 ± 0.370 95.4 ± 0.452 1.56 ± 1.170 
FMOC-D .................. 291 ± 18.5 5.55 ± 0.550 92.4 ± 0.601 2.08 ± 0.256 
DIGE-E ................... 178 ± 11.1 6.22 ± 0.722 93.5 ± 0.707 0.30 ± 0.079 
DIGE-D ................... 282 ± 21.8 3.53 ± 0.394 87.6 ± 0.704 8.85 ± 0.617 
    
Table 3-5: Quantification of stro1 MSC adhesions. The average number of adhesions per cell was recorded 
and the subtypes expressed as a percentage of this number. Stro1 cells expressed more adhesions per cell 
than PromoCell® MSCs but the percentage of FXs and SMAs was smaller. Table shows the average number of 
adhesions per cell and percentage of each subtype for MSCs cultured at a density of 75 cells/mm2 for 7 days 
in SSM. Values correlate with Figures 3-17 and 3-18; error values are standard error (n=40 per substrate). 
 
 
Overall, the results indicate that in terms of FXs, MSCs on ARGE developed 1.7 
times more than MSCs on ARGD surfaces, 1.5 times more on DIGE-E than DIGE-D, 
and approximately 4 times more on FMOC-D than DIGE-D. Furthermore, in terms 
of SMAs, MSCs cultured on ARGD substrates expressed 6.5 times more SMAs than 
MSCs on either ARGE and PEG substrates, 30 times more on DIGE-D than DIGE-E 
and 4.5 times more on DIGE-D than FMOC-D (Figures 3-18 and 3-19).  
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Figure 3-19: Quantification of the average percentage of adhesion subtypes expressed per cell by Stro1 
MSCs seeded at 7 cells/mm2 in SSM conditions. After 7 days, the average total number of all adhesions per 
cell was recorded and subtypes plotted as a percentage of this value. Stars indicate significant differences 
between groups as determined by one-way ANOVA and Dunn’s post hoc test *P<0.5 **P<0.1 and ***P<0.001. 
Numerical values can be found in Table 3-5 and a list of all significant differences found in Table A-6; error 
bars represent standard error (n=40 per substrate) 
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3.3.4 Phosphomyosin Expression 
 
Increased phosphomyosin (p-myosin) expression is associated with an increase in 
contractile forces experienced by the cell cytoskeleton in response to adhesion 
and spreading (section 1.3.6). The assumption is that MSCs cultured on ARGD and 
DIGE-D substrates will experience a greater degree of cytoskeletal tension than 
those seeded on the other surfaces owing to the differences in size and adhesion 
formation seen in previous sections. Stro1 MSCs were cultured in SSM and seeded 
at a density of 7 cells/mm2 in accordance with optimised culture conditions. At 
day 7 cells were fixed, stained and analysed as per sections 3.2.6 and 3.2.7 with 
p-myosin expression recorded as a function of fluorescence intensity.  
 
Phosphomyosin expression was observed to differ substantially between surfaces 
with MSCs cultured on ARGD and DIGE-D substrates showing a distinct increase in 
expression compared to the other substrates including PLAIN. Accordingly, MSCs 
cultured on ARGD surfaces exhibited the highest levels of fluorescence intensity 
at 3.5 times more than levels recorded for cells on ARGE substrates. Similarly, 
intensity values were 2.6 times greater on DIGE-D than DIGE-E surfaces, and 2.9 
times greater on PLAIN than PEG surfaces. Values recorded for cells cultured on 
DIGE-D were 1.8 times greater than values expressed by MSCs seeded on FMOC-
D. As p-myosin expression is greatest on ARGD and DIGE-D, the data supports the 
assumption that surfaces functionalised with RGD in this work would experience 
increased tensional forces (compared to surfaces with low adhesive qualities) in 
accordance with their increased size and greater numbers of SMAs. 
 
Substrate  
 
 
Phosphomyosin expression 
 
         Size                 MGV                    ID 
 
  
PLAIN .....................  13909 ± 3376. 57.1 ± 2.16 482142 ± 18356 
PEG........................  04484 ± 205.8 46.7 ± 1.60 164137 ± 87620 
ARGE ......................  05912 ± 224.8 43.1 ± 1.12 192268 ± 87010 
ARGD......................  19099 ± 3280. 52.5 ± 1.81 665848 ± 26528 
FMOC-E ...................  07664 ± 207.5 47.1 ± 1.47 284122 ± 13411 
FMOC-D ...................  09317 ± 287.1 51.5 ± 1.43 357355 ± 13571 
DIGE-E ....................  06090 ± 212.3 47.0 ± 1.46 222130 ± 10258 
DIGE-D ....................  17056 ± 575.7 45.0 ± 1.14 578950 ± 24303 
  
Table 3-6: Quantification of phosphomyosin expression. Integrated density values were calculated using 
mean grey value x cell area, as described in section 3.2.7. Table displays values for the average cell size, 
mean grey value (MGV) and integrated density (ID) for MSCs cultured at a density of 7 cells/mm2 in SSM. 
Note that ID values recorded in the table are corrected for background fluorescence and do not reflect the 
raw data. Data correlates with Figures 3-20 and 3-21; error values are standard error (n=40 per substrate). 
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Figure 3-20: Quantification of Phosphomyosin expression for Stro1 MSCs seeded at 7 cells/mm2 in SSM 
conditions. Phosphomyosin expression was calculated as fluorescence intensity with high values indicative 
of cytoskeletal tension. Graph refers to Stro1 MSCs cultured for 7 days. Stars indicate significant difference 
between groups as determined by one-way ANOVA and Dunn’s post hoc test where *P<0.5, **P<0.01 and ***P 
<0.001. Numerical values can be found in Table 3-6 and a complete list of significant differences can be 
found in Table A-9. Y-axis values are in thousandths; error bars are standard error (n=40 per substrate). 
 
 
3.3.5 Summary of Optimisation Studies 
 
The results obtained from cell culture optimisation studies suggest, that in order 
to elicit optimal responses from MSCs cultured on these surfaces (excluding PEG 
and PLAIN) future experiments should be conducted using !-MEMs supplemented 
with 10% FBS, and a cell seeding density of 7 cells/mm2. Under these conditions, 
MSCs cultured on ARGD and DIGE-D surfaces tended to be much larger than their 
FMOC and RGE counterparts, and consequently developed more adhesions in line 
with this increase in size. Furthermore, the percentages of FXs and SMAs were 
reversed e.g. cells cultured on ARGD and DIGE-D expressed fewer FXs and more 
SMAs than those cultured on ARGE, FMOC and DIGE-E. Table 3-7 summarises the 
outcome of the optimisation studies for FMOC and peptide presenting substrates. 
 
Substrate     
 
Size 
 
(µm) 
 
 
FX 
 
(%) 
 
 
SMA 
 
(%) 
 
 
p-Myosin 
 
(Intensity) 
 
    
ARGD vs. ARGE ......... ARGD ARGE ARGD ARGD 
ARGD vs. FMOC-D ...... ARGD ARGE ARGD ARGD 
DIGE-D vs. DIGE-E...... DIGE-D DIGE-E DIGE-D DIGE-D 
DIGE-D vs. FMOC-D..... DIGE-D DIGE-E DIGE-D DIGE-D 
    
Table 3-7: Summary of optimisation studies. Table data indicates which of the two substrates in the first 
column has the higher recorded value using SSM conditions and a seeding density of 7 cells/mm2. MSCs on 
ARGD and DIGE-D substrates tend to be larger than those cultured on ARGE, FMOC-D and DIGE-E substrates, 
have more SMAs and a higher expression of p-myosin. MSCs on ARGE, FMOC-D and DIGE-E display more FXs. 
0 
100 
200 
300 
400 
500 
600 
700 
800 
PLAIN PEG ARGE ARGD FMOC-E FMOC-D DIGE-E DIGE-D F
lu
or
es
ce
nc
e 
In
te
ns
ity
 (
a.
u.
) 
Substrate 
Chapter 3: Cell Culture Optimisation and MSC Characterisation 
84 
 
Figure 3-21::Immuno-fluorescence images of Stro1 MSCs seeded at 7 cell/mm2 in SSM immuno-labelled 
for phosphomyosin. Figure shows grey-scale images of MSCs cultured in line with optimised conditions and 
labelled for phosphomyosin. MSCs displayed distinct differences in phosphomyosin expression between the 
different surfaces. MSCs seeded on ARGD and DIGE-D expressed the highest levels of fluorescence compared 
to the other substrates suggesting cells on these surfaces experienced a greater amount of tensional forces 
in the cytoskeleton. Areas of brighter of staining reflect areas under increased tension; scale bar is 100 !m. 
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3.4 Discussion and Conclusion 
 
Continuing from Todd et al. (Todd et al., 2009), developing a system capable of 
altering surface properties in situ presented a challenge in terms of inducing this 
change without reducing cell viability. In this work it was shown that introducing 
elastase at a concentration of 0.1 mg/ml 48 hours after seeding, was sufficient 
to expose the sterically blocked RGD ligands (as seen from previous work and by 
changes in cell behaviour etc) without killing the cells. Similar to the osteoblasts 
described in previous work (Todd et al., 2009), most of the substrates were well 
tolerated by MSCs. As per section 3.3, MSCs attached to all surfaces and spread 
to varying degrees depending on the surface chemistry. PLAIN, ARGD and DIGE-D 
were particularly amenable to cell adhesion and growth as demonstrated by the 
development of strong actin stress fibres, numerous adhesions and increased size 
exhibited by cells on these surfaces compared to PEG, ARGE and DIGE-E. While 
ARGD and DIGE-D both contain the integrin-binding RDG ligand, ARGE and DIGE-E 
surfaces contain the non integrin-binding RGE peptide; thus these surfaces were 
not expected to support cell adhesion and growth to the same extent. Although 
MSCs did adhere to ARGE and DIGE-E, and in fact also to PEG and FMOC surfaces, 
this was likely due to serum proteins adsorbing to the surface.  
 
As discussed in chapter 1, surfaces in culture are subject to non-specific protein 
adsorption depending on their chemical properties (Hirsh et al., 2013; Rabe et 
al., 2011). The protein resistant properties of PEG inhibits protein adsorption in 
most cases, however the complex composition of cell culture media proteins can 
result in a loss of this function over time. After incubating SAMs of different end-
groups with BSA, Faucheux et al. identified a number of proteins that adsorbed 
to substrates coated with SAMs terminating in PEG. Furthermore, using a system 
of micro-patterned adhesive islands separated by PEG, Kilian et al. observed a 
small number of cells adhering to the inter-island spaces after 7 days (Kilian et 
al., 2010; Faucheux et al., 2004). Given these data, it is unsurprising that some 
MSCs were able to attach to ARGE, FMOC, DIGE-E and even PEG substrates.  
 
Despite this, small amounts of adsorbed proteins had little affect on the overall 
study. MSCs seeded on PEG, ARGE, FMOC and DIGE-E substrates developed clear 
morphological differences compared to cells adhered to PLAIN, ARGD and DIGE-D 
substrates. Initial viability studies, FBS concentration and seeding density studies 
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all revealed cell size and adhesion formation were reduced on PEG, ARGE, FMOC 
and DIGE-E. As these are important regulators of cellular processes such as MSC 
commitment etc (Gao et al., 2010; McBeath et al., 2004; Chen et al., 1997), it 
can be assumed, that despite some level of interaction between cells and these 
substrates, their functional output was different. Also, as previously mentioned, 
the main objective of this study is to switch from a system that has limited cell 
adhesion properties where cells exist in a low-tension state, to one that actively 
promotes adhesion by increasing ligand availability and switching the cells to a 
high-tension state. That MSCs adhered to FMOC substrates is then preferable in 
this case.  
 
Cells size analysis and adhesion analysis of MSCs cultured in standard conditions 
revealed a general trend in MSC development between the different substrates. 
Lowering the concentration of FBS in subsequent cultures did not alter this trend 
but resulted in a decrease in cell size and, in SFM cultures, a reduction in overall 
cell numbers. FBS is commonly added to cell culture as a means to support cell 
growth and a widely used approach for synchronising the cell cycle of cultures is 
by starving the cells of serum (Liu et al., 2011; Cooper, 2003). It then stands to 
reason that lowering FBS concentration in LSM and SFM cultures directly affected 
growth by inhibiting normal progression through the cell cycle. Also, it cannot be 
ruled out that cell numbers were much lower in SFM because initial attachment 
numbers were low, or as a result of cells becoming detached during culture. The 
fact that cell size in SFM was greatest on ARGD and DIGE-D substrates suggests 
that MSCs on these substrates were able to attach and spread exclusively due to 
the RGD ligand. Regardless, despite our original intention to reduce or remove 
FBS for future proteomic studies, both LSM and SFM conditions were found to be 
unsuitable for maintaining MSCs on these surfaces owing to the reduced size and 
number of cells observed in both systems.  
 
Initial adhesion studies and cell culture optimisation (including FBS and elastase 
concentration studies) were carried out using PromoCell® MSCs, while all other 
experiments were performed with STRO-1 selected cells. The decision to replace 
PromoCell® MSCs was based on two main reasons. Firstly, the stro1 cells in this 
study were derived from bone marrow obtained during routine hip replacement 
surgery, and delivered as live proliferating cells at passage P0. PromoCell® MSCs 
on the other hand, were usually delivered at a later passage after quality control 
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testing. Secondly, stro1 cells were isolated from the bulk MSC population using 
an antibody against the STRO-1 surface antigen (section 3.2.2.1) ergo these cells 
represent a more homogenous subpopulation (Oyajobi et al., 1999). Differences 
observed in behaviour between the cells could then be attributed to variation in 
passage number (cell culture age), homogeneity and patient variability.  
 
Similar to lowering FBS concentration, changing cell density also had an obvious 
affect on MSC behaviour. In accordance with a decrease in cell seeding density 
from 75 to 7 cells/mm2, initial cell attachment to PEG, ARGE, FMOC and DIGE-E 
surfaces was delayed, and while cell size decreased on most substrates including 
PLAIN, it increased on ARGD and DIGE-D. Adhesion analysis of cells seeded at the 
lower density revealed MSCs on these surfaces developed more adhesions in line 
with their increased surface area. Compared with their RGE counterparts (ARGE 
and DIGE-E), cells on these surfaces displayed fewer FXs and more SMAs. FXs are 
primarily associated with migration as they are located at the leading cell edge 
during the early stages of cell attachment, and subject to rapid turnover. Larger 
adhesions are more commonly associated with well spread cells and high degrees 
of tensional force (Zaidel-Bar et al., 2004; Zaidel-Bar et al., 2003). This suggests 
that MSCs on ARGD and DIGE-D were under increased cellular tension compared 
to MSCs on the other substrates, a fact confirmed by p-myosin expression, which 
was greatest on ARGD followed by DIGE-D and PLAIN.  
 
Seeding density is a well-known modulator of cell dynamics. A number of studies 
have shown that cells plated at relatively low densities undergo a faster rate of 
proliferation compared to higher seeding densities (Mandl et al., 2004; Sekiya et 
al., 2002; Colter et al., 2000). This is presumed to be because cells plated at 
low density are not subject to spatial constraints imposed by neighbouring cells. 
Indeed, high cell density is associated with growth arrest in some cell types due 
to inhibitory factors associated with cell-cell contact (McBride and Knothe-Tate, 
2008; Batt and Roberts, 1998) and the up-regulation of Hippo signalling pathways 
(Halder and Johnson, 2011; Wada et al., 2011). Moreover, Huang and co-workers 
found that size-dependent cellular tension is responsible for the up-regulation of 
cyclin D1 and concurrent down-regulation of the cdk inhibitor p27kip1 leading to 
cell cycle progression through the G1/S checkpoint (Huang et al., 1998). Hence 
cells at low density with sufficient room to spread, continue to proliferate until 
they run out of space to do so and growth rate becomes inhibited. The increased 
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growth rate observed in cells at low density means that population doubling also 
increases so large cell yields can be achieved in a shorter period of time (Sekiya 
et al., 2002). This is essential to producing sufficient quantities of cells for use 
in regenerative medicine. 
 
In addition to cell growth rates, seeding density has also been shown to regulate 
MSC differentiation. Using induction media, McBeath et al., observed that MSCs 
at low seeding densities (1000–3000 cell/cm2) and cultured in adipogenic media, 
failed to exhibit markers for adipocytes, while those cultured at a higher density 
(21000–25000 cells/cm2) did. Conversely, MSCs cultured using osteogenic media 
only expressed osteogenic markers at the lower densities (McBeath et al., 2004). 
This observation is also attributed to size-dependent cellular tension since MSCs 
seeded at low density are able to spread and therefore generate tensional forces 
necessary to support osteogenic differentiation (Wang et al., 2011). MSCs seeded 
at high density are spatially restricted and thus are unable to generate the same 
level of tension. In the same study, individual MSCs were seeded onto different 
sized fibronectin islands separated by non-adhesive regions. MSCs on the smaller 
islands (1024 !m2) primarily differentiated into adipocytes, while those on larger 
islands (10000 !m2) preferentially gave rise to osteoblasts.  
 
In this chapter, MSCs were seeded at a density of 75, 39 and 7 cells/mm2, which 
is equivalent to 7500, 3900 and 700 cells/cm2. MSCs plated at the lowest density 
can be considered to be similar to the lower seeding density of 1000 cells/cm2 in 
work published by McBeath et al. (McBeath et al., 2004). At this density cell size 
between the different surfaces was significantly different in most cases and the 
largest cells were recorded on PLAIN, ARGD and DIGE-D surfaces at 15790, 22700 
and 18060 !m2, which in some cases is 4 times larger than the other surfaces. At 
this size, MSCs on PLAIN, ARGD and DIGE-D were larger than those restricted to 
10000 !m2 by the size limit of the adhesive islands. The conclusion drawn from 
this data is that size-dependent cytoskeletal tension is a major regulator of MSC 
growth and differentiation. Furthermore, based on increased size, the formation 
of mature focal adhesions, and increased cytoskeletal tension (determined by an 
increased expression of phosphorylated myosin), it can be suggested that MSCs 
cultured on RGD positive controls (ARGD), and those on surfaces that have been 
switched from a low adhesive state (FMOC) to a high adhesive state (DIGE-D) are 
likely to differentiate along an osteogenic lineage.  
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4.1 Introduction 
 
Stem cell differentiation is characterised by a decline in the expression of genes 
associated with proliferation, and a concomitant up-regulation in the expression 
of genes associated with a change in morphology, function and ECM organisation. 
In the context of osteogenic differentiation, Stein and co-workers posit the idea 
of three main stages that define the development of osteoprogenitors to mature 
osteoblasts. The progression of one to the other is described as a reciprocal and 
functionally linked relationship between the decline in proliferative activity, and 
the induction of ECM maturation and mineralisation (Lian and Stein, 1995; Stein 
and Lian, 1993). Accordingly, these phases are marked by a decrease in collagen 
(COL) type I and fibronectin (FN), and a concurrent rise in alkaline phosphatase 
(ALP) production during the transition from proliferation to matrix maturation. 
Osteopontin (OPN) levels decline during late-stage proliferation then reach peak 
levels during the mineralisation phase, while osteocalcin (OCN) levels also peak 
during this stage (Owen et al., 1990; Stein et al., 1990). 
 
 
Figure 4-1: Osteoblast development. Schematic illustration of the three experimentally determined stages 
involved in osteoblast proliferation and differentiation. Each developmental stage is distinguished between 
by two transition points that mark the change from proliferation to ECM maturation, and the shift from ECM 
maturation to mineralisation. Specific growth and differentiation-related proteins are expressed according 
to their roles in each period (redrawn and adapted from Lian and Stein, 1995). 
 
 
Using this model, it is possible to follow the development of MSCs in vitro from 
non-committed precursors to mature osteoblasts on the basis of their expression 
of certain phenotypic proteins (proteins typical of a particular cell phenotype). 
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The matrix proteins OPN and OCN are regularly used as positive indicators of the 
onset of osteogenic commitment (Kim et al., 2005; Rickard et al., 1996). OPN is 
a glycophosphoprotein found in several tissues types (Denhardt and Guo, 1993), 
but expressed abundantly in bone where it is involved in cell binding and mineral 
nucleation (McKee and Nanci, 1996). OCN is an osteo-specific protein expressed 
post-proliferatively by osteoblasts (Malaval et al., 1999; Lian et al., 1989). 
  
In addition to looking at phenotypic protein expression, metabolomic output was 
also investigated. Metabolomics is described as the study of the unique chemical 
fingerprint that specific cellular processes leave behind (Daviss, 2005) while the 
metabolites themselves are low molecular weight biomolecules (<1500 Da), such 
as nucleic acids, amino acids, peptides, lipids and carbohydrates (Wishart et al., 
2009; Wishart et al., 2007; Wishart, 2007). Although a relatively new addition to 
the ‘omics’ family it has thus far found application in a range of research areas. 
Cezar et al. used metabolomics to measure and identify metabolites secreted by 
ESCs and ESC-derived neural progenitors, thereby building a metabolic profile of 
these cells in vitro. Furthermore, after treatment with an anticonvulsant drug, 
significant changes were seen in a number of metabolic pathways thus they were 
also able to analyse the effect this drug had on these cells (Cezar et al., 2007). 
Other groups have similarly used metabolomics as a means to study drug efficacy 
and toxicity, and to look for biomarkers as indicators of disease (Jansson et al., 
2009; Kim et al., 2009; Sun et al., 2009; Bogdanov et al., 2008). 
 
As well as determining drug and disease-related changes, metabolomics can be 
used to investigate non-pathological changes to metabolite output. In relation to 
tissue engineering and stem cell research, metabolomics has been used to garner 
information about stem cell phenotypes as a function of their different energetic 
states e.g. quiescence, proliferation, commitment and differentiated (Folmes et 
al., 2012; McNamara et al., 2012; Yanes et al., 2010). For example, Panopoulos 
et al. determined that iPSCs share a common pluripotent metabolic profile with 
ESCs but it is distinct from the parent cell and characterised by changes that are 
associated with cellular respiration, specifically that iPSCs switch from oxidative 
to glycolytic respiration in long-term culture as the cells begin to take on a more 
ESC-like genotype (Panopoulos et al., 2011). At early passage, iPSCs retain DNA 
methylation signatures characteristic of the tissue they were derived from (Shao 
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et al., 2012; Nishino et al., 2011; Kim et al., 2010). Most of these tissue-specific 
modifications are eventually lost at later passages (Nishino et al., 2011). Simsek 
et al. were similarly able to determine from the haematopoietic stem cell (HSC) 
metabolome, that these cells also respire using glycolytic respiration rather than 
aerobic respiration (Simsek et al., 2010). This is supportive of HSC adaption to a 
hypoxic niche and the fact that reactive oxygen species produced during aerobic 
respiration can deplete the HSC population (Chen et al., 2008; Ito et al., 2006).  
 
Metabolomics is routinely conducted using mass spectrometry (MS) though it has 
also been carried out using nuclear magnetic resonance and Fourier transform-
infrared spectroscopy (Dettmer et al., 2007; Dunn and Ellis, 2005). Typically, MS 
is used in tandem with separation techniques such as liquid chromatography (LC) 
which first separates metabolites based on retention time, and then determines 
their molecular composition based on their mass-to-charge (m/z) ratio (Pan and 
Raftery, 2007). LC-MS has become increasingly popular for metabolite analysis in 
line with the development of ultra-high resolution (within 1 ppm) mass detectors 
e.g. Orbitraps, and improved separation columns like the hydrophilic interaction 
columns which readily separate rapidly eluting polar metabolites (Zhang et al., 
2012; Hu et al., 2005). The combined sensitivity and selectivity of LC-MS enables 
increasingly complex mixtures of metabolites to be analysed, which is essential 
to achieving a comprehensive metabolic profile in many avenues of research.  
 
The first part of this chapter was to use immunocytochemistry to document the 
expression of phenotypic proteins associated with osteoblast differentiation over 
time. MSCs were also labelled for STRO-1 and activated leukocyte cell adhesion 
molecule (ALCAM), which are both surface antigens associated with MSCs in their 
undifferentiated state, and are down-regulated during differentiation (Bruder et 
al., 1998; Bruder et al., 1997a; Gronthos et al., 1994; Simmons and Torok-Storb, 
1991). Collectively, STRO-1, ALCAM, OPN and OCN can thus be used to track MSC 
growth and commitment. The second part of this work was to use metabolomics 
to identify any differences in metabolic output before and after the initiation of 
the enzyme switch, which might indicate a change in cell function. Ultimately, 
the intention of this work was to determine whether or not MSCs preferentially 
differentiated into osteoblasts on surfaces presenting RGD (ARGD and DIGE-D), 
over substrates with lower cell-binding properties (PLAIN and FMOC).  
Chapter 4: MSC Differentiation 
94 
4.2 Materials and Methodology 
 
 
4.2.1 Materials 
 
List of Reagents 
 
 
Cell culture reagents...................................................................... 
MEM-Alpha culture medium ..........................................PAA Laboratories 
Antibiotic mix .................................................................... In-house 
L-glutamine (200 mM)...............................................................Sigma 
Penicillin streptomycin .............................................................Sigma 
Ampotericin B (250 !g/ml) ................................................... Invitrogen 
Foetal bovine serum.................................................................Sigma 
Trypsin.................................................................................Sigma 
Versine............................................................................. In-house 
Sodium chloride ......................................................................Sigma 
Potassium chloride...................................................................Sigma 
Glucose ................................................................................Sigma 
Phenol red indicator.................................................................Sigma 
Ethylenediaminetetraacetic acid..................................................Sigma 
4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid.............. Sigma-Aldrich 
 
Immunocytochemistry reagents ........................................................ 
1X Phosphate buffer saline ............................................... Sigma-Aldrich 
Formaldehyde .............................................................. Sigma-Aldrich 
Permeabilisation buffer......................................................... In-house 
Sucrose ...................................................................... Sigma-Aldrich 
Triton® X 100 ............................................................... Sigma-Aldrich 
Magnesium chloride hexahydrate ....................................... Sigma-Aldrich 
Bovine serum albumin..................................................... Sigma-Aldrich 
Tween 20® .................................................................. Sigma-Aldrich 
Rhodamine phalloidin ................................... Invitrogen, Molecular Probes 
Fluorescein streptavidin ...........................................Vector Laboratories 
Horse-biotinylated anti mouse IgG...............................Vector Laboratories 
Horse-biotinylated anti rabbit IgG ...............................Vector Laboratories 
Vectashield mounting media with DAPI .........................Vector Laboratories 
Rabbit polyclonal anti ALCAM IgG ............................................ Epitomics 
Mouse monoclonal anti-STRO-1 IgM ..........................Insight Biotechnologies 
Mouse monoclonal anti-osteopontin IgG ....................Insight Biotechnologies 
Mouse monoclonal anti-osteocalcin IgG .....................Insight Biotechnologies 
 
Metabolomic reagents..................................................................... 
Chloroform............................................................................Sigma 
Methanol ..............................................................................Sigma 
Acetonitrile ...........................................................................Sigma 
Formic acid ...........................................................................Sigma 
 
Other reagents ............................................................................. 
Ethanol ................................................................................Sigma 
Porcine pancreatic elastase (4.61 U/mgP)............... Worthington Biochemical 
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4.2.2 MSC Maintenance and Experiment Setup 
 
Prior to use, MSCs were maintained as per section 3.2.3. Briefly, cells were kept 
at 37°C and 5% CO2 in !-MEM containing 10% v/v FBS and 2% v/v antibiotic mix. 
For all experiments cells were rinsed in HEPES saline solution, followed by 4 ml 
of trypsin-versene until cells were completely detached from the tissue culture 
flask. Cells were transferred to a sterile falcon tube and centrifuged at 376 g for 
4 minutes. The supernatant was discarded and cells resuspended in 5 ml of fresh 
media. Cell numbers were counted using a Neubaur haemocytometer and seeded 
at 7 cells/mm2 in standard culture medium containing 10% FBS. Substrates were 
sterilised in 70% ethanol (3x 5 minutes) and rinsed with HEPES saline and !-MEM.  
 
 
4.2.3 Immunocytochemistry  
 
Samples were washed with PBS and fixed with 10% v/v formaldehyde/PBS for 15 
minutes at 37°C as per section 3.2.6. Cultures immuno-labelled for OPN and OCN 
were permeabilised at 4°C for 5 minutes; all samples were treated with 1% w/v 
BSA/PBS for 15 minutes at 37°C to block non-specific binding epitopes. Primary 
antibodies were diluted in BSA/PBS to make up solutions of rhodamine-phalloidin 
(1:500) with either mouse monoclonal anti-STRO-1 IgM (1:50), rabbit polyclonal 
anti-ALCAM IgG (1:50), mouse monoclonal OPN IgG (1:50), or mouse monoclonal 
OCN IgG (1:50). Samples were incubated for 1 hour at 37°C and rinsed with 0.5% 
v/v PBST (3x 5 minutes under agitation) to minimise background labelling. Horse 
biotinylated anti-mouse IgG (1:150) in BSA/PBS was added to STRO-1, OPN and 
OCN samples, and horse biotinylated anti-rabbit in BSA/PBS was added to ALCAM 
samples. All samples were incubated for 1 hour at 37°C then washed with PBST. 
After washing, samples were incubated for 30 minutes at 4°C with FITC (1:50) in 
BSA/PBS, followed by a final wash. Coverslips were placed on glass slides in DAPI 
mountant and cells were imaged with a Zeiss Axiovert fluorescence microscope 
at 20X magnification (0.50 NA). Images were taken using an Evolution QEi digital 
monochromatic CCD camera (Media Cybernetics, USA) with ImagePro software.  
 
 
4.2.4 Metabolomics 
 
For metabolomic analysis, substrates were removed from the culture well plates 
and transferred to new sterile plates so that only cells that were attached to the 
Chapter 4: MSC Differentiation 
96 
substrates were used in the analysis. Substrates were washed once with warmed 
PBS then 0.5 ml of ice-cold extraction solvent (chloroform: methanol: water at 
1:3:1 v/v) was added to the wells. Plates were sealed with parafilm to minimise 
evaporation and placed on a rotary shaker for 1 hour at 4°C. After this time the 
extraction solvent was transferred to sterile 0.5 ml eppendorfs and centrifuged 
at 13,000 g for 5 minutes to remove cell debris. The supernatant was transferred 
to LC vials otherwise samples were stored at -80°C in eppendorf tubes until use.  
 
All samples were diluted 1 in 2 with acetonitrile prior to being aspirated to HPLC 
vials; an additional 5 !l of each sample was combined into a single aliquot to be 
used as a quality control sample. This pooled sample was injected several times 
throughout the duration of each run in order to monitor metabolite quality and 
sample degradation. Three standards containing a number of known metabolites 
were also run alongside unknown samples for the purpose of identifying all other 
metabolites. Chromatographic separation of metabolites was performed using an 
UltiMate 3000 RS-LC (Thermo Fisher) with a zwitterionic hydrophilic interaction 
liquid chromatography (ZIC-HILIC) column (C18 150 x 4.6mm; Merck Sequant) as 
the stationary phase, 1% v/v formic acid in acetonitrile as the organic mobile 
phase, and 1% v/v aqueous formic acid as the aqueous mobile phase. The mobile 
phase was run as a gradient over 46 minutes (Table 4-1). Injection volumes were 
10 !l and a ZIC-HILIC C8 20 x 2.0 guard column was used to protect the main 
column from impurities; chromatography columns were maintained at 25°C. 
 
 
Time 
(min) 
 
 
Aqueous 
(%) 
 
 
Organic 
(%) 
 
 
Flow rate 
(ml/min) 
 
 
Gradient 
curve 
 
     
0 20 80 0.3 1 
30 20 80 0.3 6 
32 80 20 0.3 6 
40 95 5 0.3 6 
42 95 5 0.3 6 
  
Table 4-1: LC-MS mobile phase parameters. Chromatographic separation of metabolites was carried out 
using an organic (1% v/v formic acid in acetonitrile)/aqueous (1% v/v aqueous formic acid) mobile phase run 
over a period of 46 minutes. Table data shows the percentage of each mobile phase at particular time 
points, flow rate and gradient curve conditions.  
 
 
MS was performed using an Orbitrap Exactive accurate mass mass spectrometer 
(Thermo Fisher Scientific). Scans were conducted at a mass resolution of 50,000 
in both positive and negative ion modes across a range of 70-1400 m/z. Prior to 
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data acquisition, mass calibration was performed in positive and negative modes 
using a calibration mix containing a number of compounds with known masses 
across the acquisition range. Data conversion, chromatographic peak selection, 
and metabolite identification were carried out using the IDEOM/MzMatch Excel 
interface (Creek et al., 2012; Scheltema et al., 2011) and chromatographic peak 
intensities (peak area) were normalised against the calculated protein content. 
Known standards were used to define both mass and retention times of analytes. 
Putative metabolites were also identified on this basis using predicted retention 
times as described in Creek et al. 2011. 
(Creek et al., 2011) 
 
4.2.5 Image Analysis 
 
Fluorescence images were exported into Photoshop® for the purpose of labelling 
and superimposing colour channels as per section 3.2.7. In order to quantify the 
expression of phenotypic markers, fluorescence images were exported to ImageJ 
and highlighted with the threshold tool. ID values (area x mean grey value) were 
recorded and the values divided by the number of nuclei to average fluorescence 
across the number of cells in the same field of view. As background fluorescence 
could not be recorded because of cell confluency, only images taken at similar 
exposure levels were used. Data was analysed using one-way ANOVA and Dunn’s 
post-hoc test to identify significant differences between groups; significance was 
set at P<0.05. 
 
 
4.3 Results 
 
 
4.3.1 Expression of Phenotypic Markers 
 
MSCs were cultured in triplicate on PLAIN, ARGD, FMOC-D and DIGE-D substrates 
in accordance with optimised culture conditions as outlined in section 4.2.2 (10% 
FBS, 7 cells/mm2). MSCs were cultured for 7, 21 and 28 days then treated as per 
section 4.2.3 at each time point. Morphologically, MSCs cultured on both ARGD 
and DIGE-D substrates appeared large and well spread whereas MSCs cultured on 
FMOC-D surfaces adopted a more bipolar fibroblast-like appearance (Figure 4-2). 
This is particular evident at later time points where MSCs on FMOC-D are densely 
packed but MSCs on both ARGD and DIGE-D maintain their polygonal morphology. 
MSCs cultured on PLAIN surfaces displayed varying degrees of both morphologies. 
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Figure 4-2: Immuno-fluorescence images of Stro1 MSCs. MSCs seeded on ARGD and DIGE-D surfaces were 
large and well spread whereas MSCs seeded on FMOC-D were bipolar and fibroblast like. This is particularly 
obvious at later time points where MSCs on FMOC-D appeared densely packed but MSCs on ARGD and DIGE-D 
maintained their polygonal appearance. Colours are red (actin) and blue (nuclei); scale bar is 100 !m.  
 
 
Although cultures were immuno-labelled for STRO-1, ALCAM, OPN and OCN, only 
OPN and OCN expression was quantified. STRO-1 expression was observed in all 
samples at day 7 but was distinctly reduced by day 21 and negligible at day 28 in 
PLAIN ARGD and DIGE-D samples. Similarly, ALCAM expression was also observed 
at day 7 with expression persisting in day 21 cultures; however very little ALCAM 
was seen at day 28 in all samples (Figures 4-3 to 4-5). Quantification of OPN and 
OCN determined that their expression increased over time, the exception being 
OPN in PLAIN cultures where little change in expression was observed between 
time points. At day 7 OPN levels were significantly lower in FMOC-D compared to 
the other surfaces. This difference became less pronounced over time so that by 
day 28, OPN levels were similar to DIGE-D cultures at the same time point. OPN 
expression in ARGD cultures was not significantly greater than PLAIN or DIGE-D 
at day 7, but it was at day 21 and 28. OCN expression was consistently lower in 
FMOC-D cultures compared to the other samples, and greatest in ARGD cultures. 
OCN expression in both DIGE-D and PLAIN cultures increased over time with OCN 
levels in DIGE-D samples similar to ARGD by day 21, and levels in PLAIN samples 
similar to ARGD cultures by day 28 (Figures 4-3 to 4-8 and Tables 4-2 to 4-3). 
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Figure 4-3: Immuno-fluorescence images of Stro1 MSCs at day 7. MSCs cultured on PLAIN, ARGD, FMOC-D 
and DIGE-D surfaces expressed different levels of STRO-1, ALCAM, OPN and OCN. While STRO-1 and ALCAM 
were expressed on all substrates (not quantified), OPN and OCN levels were greatest on ARGD and lowest 
on FMOC-D. Colours are actin (red), STRO-1/ALCAM/OPN/OCN (green), nuclei (blue); scale bar is 100 !m.  
 
 
 
Figure 4-4: Immuno-fluorescence images of Stro1 MSCs at day 21. At day 21 the STRO-1 marker was seen 
to have substantially decreased on all substrates while ALCAM was still visible. OPN levels were significantly 
increased on all substrates except PLAIN and expression was greatest on ARGD as were OCN levels. Colours 
are actin (red), STRO-1/ALCAM/OPN/OCN (green), nuclei (blue); scale bar is 100 !m.  
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Figure 4-5: Immuno-fluorescence images of Stro1 MSCs at day 28. STRO-1 was no longer observed on most 
of the substrates except FMOC-D while ALCAM was similarly much lower. OPN levels were increased on all 
surfaces except PLAIN while OCN expression was similar on PLAIN, ARGD and DIGE-D but was much lower on 
FMOC-D. Colours are actin (red), STRO-1/ALCAM/OPN/OCN (green), nuclei (blue); scale bar is 100 !m. 
 
 
Substrate  
 
 
OPN Expression (Integrated Density) 
 
          7                  21                    28 
 
  
PLAIN ..........................  110206 ± 6793 140127 ± 75430 122631 ± 49080 
ARGD...........................  110598 ± 4373 234078 ± 85470 0288242 ± 210511 
FMOC-D ........................  072593 ± 6856 170250 ± 12969 228234 ± 17363 
DIGE-D .........................  116056 ± 4884 187359 ± 22540 1218943 ± 16897. 
  
Table 4-2: Quantification of OPN expression. Table data refers to OPN expression in PLAIN, ARGD, FMOC-D 
and DIGE-D cultures seeded at 7 cells/mm2 in SSM conditions for 7, 21 and 28 days. Values correlate with 
Figures 4-2 to 4-4; error values are standard error (n=10 per substrate for day 7, and 20 per substrate for 
days 21 and 28). 
 
 
Substrate  
 
 
OCN Expression (Integrated Density) 
 
          7                  21                    28 
 
  
PLAIN ..........................  080879 ± 3533 108393 ± 85000 192752 ± 17324 
ARGD...........................  119448 ± 5621 206436 ± 12181 0204424 ± 133860 
FMOC-D ........................  040258 ± 3857 100032 ± 44010 129491 ± 12028 
DIGE-D .........................  066634 ± 3617 191164 ± 13617 1189348 ± 15968. 
  
Table 4-3: Quantification of OCN expression. Table data refers to OCN expression in PLAIN, ARGD, FMOC-D 
and DIGE-D cultures seeded at 7 cells/mm2 in SSM conditions for 7, 21 and 28 days. Values correlate with 
Figures 4-2 to 4-4; error values are standard error (n=10 per substrate for day 7, and 20 per substrate for 
days 21 and 28). 
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Figure 4-6: Quantification of OPN and OCN expression in Stro1 cultures seeded at 7 cells/mm2 in SSM 
conditions. To determine OPN and OCN expression (upper and lower graph respectively), integrated density 
values were recorded for each image taken; values were then plotted as fluorescence intensity. Expression 
levels were recorded at day 7, 21 and 28 in line with osteoblast developmental stages described in section 
4.1. In most cases, OPN and OCN expression was found to increase over time consistent with a shift in cell 
behaviour though OCN expression was found to be lower than OPN expression at all time points. Y-axis is in 
thousandths (e.g. 250 = 250,000); error bars are standard error (n=10 per substrate for day 7, and 20 per 
substrate for days 21 and 28). 
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Figure 4-7: Quantification of OPN expression in Stro1 cultures seeded at 7 cells/mm2 in SSM conditions. 
Individual graphs refer to OPN levels expressed by Stro1 MSCs cultured on PLAIN, ARGD, FMOC-D and DIGE-D 
at day 7, 21 and 28. OPN expression was observed to increase over time on ARGD, FMOC-D and DIGE-D but 
very little on PLAIN substrates. Initial expression was reduced in FMOC-D cultures but increased to similar 
levels in DIGE-D at later time points. Stars indicate significant difference between groups as determined by 
one-way ANOVA and Dunn’s post hoc test where stars are *P<0.05 **P<0.01 and ***P<0.001. Numerical values 
can be found in Table 4-2 and a list of all significant differences in Table A-10. Y-axis is in thousands; error 
bars are standard error (n=10 per substrate for day 7 and 20 per substrate for days 21 and 28).  
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Figure 4-8: Quantification of OCN expression in Stro1 cultures seeded at 7 cells/mm2 in SSM conditions. 
Individual graphs refer to Figure 4-6 where data represents OCN levels expressed by Stro1 MSCs cultured on 
PLAIN, ARGD, FMOC-D and DIGE-D substrates at day 7, 21 and 28. OCN expression increased over time on all 
surfaces being consistently higher in ARGD and DIGE-D cultures and consistently lower in FMOC-D cultures. 
Stars indicate significant difference between groups as determined by one-way ANOVA and Dunn’s post hoc 
test where stars are *P<0.05 **P<0.01 and ***P<0.001. Numerical values can be found in Table 4-3 and a list 
of all significant differences can be found in Table A-11. Y-axis is in thousands; error bars are standard 
error (n=10 per substrate for day 7, and 20 per substrate for days 21 and 28).  
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The results of OPN and OCN quantification show clear differences in expression 
between a number of the samples at each time point. For OPN expression, ARGD 
cultures displayed a 52% increase in OPN and a 197% increase in OCN expression 
than FMOC-D at day 7, while DIGE-D cultures expressed an average of 62% more 
OPN than FMOC-D cultures at the same time point. ARGD samples also expressed 
79% and 49% more OCN than DIGE-D and PLAIN cultures respectively, while PLAIN 
also expressed a 101% increase in OCN than FMOC-D. At 21 days, OPN expression 
in ARGD cultures was greater than the other sampls with 67%, 38% and 25% more 
OPN than PLAIN, FMOC-D and DIGE-D respectively. Additionally, ARGD samples 
also expressed 90% and 106% more OCN than PLAIN and FMOC-D, while DIGE-D 
expressed an average of 76% and 91% more OCN than PLAIN and FMOC-D. At day 
28 ARGD, FMOC-D and DIGE-D cultures contained 135%, 86% and 79% more OPN 
respectively than PLAIN while PLAIN, ARGD and DIGE-D surfaces expressed 49%, 
58% and 46% more OCN than FMOC-D (Table 4-2 and 4-3). 
 
 
4.3.2 Metabolomic Output 
 
MSCs were cultured in triplicate in accordance with culture conditions defined in 
section 4.2.2. MSCs were grown on PLAIN, ARGD and FMOC-D surfaces for 2 and 4 
days, and DIGE-D for 4 days (2 days as FMOC-D). Samples were processed as per 
section 4.2.4. LC-MS performed by Suzanne Eadie (Polyomics Facility, University 
of Glasgow), and data analysis using MetaboAnalyst 2.0 (Xia et al., 2012; Xia et 
al., 2009) with help from Enateri Alakpa (Centre for Cell Engineering, University 
of Glasgow). In Figure 4-9, data represents metabolic pathways associated with 
metabolites identified in all samples but differentially expressed between them. 
Percentage pathway changed is a percentage of the total number of metabolites 
in a particular pathway that were altered e.g. 16% of the known metabolites for 
the vitamin B6 pathway were changed in these samples. Data does not identify 
which samples changes to metabolite expression occurred between. 
 
Individual data for each sample is displayed in Figure 4-10 as volcano plots using 
day 2 PLAIN as controls. The y-axis refers to p-value (determined by two-tailed 
t-test) with the x-axis set at P=0.05 so that data points above the axis represent 
putative metabolites significantly different from controls. The x-axis represents 
the magnitude in difference between samples and the control. All data points on 
the left-hand side of the y-axis refer to putative metabolites down-regulated in 
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respect to the control, while data points on the right-hand side of the axis were 
up-regulated compared to the control. The higher above the x-axis the greater 
the significance difference and the further away from the y-axis the greater the 
fold change (Cui and Churchill, 2003; Xia and Wishart, 2002). Sample prefixes D2 
and D4 refer to samples extracted on days 2 and 4, while F/DIGE refers to DIGE-
D samples that were cultured for 2 days as FMOC-D then enzymatically digested 
as previously described, and cultured for another 2 days; FMOC-D and DIGE-D are 
shortened to FMOC and DIGE in this section.  
 
From Figure 4-9, it can be seen that the majority of metabolites identified using 
LC-MS belong to amino acid biosynthesis and metabolism pathways. Among these 
metabolites, metabolites relating to the vitamin B6, phenylalanine and tyrosine 
metabolism pathways were found to be significantly different between samples. 
Data in Figure 4-10 illustrates that while most metabolites were not significantly 
different from controls (data points below the x-axis), some of them were and a 
list of these metabolites can be found in Appendix II. Significant difference was 
calculated using one-tailed Fisher’s exact test where significance is P<0.05.  
 
 
Figure 4-9: Metabolite pathways. The metabolomic pathway analysis software (part of MetaboAnalyst) was 
used to identify pathways related to metabolites differentially expressed between all samples. A significant 
number of metabolites that were found to be different between samples belonged to the B6, phenylalanine 
and tyrosine metabolism pathways. Stars represent significant change in metabolite pathway as determined 
by Fisher’s exact test where *P>0.05, **P>0.01 and ***P>0.001 (n=3). 
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Figure 4-10: Metabolite volcano plot. Putative metabolites were analysed using MetaboAnalyst 2.0 and the 
data was displayed relative to D2_PLAIN. The y-axis refers to p-value (determined by two-tailed t-test), 
with the x-axis intercept set at P=0.05 so that all data points above the x-axis represent metabolites that 
were significantly different from controls. The x-axis represents fold change as a measure of the magnitude 
in difference between samples and the control. Data points to the left of the y-axis are metabolites down 
regulated with respect to controls while data points on the right of the y-axis were up regulated (n=3).  
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4.4 Discussion and Conclusion 
 
Based on the work carried out in chapter 3, it was hypothesised that MSCs grown 
on surfaces functionalised with the integrin-binding ligand RGD (ARGD and DIGE-
D), may differentiate along an osteogenic lineage while MSCs cultured on PLAIN 
glass, and surfaces with a reduced integrin-binding potential (FMOC) would not. 
To confirm this assumption, immunocytochemical staining for OPN and OCN was 
used to characterise MSC development over a period of 28 days in line with the 
osteoblast-development timeline documented by Stein and co-workers (Lian and 
Stein, 1995; Owen et al. 1990; Stein et al. 1990). As previously discussed in 4.1, 
this development progresses through a period of active growth, ECM maturation 
and ECM mineralisation; and is distinguished by changes in gene expression and 
protein output. Therefore, following this model it was expected that OPN would 
be minimally expressed at day 7, increase in line with ECM maturation at day 21, 
and peak at day 28, which coincides with ECM mineralisation (Figure 4-1). It was 
also expected that OCN would only be present at the 21 and 28 day time points. 
Interestingly, although OPN followed this trend for the most part, there was an 
obvious difference between substrates, and while OCN was not expected to have 
been detected at the earlier time point, it was detected as early as day 7.  
 
OPN expression was similar between PLAIN, ARGD and DIGE-D cultures at day 7, 
but significantly lower in FMOC-D cultures. At this time point it is expected that 
the cells would be in an active state of proliferation during which OPN mRNA has 
been shown to be expressed at approximately 25% of OPN levels detected during 
ECM maturation (Owen et al., 1990). This biphasic expression reflects OPN’s dual 
function as a cell-ECM binding protein through its RGD domains, and a regulator 
of mineral nucleation (George and Veis, 2008; Lian and Stein, 1992). As protein 
expression on PLAIN, ARGD and DIGE-D substrates differed only slightly this could 
indicate maximal expression of OPN at this time point. The low levels in FMOC-D 
cultures could be explained by a delayed onset of expression. All work so far has 
indicated MSCs cultured on FMOC experience an initial difficulty in establishing 
themselves on these substrates as evidenced by a failure of some cells to attach 
after seeding, limited size once attached and the tendency for them cluster into 
islands. As OPN levels in DIGE-D were comparable to PLAIN and ARGD cultures, it 
can be assumed that by enzymatically digesting FMOC-D surfaces to expose the 
underlying RGD, the cells were able to recover and increase OPN expression.  
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At the later time points, OPN expression increased in all cultures consistent with 
its increased production during the post-proliferation stage and the onset of ECM 
mineralisation. At 21 days, OPN expression in FMOC-D cultures was significantly 
increased to similar levels seen in DIGE-D cultures and more than that detected 
in PLAIN; the highest level of expression was not surprisingly seen in ARGD. This 
pattern was also observed at day 28. The similarity in FMOC and DIGE cultures in 
contrast to day 7 cultures (where OPN expression in DIGE-D cultures was equal 
to ARGD) likely indicates an elevated expression of OPN in ARGD cultures rather 
than a levelling-off in DIGE-D. Moreover, the increase of OPN detected in FMOC-
D samples may not relate to its role in mineralisation. Although extensively used 
as a marker of osteogenic differentiation, OPN is not specific to bone cells or to 
ECM mineralisation (Lund et al., 2013; Goksoy et al., 2008; Liaw et al., 1994), 
and can also be expressed by fibroblasts. If cells in FMOC-D cultures had adopted 
a fibroblastic state in agreement with their morphological appearance, then OPN 
expression could be attributed to a function not related to the development of a 
mineralised matrix (Pirraco et al., 2012; Ashizawa et al., 1996).  
 
In comparison to OPN, OCN expression was detected mostly in ARGD samples and 
at lower levels in the other cultures at day 7. While OCN was not expected to be 
present during the proliferative stage due to its function as a matrix mineralising 
protein (Kasugai et al., 1991), Kulterer et al. detected OCN at the mRNA level at 
day 4 while following the osteogenic development of chemically inducted human 
MSCs (Kulterer et al., 2007). The enhanced expression of OCN in ARGD cultures 
suggests an accelerated rate of osteogenic progression in these cultures whereas 
the comparatively lower expression in DIGE-D samples may indicate an inhibited 
rate because of initial differences in MSC behaviour between the FMOC and DIGE 
forms of these substrates. The fact that OCN was detected at much lower levels 
in FMOC-D cultures seems to corroborate this idea. 
 
Like OPN, OCN expression increased over time and was shown to be consistently 
higher in ARGD and lower in FMOC-D cultures compared to PLAIN and DIGE-D. By 
day 21, OCN expression in DIGE-D samples was similar to ARGD and its expression 
in PLAIN cultures reached the same level by day 28. The assumption of this trend 
is again that MSCs cultured on ARGD substrates experienced an enhanced rate of 
matrix maturation and mineralisation compared to the other substrates resulting 
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in maximal expression at 21 days. While this development was slower in DIGE-D 
and slower still in PLAIN cultures, OCN expression also reached maximal levels at 
day 21 and 28 respectively. OCN was significantly lower in FMOC-D cultures even 
at 28 days post seeding. Since osteocalcin is osteoblast specific unlike OPN, it is 
perhaps the more telling of the two markers in terms of the phenotypic state of 
the cell and ECM microenvironment. On the basis of OCN alone it can be implied 
that RGD facilitates MSC differentiation along an osteogenic route. Interestingly, 
at 28 days, some evidence of STRO-1 and ALCAM labelling can be seen in FMOC 
cultures suggesting MSCs on these surfaces may retain a level of self-renewal, or 
limited ability to differentiate. As this could not be quantified, further work will 
have to be carried out to confirm this observation. 
 
In addition to protein expression, immunocytochemistry also identified a distinct 
contrast in cell size and shape. Although cell characterisation studies previously 
documented differences in size between MSCs cultured on these substrates, this 
was with respect to individual cells cultured for 7 days (chapter 3 section 3.3). 
At 7 days, the majority of cells in all cultures were spatially separated from each 
other, flattened and spread. The degree of spread depended on the underlying 
properties of the substrate e.g. cells on ARGD demonstrated an enhanced degree 
of spread due to the presence of integrin-binding RGD peptides, while MSCs that 
were grown on FMOC, ARGE and PEG spread to a lesser degree. MSCs physically 
in contact with each other switched to a more elongate-like morphology on non-
RGD substrates, but maintained a degree of spread on RGD surfaces.  
 
In long-term cultures, MSCs seeded on FMOC surfaces persisted with a fibroblast-
like morphology, while MSCs cultured on ARGD and DIGE-D substrates favoured a 
polygonal osteoblast-like shape despite both cultures being nearly confluent. As 
previously discussed, cell size is a critical modulator of MSC development and 
fate with the formation of a highly contractile cytoskeleton and strong adhesions 
favouring an osteogenic commitment (Wang et al., 2011; McBeath et al., 2004). 
One of the pathways implicated in MSC differentiation is MAPK (Ge et al., 2009; 
Xiao et al., 2002; Gallea et al., 2001; Jaiswal et al., 2000) which may also 
contribute to the cell cycle progression through the G1/S checkpoint (Yamamoto 
et al., 2006) in a tension-dependent manner that increases cyclin D1 (Roovers 
and Assoian, 2003; Huang et al., 1998). Cellular tension through spreading, ROCK 
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activation and the formation of actin stress fibres will thus feed into MAPK and 
initiate preferential commitment to an osteoblast state. It is then reasonable to 
propose that MSCs on both ARGD and DIGE-D substrates, which maintain a well-
spread phenotype and thus a degree of contractile tension in the cytoskeleton, 
will differentiate into osteoblasts. On that basis, MSCs on FMOC surfaces would 
then be expected to differentiate along a different route given that they do not 
display these qualities. This assumption is backed-up by the higher level of OPN 
and OCN detected in ARGD and DIGE-D compared to FMOC cultures.  
 
In terms of cellular activity, metabolomics identified differences in a number of 
metabolites associated with amino acid synthesis and metabolism during energy 
production. Two in particular: 3-hydroxy-2-methylpyridine-4,5-dicarboxylate and 
(S)-2-aceto-2-hydroxybutanoate, were particularly interesting as the former was 
significantly up-regulated only at day 2 in ARGD and day 4 in DIGE-D cultures and 
the latter was significantly up-regulated in all cultures at both time points. 3-
hydroxy-2-methylpyridine-4,5-dicarboxylate is an intermediate of B6 metabolism 
and a coenzyme involved in amino acid synthesis (Depeint et al., 2006). The fact 
that this metabolite was significantly up-regulated at day 2 in ARGD samples and 
DIGE-D samples at day 4 but not FMOC-D at day 2 or PLAIN at either time point, 
suggests this pathway could have been altered in response to RGD, while the 48-
hour difference in expression between ARGD cultures at day 2 and DIGE-D at day 
4 could be explained by the fact DIGE-D substrates were in the FMOC form for 48 
hours prior to being switched to the DIGE form. (S)-2-aceto-2-hydroxybutanoate 
is an intermediate in branched-chain amino acids synthesis (Bromke, 2013). 
 
Changes in metabolic activity during stem cell differentiation have recently been 
described in literature. Yanes et al. for example reported that undifferentiated 
ESCs express a high degree of structurally unsaturated metabolites compared to 
ESCs undergoing differentiation and proposed that this is important in supporting 
chemical plasticity. The general conclusion is that stem cells are metabolically 
quiet during renewal and that differentiation is regulated by metabolic oxidation 
(Yanes et al., 2010). Both McMurray et al. and Tsimbouri et al. have extended 
this observation to MSCs. MSCs cultured on nanopits that were shown to maintain 
stem cell renewal (SQ topographies) expressed an increased level of unsaturated 
metabolites compared to MSC cultured on nanopits shown to promote osteogenic 
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differentiation (NSQ50). Differentiation in general was associated with a higher 
state of metabolic activity (McMurray et al., 2011). Tsimbouri et al. additionally 
linked this higher state of metabolic activity with longer focal adhesions and an 
increase in p-myosin activity indicative of a highly contractile actin cytoskeleton 
(Tsimbouri et al., 2012). Serra-Franzoso et al. demonstrated that MSCs with this 
particular phenotype expressed higher levels of osteo-specific markers compared 
to other markers. This commitment placed a high-energy demand on the cells as 
an up-regulation in the metabolism of carbohydrates, fatty acids, proteins lipids 
and nucleotides was detected in these cells (Seras-Franzoso et al., 2013).  
 
Although metabolomic analysis provided a brief insight into metabolite output, it 
was surprising that so few pathways were up-regulated compared to the control. 
This can perhaps be explained by growth rate kinetics, which depicts cell growth 
as a three-step process. The initial stage is marked by minimal cell growth (lag 
phase) followed by a phase of rapid expansion (log phase) and a final stationary 
phase where cell growth rates plateau (Higuera et al., 2009; Colter et al., 2000; 
Bruder et al., 1997b). In this work, metabolites were extracted at 2 and 4 days, 
which puts it within the initial lag phase. Thus it might be that very little energy 
was being generated and expended by the cells at this time, or metabolites were 
below the level of detection by LC-MS. Other work in our lab has shown a similar 
outcome with metabolic profiling indicating minimal change in output at day 1, 
but an increased level of production at day 7 (Alakpa, unpublished work).  
 
The conclusion of this chapter is as follows: (I), surfaces functionalised with the 
integrin-binding peptide RGD support the development of MSCs to an osteoblast 
phenotype as indicated by the presence of the osteoblast markers OPN and OCN, 
and an osteoblast-like morphology. (II), substrates that terminate in Fmoc do not 
promote osteogenic commitment, but may maintain MSCs in an undifferentiated 
state as suggested by the presence of STRO-1 and ALCAM in these cultures. (III), 
FMOC substrates treated with elastase to remove the Fmoc group and expose the 
underlying RGD ligand are similar to ARGD surfaces that readily present RGD, as 
evidenced by a similar levels of OPN and OCN in cultures, and cells displaying an 
identical morphology to those grown on RGD. (IV), Metabolomics detected small 
changes in amino acid and energy-related metabolites, and is suggestive that a 
longer time point may reveal more changes. 
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5.1 General Discussion 
 
In the context of tissue regeneration, stem cells represent the latest generation 
of therapeutics for the treatment of diseased or damaged tissues. Somatic stem 
cells in particular are of great interest in this regard. While HSCs have been used 
clinically since the 1960s (Gratwohl et al., 2010; Copelan, 2006), new strategies 
are continually being developed to bring stem cells fully into the clinical setting. 
Before this can be properly realised, two fundamental issues must be addressed. 
Firstly, stem cells represent only a fraction of cells isolated from adult tissues. It 
is estimated that less than 0.01% of all cells isolated from bone marrow are MSCs 
(Pittenger et al., 1999), thus there is a need to expand their numbers in culture. 
The down side to this however, is that stem cells tend to lose their multipotent 
capacity during in vitro expansion (Siddappa et al., 2007). The first issue to be 
addressed then is the development of a system where stem cell numbers can be 
expanded while maintaining the stem cell phenotype.  
 
In addition to expanding their numbers, there is also a need to identify the exact 
regulatory stimuli that direct stem cell commitment in a specified manner. ESCs 
and iPSCs will spontaneously differentiate into mixed lineages in the absence of 
embryonic feeder layers or conditioned media (Weber et al., 2010; Takahashi et 
al., 2007; Xu et al., 2001). MSCs and other SSCs similarly have this potential, and 
without specific regulatory signals to support their development, will eventually 
produce heterogeneous cultures of stem and committed cells through a process 
of asymmetrical division. The second issue then is to address the unpredictable 
nature of stem cell differentiation however the signalling pathways that regulate 
stem cell growth and commitment are complex so understanding the processes 
that underlie them is critical to stem cell use in tissue regeneration. 
 
 
5.2 Biomimetic matrices for Tissue Regeneration 
 
That cells respond to their environment has been established for some time. As 
such, modern biomaterials attempt to mimic certain biophysical and biochemical 
features of the ECM in a bid to reproduce the same behaviour in vitro. The need 
to expand stem cells while maintaining the stem cell phenotype has prompted 
many to look to the stem cell niche for answers. Niches are predicted to exist in 
most adult tissues providing stem cells with a myriad of complex spatiotemporal 
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cues that dictate quiescence, proliferation, commitment and mobilisation out of 
the niche (Walker et al., 2009; Scadden, 2006; Morrison and Spradling, 2008). A 
vast amount of research has been invested into identifying individual elements 
that contribute to niche dynamics as it is hoped that by emulating these unique 
environments it will enable us to develop tissue culture plastics more suited to 
stem cells. Moreover, engineering biomimetic materials endowed with niche-like 
properties could eventually lead to a new generation of biomaterials. 
 
In spite of this potential however, materials that mimic the stem cell niche may 
not be sufficient enough on their own to address the problems associated with in 
vitro expansion and differentiation. During the wound healing process stem cells 
exit the niche and localise to the injury in response to cytokines and chemokines 
that act to guide mobilisation (Ponte et al., 2007; Ries et al., 2007). Away from 
the niche it is the surrounding environment of the new tissue that influences the 
behaviour of these cells. Thus while the niche may provide insight into retaining 
the stem phenotype, additional factors will be required to direct differentiation 
and subsequent maturation of the terminal cell phenotype.  
 
Numerous avenues of research, some of which have been described in chapter 1, 
have been carried out in order to identify key effectors of both these processes. 
The current emphasis is on copying certain aspects of the ECM. For example, one 
area of research relates to the mechanical properties of the ECM. Engler and co-
workers identified the importance of matrix elasticity on stem cell commitment, 
and demonstrated that polyacrylamide gels of different degrees of stiffness were 
able to influence cells along a specific lineage e.g. MSCs grown on a stiff matrix 
with a modulus close to bone developed an osteogenic phenotype (Engler et al., 
2006). Interestingly, Winer et al. showed that stem cells cultured on gels with a 
similar modulus to marrow remained in a quiescent state. These same cells were 
then able to differentiate when provided with induction media proving that their 
quiescent state could be over come with soluble signals (Winer et al., 2008). 
 
In a series of studies performed by Dalby and colleagues, it has been established 
that nanotopography can also affect both phenotype and function. In Biggs et al. 
it was shown that nanogrooves and nanopits can alter how a cell interacts with a 
surface including time until spread, the development of small FXs versus large 
FAs or SMAs, and morphology e.g. elongate versus spread. Microarray analysis of 
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MSCs grown on these topographies indicated that a number of genes were up or 
down-regulated compared to controls including several associated with integrins 
and MAPK, and a number of transcription factors including signal transducers and 
activators of transcription (STAT1/3) and PPAR! (Biggs et al., 2009) 
 
Further work by this group has shown that nanotopography arrangement can also 
regulate MSC renewal and commitment. In McMurry et al. two nanotopographies 
with similar nanopit arrangements (SQ: square arrangement and NSQ50: square 
arrangement with ±50 nm offset) elicited very different responses. MSCs seeded 
on the SQ topography were able to maintain the stem cell phenotype long-term 
as determined by the retention of the stem cell markers STRO-1 and ALCAM, and 
a lack of osteo-specific OPN and OCN expression even after 8 weeks of culture. 
Conversely, MSCs cultured on NSQ50 topographies differentiated into osteoblasts 
as confirmed by a successive loss of STRO-1 and ALCAM, and the development of 
OPN and OCN over time. Thus while SQ topographies were able to maintain MSCs 
in a state of symmetrical renewal, a slight change in the spatial arrangement of 
this pattern was able to induce differentiation (McMurray et al., 2011). 
 
At the centre of these examples are integrins. In addition to providing anchorage 
support, integrins transmit forces through a series of intracellular cascades that 
translate these forces into biochemical signals (Schwartz, 2010; Hynes, 2002). 
Integrin involvement with matrix elasticity is a feedback loop between integrins, 
the actomyosin complex and the resistive forces experienced at the site of focal 
adhesions. The forces experienced on a matrix that is stiff, are greater than the 
forces experienced on a softer matrix hence there is a higher degree of tensional 
force experienced by the cell (refer to chapter 3: Bhadriraju et al., 2007; Chen 
et al., 1997). The effect of nanotopography on integrins is less obvious but may 
relate to how the topography modulates the orientation and stability of integrin 
clustering and the formation of the adhesion plaque (Biggs et al., 2010). Indeed 
Tsimbouri et al. confirmed that MSCs cultured on the NSQ50 nanotopographies as 
described above, developed larger adhesions than those on the SQ topographies 
which retained cells in the self-renewing state (Tsimbouri et al., 2012).  
 
Le Saux et al. suggest that topographical features dictate the overall number of 
cells that adhere to a surface but cell size and adhesion length is determined by 
ligand density because of a complex interplay whereby topography increases the 
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number of ligands per unit area and also affects their orientation (Le Saux et al., 
2011a). This was concluded from the fact more bovine endothelial cells adhered 
to planar surfaces than to substrates patterned with nano or micro pyramids, but 
cell size remained similar across all surfaces. After the addition of RGD ligands, 
cell adhesion was maximal on all surfaces at a density of 6x105 ligands/mm2 but 
greatest on flat controls and surfaces patterned with nano-pyramids. On micro-
pyramids cell adhesion was independent of ligand density. Finally, cell size was 
found to be greatest on surfaces functionalised with ligands at a density of 6x108 
irrespective of pyramid size (Le Saux et al., 2011a).  
 
Since integrins both facilitate cell attachment and mediate bidirectional signals 
between the ECM and the nucleus, they represent an easily accessible target for 
manipulating cell behaviour. In vivo, integrins bind to short peptide sequences in 
the structure of the fibril proteins such as collagen, fibronectin and vitronectin, 
which enable the cell to attach to the ECM, spread and migrate etc (Ricard-Blum 
and Ballut, 2011). While initial studies focused on using integrin-binding ligands 
as a means to make biomaterials more adhesive, the current emphasis of these 
works has now moved to fine-tuning integrin adhesion in order to understand the 
molecular pathways involved in integrin-mediated signalling. This is of particular 
importance when considering the different behaviour integrins elicit in the stem 
cell niche and in tissues outside the niche.  
 
Within the stem cell niche it is presumed integrins act to anchor the cells to the 
basement membrane and properly orientate them during division (LaFlamme et 
al., 2008; Watt and Hogan, 2000). As integrins can also control the cell cycle via 
tension-mediated mechanisms and MAPK (Assoian and Schwartz, 2001; Mettouchi 
et al., 2001) they may also function to retain cells in a quiescent state (Winer et 
al., 2008; Chen et al., 1997). Moreover, integrins enable migration by generating 
tractional forces (Vicente-Manzanares et al., 2009) and thus are important in the 
relocation of stem cells between different locations. Outside of the niche, these 
same mechanisms similarly determine cell fate (Spatz et al., 2012) thus integrins 
appear to be able to modulate quiescence, self-renewal and differentiation in a 
context-dependent manner. This ability is likely related to the different type of 
integrins involved, the molecular composition of the adhesion assembly and the 
induction of specific intracellular signalling pathways.  
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As seen in Le Saux et al., ligand density is equally important in determining cell 
behaviour (Le Saux et al., 2011a). Several works by Spatz et al. have shown that 
integrins need a ligand spacing of less than 73 nm to achieve sufficient clustering 
and intracellular tension necessary to organise adhesions and induce spreading in 
rat fibroblasts and other rodent cell lines (Cavalcanti-Adam et al., 2007; Arnold 
et al., 2004). In contrast, Massia and Hubbell established that a ligand spacing of 
440 nm is optimal to iduce spreading in human foreskin fibroblasts, but a spacing 
of 140 nm is needed to support adhesion and stress fibre formation (Massia and 
Hubbell, 1991). In other work, Le Saux et al. found that bovine endothelial cells 
attached to and spread on surfaces independently of RGD-to-RGD spacing but, in 
order to properly organise focal adhesions and induce membrane order, a ligand 
spacing of 44 nm is needed (Le Saux et al., 2011b). Massia and Hubbell posit the 
reason for this observed variation in ligand density may be due to some ligands 
being sterically unrecognisable to cells leading to an overestimation of optimal 
ligand density (Massia and Hubbell, 1991). Le Saux et al. suggest optimal ligand 
density is governed both by substrate chemistry and nanotopography, explaining 
different values between different cells and systems (Le Saux et al., 2011a).  
 
Further to this, Mrksich and co-workers used RGD-tagged thiol SAMs to show that 
ligand affinity as well as ligand density is important in guiding MSC fate. In this 
work, SAMs coupled to a high affinity cyclic RGD patterned at high or low density 
induced osteogenic commitment, while a low affinity linear RGD at high density 
led to myogenesis, and a low affinity ligand at low density induced neurogenesis 
(Kilian and Mrksich, 2012). Overall, it would seem that the biophysical features 
of the ECM e.g. topography, modulus and receptor ligands combine to regulate 
cell spreading, growth and differentiation by impacting on integrin activity. High 
tensional feedback from the matrix as a result of matrix stiffness, ligand spacing 
and ligand affinity, results in a highly contractile cytoskeleton and a preferential 
differentiation toward osteogenesis. Conversely, low tensional feedback leads to 
limited tension, resulting in neurogenesis for example or even quiescence (Spatz 
et al., 2012; Winer et al., 2008; McBeath et al., 2004).  
 
In addition to the physical properties of the matrix, the biochemical components 
of the ECM e.g. growth factors etc also regulate cell behaviour. Growth factors 
can be introduced to a system over a sustained period of time by incorporating 
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them into gel-based platforms. Works carried out by Anseth and co-workers have 
shown that hydrogels infused with osteoinductive growth factors are capable of 
inducing an osteoblast phenotype as evidenced by an increase in the expression 
of the osteo-specific markers ALP COL type I and OCN, and the ability to induce 
ectopic bone formation after subcutaneous implantation in rats (Burdick et al., 
2002). Although in this setup the hydrogels were suspended above the cell layer, 
more recent work by the same group has shown that co-encapsulation of growth 
factors and MSCs within a hydrogel can also induce differentiation. In this system 
transforming growth factor beta proteins were covalently incorporated into the 
gels along side MSCs. These cells expressed increased levels of COL type II and 
glycoaminoglycans indicative of a chondrogenic phenotype (McCall et al., 2012). 
Hydrogels thus present a viable means of introducing specific growth factors and 
even pharmacological agents to cells and surrounding tissue at the implant site. 
 
Engineering materials that fulfil the functions of the stem cell niche may enable 
us to overcome the current problems associated with stem cell in vitro culture. 
Likewise, materials designed to emulate a specific tissue type may enable us to 
predictably direct differentiation. However, having two separate materials (one 
to facilitate self-renewal the other to direct differentiation) is impractical and a 
more favourable idea would be to combine these functions into one system such 
as in stimuli responsive materials. Two examples of SRMs have been described in 
chapter 2. In the first example light was used to photolytically expose surface-
bound RGD to promote cell adhesion (Wirkner et al., 2011) while in the second 
example, cell attachment and detachment were controlled using a temperature 
responsive polymer (Ebara et al., 2004). In other works, Todd et al. investigated 
the use of an in situ enzyme-mediated switch to cleave Fmoc groups from a PEG-
acrylamide (PEGA) hydrogel in order to expose and activate the underlying RGD 
peptides (Todd et al., 2007). Finally, in Yeo et al. cell adhesion was controlled 
by the application of an electric potential to SAM-coated surfaces with different 
electroactive tethers. Here, it was shown that RGD ligands could be selectively 
released from the surface in response to reductive or oxidative potentials and as 
a result, cell detachment could also be controlled (Yeo and Mrksich, 2006).  
 
To summarise, biomimetic materials aim to recreate the in vivo environment in 
an in vitro setting to better support stem cell growth and differentiation. Here, 
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several works relating to different systems have been described to highlight how 
these approaches can potentially achieve this goal. What is becoming clear from 
these studies is that both physical and chemical features of the in vivo system, 
right down to the nanoscale spacing of ECM ligands, are essential to defining cell 
function, and that these cues converge at integrin receptors. With this in mind, 
there is now a need to pick apart the molecular pathways associated with these 
signals in order to understand the mechanisms involved.  
 
 
Figure 5-1: Biomimetic strategies. The stem cell niche provides biophysical and biochemical signals that 
dictate cell behaviour. Physical interaction with the niche architecture, other stem and non-stem cells, 
and chemical signals contribute to maintaining the niche; these same signals guide the development of the 
mature phenotype outside the niche. Figure depicts the different signals thought to maintain the niche 
microenvironment (A; Scadden, 2006) and several biomimetic approaches to reproduce aspects of the 
niche and tissue ECM in vitro including: nanotopography e.g. grooves and pits (B), matrix elasticity e.g. 
soft (top) and stiff (bottom) matrices (C), growth factor hydrogels (D) and mimetic ligands (E). 
 
 
5.3 Thesis Conclusion 
 
The work described in this thesis is a continuation of that described in Todd et 
al., 2009. Previously the focus was on the development and characterisation of 
the substrates themselves with limited data collected on cell responses beyond 
their ability to adhere. Thus the intention of this thesis was to characterise the 
affect these surfaces had on MSC behaviour. Furthermore, where initial proof of 
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concept studies established that these surfaces could be enzymatically switched 
prior to culture, here it was demonstrated that this switch could be initiated in 
situ. The overall objectives of this project were to (I), optimise the cell culture 
conditions including culture medium, seeding density and enzymatic switch. (II), 
characterise phenotypical differences between MSCs cultured on RGD substrates 
(including substrates that were digested in situ), compared to surfaces retained 
in the undigested Fmoc form. (III), ascertain if RGD functionalised surfaces can 
induce osteogenic differentiation.  
 
RGD is an integrin binding ligand and integrins can induce changes in morphology 
and function through MAPK signalling and Rho family GTPases, it was therefore 
expected that MSCs cultured on surfaces functionalised with RGD would develop 
an osteoblast phenotype whereas those on the other surfaces including capped 
surfaces (FMOC) would not. As confirmed in chapters 3 and 4, MSCs cultured on 
both positive RGD controls (ARGD) and digested RGD samples (DIGE-D) displayed 
several phenotypic traits consistent with a developing osteoblast i.e. well spread 
polygonal morphology with a highly organised actin cytoskeleton, and numerous 
large adhesions including SMAs. MSCs on these surfaces also expressed the bone 
specific markers OPN and OCN at an elevated level and at an earlier time point 
than PLAIN surfaces. MSCs cultured on FMOC substrates were a lot smaller with 
fewer adhesions including more FXs and displaying a fibroblast-like phenotype. 
Although OPN and OCN were also detected in these samples it was significantly 
reduced compared to RGD substrates. 
 
Overall, the work conducted in this thesis has shown that surfaces functionalised 
with the integrin ligand RGD were able to support MSC growth and commitment. 
Specifically, RGD appeared to induce MSCs to undergo osteogenic commitment, 
which is consistent with other works (Frith et al., 2012; Alvarez-Barreto et al., 
2011; Garcia and Reyes, 2005; Yang et al., 2005). Further to this, this work also 
shows that manipulating the properties of the local microenvironment can alter 
MSC behaviour and fate. While it is unlikely that this system in its current format 
will find application as an in vivo platform for bone cell therapies, the concept 
of dynamic substrates that mimic the ECM microenvironment hold promise for 
other aspects of tissue regeneration. Particularly, how these changes to the ECM 
affect intracellular cascades and cell processes.  
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5.4 Further Work 
 
 
5.4.1 Using Omics to Characterise Cell Responses 
 
Omics-based approaches aim to comprehensively characterise all constituents of 
a biological system e.g. single cell or whole organism, from the DNA upwards. At 
present the ‘omics family’ includes genomics, transcriptomics and proteomics as 
well as the recently added metabolomics, and several subgroups e.g. lipidomics 
and secretomics. While genomics concentrates on the structure and function of 
all genes within an organism, transcriptomics is concerned with gene expression, 
and proteomics the structure, function and modification of proteins; hence their 
combined data can be used to discern the state of a system at a specific point in 
time and in response to certain stimuli. This is particularly advantageous in stem 
cell research where stem cells not only exhibit changes in response to their local 
environment, but also during their development from non-committed precursor 
to mature differentiated cell. How stem cells respond to a particular biomaterial 
or pharmaceutical, and how this impacts their differentiation, is critical to their 
use as a therapeutic agent. 
 
As part of this work, it was intended that changes in cell behaviour in response 
to the different surfaces, be characterised using proteomics and metabolomics. 
In chapter 4 (section 4.3.2), attempts were made to compile a metabolic profile 
to identify differences in energy production and signalling pathways etc between 
MSCs grown on surfaces in the ‘off’ mode (FMOC), and MSCs grown on surfaces in 
the ‘on’ mode (ARGD and DIGE). In this case, metabolite analysis revealed only a 
few up-regulated pathways involved in amino acid biosynthesis and metabolism, 
and it was assumed that the lack of conclusive data was as a result of metabolite 
extraction being carried out too early in the cell cycle when growth and energy 
production/consumption would have been low. A later time point during the log 
phase of growth (Higuera et al., 2009; Sekiya et al., 2002) might have resulted 
in a more detailed understanding of metabolic signalling. 
 
In terms of proteomics, several techniques were discussed such as differential in 
gel electrophoresis, SILAC and stable isotope dimethyl labelling (Kantawong et 
al., 2009; Ong and Mann, 2007; Hsu et al., 2003); secretomics was discussed as 
well. Secretomics is an division of proteomics that focuses on proteins secreted 
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into the surrounding extracellular milieu (Makridakis et al., 2013). Examining the 
cellular secretomes allows us to identify secreted extracellular components that 
play key roles in cell development. A number of intracellular signalling pathways 
operate through autocrine and paracrine mechanisms whereby cells are able to 
effect changes in their own behaviour (autocrine) or in other cells (paracrine) by 
secreting growth factors into the ECM that target specific corresponding surface 
receptors. Examples of such signalling pathways include Wnt and TGF-"/BMP.  
 
Secretomics has recently been applied to characterise differences in the types of 
proteins secreted by undifferentiated stem cells, and stem cells that have been 
chemically induced to differentiate. Kim et al., identified a total of 315 proteins 
in the secretome of undifferentiated bone marrow-derived MSCs and MSCs that 
had been subjected to osteogenic media and differentiated into osteoblasts. Of 
these proteins, 177 were found to be up-regulated in osteogenic samples, while 
88 were down-regulated and the remaining 50 were not significantly altered. Of 
the up-regulated proteins, most were calcium-binding proteins as well as several 
cytoskeletal and signalling proteins. Those proteins down-regulated in osteoblast 
cultures included TGF-" proteins and negative regulators of osteogenesis (Kim et 
al., 2013). In a similar study, Choi et al. separated chemically induced MSCs into 
low osteogenic potential or high osteogenic potential (LOP versus HOP) based on 
ALP expression. Of a total of 138 proteins, 70 were specific to LOP samples and 
64 were unique to HOP. HOP samples expressed a number of proteins involved in 
metabolic processes, the cytoskeleton, adhesion and receptor signalling. In the 
same study, the SPARC-related modular calcium binding (SMOC1) was identified 
as being an important protein in osteogenic differentiation (Choi et al., 2010). 
 
 
5.4.3 PEG as an Alternative Capping Group to Fmoc 
 
The Fmoc n-protecting group is routinely used in SPPS to build up short and long-
chain peptides. Usually most Fmoc-based approaches remove the terminal Fmoc 
group after completion of the peptide chain, here however it was left in place to 
take advantage of its bulky properties. Despite no obvious signs of toxicity being 
observed in this work, the toxic and immunogenic properties of Fmoc in vivo are 
yet to be established, which may later present a problem in terms of using these 
systems in tissue regeneration schemes. In this case an alternative capping group 
would be required in order to maintain the ‘off-on’ nature of this substrate. One 
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option is to replace the terminal Fmoc with PEG. PEG has been reported to lack 
toxicity and have negligible immunogenic properties; there are a number of FDA 
approved PEG-conjugated drugs available (Jevsevar et al., 2010). 
 
PEG is commonly used as an antifouling coating due to its ability to resist protein 
adsorption and cell adhesion. In this work PEG was incorporated into the peptide 
chain specifically as a bioinert linker. The extent to which PEG can resist protein 
adsorption etc, has been linked to molecular weight, the general rule being that 
high molecular weight PEGs have a greater capacity to do so than low molecular 
weight PEGs (Dong et al., 2011; Zhu et al., 2001). Taking this into consideration, 
Fmoc could be replaced with a PEG cap that permits minimal but sufficient cell 
binding, but can later be switched to allow high levels of adhesion on demand. 
 
 
5.4.4 Cell-Mediated Surface Switching 
 
Cell-mediated surface switching is a novel idea that builds on the foundations of 
SRMs. SRMs operate using an external stimulus arbitrarily added to the system to 
induce a change in surface properties. In a cell-mediated system, these changes 
could be induced by the cell themselves in line with their developmental needs. 
For example, in this work FMOC surfaces allowed cells to adhere and proliferate 
but failed to induce osteogenesis whereas DIGE surfaces that were enzymatically 
cleaved to reveal the underlying RGD peptides, were able to elicit an osteogenic 
response. In this case, the switch was initiated by exogenous elastase added to 
cultures 48 hours after seeding. In comparison, a cell-mediated switching would 
allow cells to proliferate on FMOC substrates until the point at which they stop 
dividing and begin to differentiate. At this point the cells could then expose the 
RGD upon secretion of a particular enzyme during remodelling of the ECM.  
 
One way in which this could be achieved is by using secretomics to characterise 
the developing ECM throughout the course of stem cell growth and commitment, 
such as in Kim et al. and Choi et al. (Kim et al., 2013; Choi et al., 2010) in order 
to identify secreted enzymes up-regulated over time. A new enzyme-cleavable 
peptide could be developed based on this enzyme, which would then be digested 
upon its expression. The matrix metalloproteinases (MMPs) have been considered 
as potential candidates owing to their ability to cleave most proteins during ECM 
remodelling, tissue repair, and stem cell differentiation (Mannello et al., 2006).  
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A.1 Intracellular Signalling Cascades 
 
Signal transduction and intracellular cascades underlie all fundamental processes 
of a living cell. They are essential to maintaining homeostasis as deregulation of 
these signalling cascades leads to developmental pathologies and tumourigenesis 
etc. As discussed in the previous section there is a clear need to pick apart these 
pathways so that we can understand the intermediate processes and accurately 
determine functional output in response to certain stimuli. This is unlikely to be 
an easy task however because, although these cascades appear linear in places, 
they function together as part of much larger network and so changes to one will 
result in changes to another. The work in this thesis focused on integrin binding, 
which is known to primarily activate the MAPK cascade. MAPK is also activated in 
response to growth factors, and is clearly linked to Rho-mediated pathways that 
regulate cell behaviour through the cytoskeleton (Guilluy et al., 2011; Aplin and 
Juliano, 1999) thus the outcome of MAPK activity can be diverse. In this section, 
three pathways closely related with MAPK are discussed with particular emphasis 
on their role in regulating the cell cycle, growth and differentiation in MSCs.  
 
 
A.2 The Hippo Signalling Pathway 
 
The Hippo pathway is a tumour-suppressor cascade initiated by cell-cell contact 
(Schroeder and Halder, 2012). Extensively characterised in Zhao et al. and Lei et 
al., the core pathway centres around the cytoplasmic versus nuclear localisation 
of the Yes-associated protein (YAP) and the transcription co-activator with PDZ 
binding motif (TAZ), which activate the TEA-domain (TEAD) transcription factors 
(Lei et al., 2008; Zhao et al., 2007). Hippo plays a key regulatory role in tissue 
growth and tumourigenesis by maintaining a balance between proliferation and 
apoptosis in a cell density-dependent manner (Bao et al., 2011). At low density, 
YAP and TAZ are active and predominantly localised in the nucleus contributing 
to growth through TEAD1-4. Upon phosphorylation, YAP and TAZ accumulation in 
the nucleus is inhibited by the binding of proteins that retain them in the cytosol 
(Lei et al., 2008; Zhao et al., 2007).  
 
This process of contact inhibition links back into studies carried out by Sekiya et 
al. which demonstrated that cells that were seeded at low density were able to 
undergo a greater number of population doublings than cells seeded at a higher 
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density (Sekiya et al., 2002). Given that Hippo signalling suppresses cell growth 
upon confluency it can be assumed that the higher doubling rate is linked to a 
sustained inactivation of Hippo. Considering the need to cultivate large stem cell 
populations in vitro low seeding densities may be advantageous in achieving this. 
Hippo signalling has also been associated with stem cell differentiation through a 
direct interaction between TAZ and CBFA1 (Cui et al., 2003). In the nucleus, TAZ 
binds to CBFA1 and the adipogenic transcription factor PPAR! stimulating CBFA1-
driven gene expression and suppressing PPAR!-dependent transcription similar to 
MAPK (Hong et al., 2005). Like ERK, TAZ operates as a regulator of osteogenic/ 
adipogenic commitment by suppressing adipogenesis and activating CBFA1 target 
genes involved in osteogenesis. Conversely, while YAP was also found to bind to 
CBFA1, Zaidi et al. determined that it was an inhibitor rather than an activator 
of osteogenesis (Zaidi et al., 2004).  
 
Unsurprisingly, cytoplasmic versus nuclear localisation of both TAZ and YAP may 
be dependent to some extent on cell shape. At low density, cell-cell contact is 
low or non-existent and the lack of spatial constraints allows cells to spread and 
flatten. Cells at high density are spatially confined and physical contact between 
neighbouring cells is increased forcing them to develop a compact and rounded 
morphology. Several studies have reported on the importance of cell density and 
shape as a defining factor in cell fate with the general agreement that cells at 
low density with a spread morphology will become osteoblasts, whereas those at 
high density with a compact morphology will likely become adipocytes (Kilian et 
al., 2010; McBeath et al., 2004; Chen et al., 1997). Wada et al., found that YAP 
accumulation in the nucleus was inhibited in the high-density compact state, but 
YAP was readily found in the nucleus in spread cells with a highly organised actin 
cytoskeleton (Wada et al., 2011).  
 
Dupont et al. likewise found YAP and TAZ were primarily localised to the nucleus 
in MSCs that were both spread and cultured on stiff matrices, whereas they were 
predominantly cytoplasmic in rounded cells on soft matrices. In both cases cells 
were confined to single cell islands to abrogate the effects on cell-cell contact 
(Dupont et al., 2011). In this work Dupont et al. posited that YAP and TAZ might 
also operate independently of the Hippo signalling pathway through Rho and the 
actomyosin complex. MCF10A mammary epithelial cells rendered insensitive to 
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Hippo activation but still maintaining normal cytoskeletal morphology, exhibited 
stable nuclear TAZ in monolayer conditions whereas the parental cells subject to 
Hippo, displayed inhibited YAP and TAZ. Additionally, depleting nuclear YAP and 
TAZ inhibited osteogenic differentiation in MSCs on stiff substrates similar to the 
effects of culturing them on soft surfaces or inhibiting Rho, and actually enabled 
adipogenesis (Dupont et al., 2011). 
 
 
Figure A-1: The Hippo signalling pathway. Hippo signalling is a density-dependent regulator of cell growth 
activated in response to cell-cell contact. Prior to activation, the transcription coactivtors YAP/TAZ reside 
primarily within the nucleus contributing to cell growth via the TEAD transcription factors. Hippo activation 
results in YAP/TAZ being retained in the cytoplasm thereby preventing their stimulation of TEAD ultimately 
leading to cell growth arrest (image courtesy of Cell Signaling Technology®). 
 
 
The overall conclusion of the Hippo signalling pathway seems to be that, while it 
may be involved in regulating cell proliferation by inhibiting growth in a density-
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dependent manner, the main components YAP and TAZ can also operate out with 
the cascade via the actomyosin complex. This may represent a molecular switch 
where the termination of active growth by disrupting YAP/TAZ interaction with 
the TEAD family transcription factors, kick-starts the onset of differentiation. In 
this case, the nuclear localisation of TAZ, which is normally inhibited by Hippo 
signalling, acts to influence stem cell differentiation. Tension in the actomyosin 
assembly favours nuclear TAZ resulting in the simultaneous stimulation of CBFA1 
and suppression of PPAR! to induce osteogenic commitment (Hong et al., 2005).  
 
 
A.3 The Wnt Signalling Pathway  
 
Wnt signalling pathways can be divided into the canonical "-catenin cascade and 
the non-canonical "-catenin independent cascades: planar cell polarity and Wnt/ 
calcium pathways (Ling et al., 2009). In the absence of Wnt signalling, "-catenin 
is phosphorylated by casein kinase CK1# and glycogen synthase kinase GSK3, and 
held in a destruction complex containing several cytoplasmic proteins including 
the scaffold protein Axin and the tumour suppressor adenomatosis polyposis coli. 
The complex targets "-catenin for ubiquitin-mediated proteolysis preventing it 
from activating the T-cell factor/Lymphoid enhancer-binding protein (TCF/ LEF) 
transcription factors (Katoh and Katoh, 2007). Wnt proteins target two different 
receptors on the cell surface, one belonging to the Frizzled receptors (Fzd), and 
the other the lipoprotein receptor-related protein (LRP)5/6 (Cong et al., 2004). 
Activation of Fzd and LRP5/6 breaks up the destruction complex by recruiting 
Axin to LRP5/6 (Mao et al., 2001). The stabilised "-catenin translocates to the 
nucleus and displaces the transcription factor inhibitors Groucho and histone 
deacetylase (Daniels and Weis, 2005). Additional interactions with transcription 
co-activators Pygo1/2, stimulates TCF/LEF transcription factors and regulates 
Wnt target genes (Hoffmans and Basler, 2007). 
 
The planar cell polarity (PCP) and Wnt/calcium pathways are poorly understood. 
PCP is thought to operate through Fzd as in the "-catenin pathway, but may use 
a different co-receptor such as the orphan receptor ROR (Oishi et al., 2003). The 
downstream components of PCP include dishevelled (Dvl) and the Dvl-associated 
scaffold protein DAAM1, which acts as an intermediate binding partner for RhoA. 
Dvl can also bind Rac and feed into the JNK signalling pathway (Katoh and Katoh, 
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2007). The PCP pathway regulates the orientation of cells within an epithelium 
and plays a role in the mirror-image symmetrical arrangement of the ommatidia 
in drosophila eyes and the orientation of stereociliary bundles in the mammalian 
cochlea etc (Montcouquiol et al., 2003; Strutt et al., 1997). Components of the 
Wnt/calcium pathway include phospholipase c and phosphodiesterase involved in 
regulating intracellular calcium levels (Kohn and Moon, 2005). This pathway also 
leads to the activation of Cdc42 involved in adhesion formation, the MAPK kinase 
NLK, which interferes with the "-catenin pathway, and the transcription factor 
NFAT (Saneyoshi et al., 2002; Ishitani et al., 1999; Nobes and Hall, 1995). 
 
 
Figure A-2: The canonical "-catenin signalling pathway. In the canonical pathway, "-catenin is retained in 
the cytoplasm and targeted for ubiquitin-mediate proteolysis by a multi-protein destruction complex. Upon 
activation this complex is disrupted during Axin recruitment to the LRP5/6 cytoplasmic domain. Stabilised "-
catenin is then able to translocate to the nucleus docking with the transcription factors TCF/LEF (image 
courtesy of Cell Signaling Technology®).  
Appendix I: Intracellular Signalling Cascades 
132 
The involvement of Wnt signalling in the cell cycle appears to be largely context 
dependent with evidence suggesting Wnt both promotes and inhibits cell growth. 
Wnt signalling is able to affect cell cycle progression through various modes. For 
example, in the canonical pathway, "-catenin is a major component of adherens 
junctions- calcium dependent cell-cell adhesion contacts that regulate the actin 
cytoskeleton (Hartsock and Nelson, 2008). At the same time, the PCP signalling 
pathway activates RhoA and Rac, and the calcium pathway activates Cdc42; all 
three of which are involved in adhesion formation and cytoskeletal organisation, 
and thus are linked to the cell cycle through tension-mediated mechanisms that 
control cyclin D1 (Huang et al., 1998; Nobes and Hall, 1995). Additionally, cyclin 
D1 is also a downstream target of "-catenin/LEF as evidenced by a LEF1 binding 
sequence in the cyclin D1 promoter region (Shtutman et al., 1999) suggesting a 
more direct route that does not involve the cytoskeleton. 
 
Interestingly, inhibitors of Wnt signalling also appear to promote proliferation in 
certain cases. A comprehensive investigation of the inhibitor dikkopf1 (Dkk1) by 
Gregory et al. presents a scenario where active Wnt suppresses proliferation and 
disruption of this affect is mediated by Wnt agonists e.g. Dkk1. In this work, PCR 
studies of MSCs at different stages of growth (early log, late log and stationary; 
see Colter et al. 2000) revealed a decreasing expression of the co-receptor LRP6 
and Dkk1 as cultures approached confluency, and while Wnt5a was not detected 
during the early log phase it was detected at moderate levels during the late log 
phase and expressed at higher levels in cultures in the stationary phase; a trend 
paralleled by "-catenin expression. High levels of Dkk1 combined with low levels 
of Wnt5a and "-catenin at the initiation of exponential cell growth, coupled with 
a reversal of this trend in stationary cultures approaching growth arrest, appears 
to confirm a regulatory role where Dkk1 is initially required for cells to enter the 
growth cycle and Wnt5a is then required to drive the cycle toward a point where 
the cells drop out of the cycle and start to differentiate (Gregory et al., 2003).  
 
The inhibitory versus stimulatory affects of Wnt signalling on cell growth appears 
to depend on the point at which it is expressed within the cycle. At G0, Wnt acts 
as an inhibitor of cycle progression. After cells enter the growth cycle, Wnt then 
acts to drive proliferation until confluency at which point the cells drop back out 
of the cycle at the onset of differentiation. Recent evidence suggests that cross-
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talk between Hippo and Wnt may contribute to this end-stage growth arrest. As 
the cells reach confluency, cell-cell contact triggers the Hippo signalling cascade 
and down-regulates growth (Zhao et al., 2010). Hippo and Wnt converge through 
YAP, TAZ and "-catenin associations which is not surprising since "-catenin plays 
a role in regulating the cytoskeleton at adherens junctions involved in cell-cell 
contact. In the absence of Hippo signalling, YAP and TAZ reside primarily in the 
nucleus, but when Hippo is active both are retained in the cytoplasm. Varelas et 
al. have shown that cytoplasmic TAZ binds to Dvl, which also binds to Frizzled. 
In this case, TAZ/Dvl binding appeared to negatively regulate Wnt because Dvl 
could not be phosphorylated when bound to TAZ. By disrupting Hippo, Varelas et 
al. also demonstrated that the accumulation of TAZ in the nucleus (leading to a 
loss in cytoplasmic TAZ) enabled Dvl phosphorylation and Wnt signalling (Varelas 
et al., 2010a). Imajo et al. were similarly able to show that YAP binds Dlv and 
both YAP and TAZ are also able to bind "-catenin. Cytoplasmic YAP/TAZ retains 
"-catenin in the cytoplasm during Hippo activity inhibiting the activation of Wnt 
target genes through TCF/LEF (Imajo et al., 2012). Hippo is thus able to induce 
growth arrest by inhibiting positive regulators of proliferation e.g. Wnt. 
 
Wnt inhibition of the Go/G1 transition is consistent with the concept of its role 
in regulating the stem cell niche. If Wnt inhibits stem cells from entering G1 this 
would correlate with the need for inhibitors such as Dkk1 to release Wnt-induced 
quiescence before Wnt signalling then becomes important in growth. In a recent 
study Fleming et al. examined the in vivo haematopoietic niche using transgenic 
mice engineered to over express Dkk1. Compared to wild-types, Wnt signalling in 
HSC niche of Dkk1 mice was markedly inhibited with a corresponding increase in 
cell cycling and a decline in regenerative function. Thus, in the HSC niche, Wnt 
signalling is essential to limiting HSC proliferation and preventing the exhaustion 
of the stem cell population (Fleming et al., 2008). 
 
The mechanisms that link Wnt signalling and differentiation are less obvious than 
those linking Wnt to cell growth. Gaur et al. identified a TCF binding site in the 
promoter region of CBFA1 suggesting Wnt signalling directly regulates osteogenic 
differentiation via "-catenin (Gaur et al., 2005). On the other hand, a number of 
reports suggest canonical Wnt pathways blocks the capacity to differentiate (Pei 
et al., 2012; Kirstteter et al., 2006; Bennett et al., 2002), while others suggest 
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Wnt facilitates this mechanism via alternative routes involving the non-canonical 
pathways (Boland et al., 2004; Koyanagi et al., 2005). Using chemically induced 
MSCs, Boland et al. observed an up-regulation of Wnt components linked to non-
canonical signalling (Wnt11, Fzd6 and co-receptor ROR2), and a down-regulation 
of Wnts associated with the canonical pathway (Wnt9a and Fzd7). Furthermore, 
Wnt3a was shown to reversibly inhibit osteogenic differentiation even in cultures 
already committed to osteogenesis, and appeared to promote proliferation. This 
led the authors to posit the idea that the canonical Wnt pathway is linked to cell 
cycle entry and growth while the non-canonical pathways are linked to cell fate 
commitment (Boland et al., 2004).  
 
 
A.4 Transforming Growth Factor Superfamily 
 
The transforming growth factor (TGF) superfamily contains two main subfamilies 
e.g. the TGF-" and the bone morphogenic protein (BMP) subfamilies. TGF-" and 
BMP transmit signals into the nucleus through the human homologues of mothers 
against decapentaplegic (SMAD) proteins with SMAD2/3 being specific to TGF-", 
and SMAD1/5/8 specific to BMP (Chang et al., 2002). Ligand binding at the cell 
surface activates type II surface receptors, which then recruit and activate type 
I receptors initiating the intracellular signalling cascade through respective TGF-
" and BMP SMAD-dependent pathways (Heldin et al., 1997). In TGF-" signalling, 
SMAD2/3 recruitment and subsequent activation is mediated by the SMAD anchor 
protein SARA (Tsukazaki et al., 1998). SMAD2/3 are phosphorylated by the type I 
receptor inducing them to break away from SARA and permitting them to bind to 
SMAD4 as a SMAD2/3/4 complex (Lagna et al., 1996). This complex is shuttled to 
the nucleus by direct contact with nucleoporins (Xu et al., 2002), karyopherins 
(Kurisaki et al., 2001) or as recently suggested, in complex with TAZ (Varelas et 
al., 2008). In the nucleus SMAD complexes bind to target genes either with DNA 
binding co-factors, or in conjunction with co-activators and co-repressors (Dijke 
et al., 2006). BMP signalling proceeds in a similar fashion to TGF-".  
 
TGF-" signalling primarily functions to inhibit proliferation in most cell types via 
the transcriptional repression of the transcription factor Myc and by inducing the 
expression of cell cycle inhibitors e.g. p27kip1 and p21cip1, thereby locking cells in 
early G1 (Frederick et al., 2004). The repression of DNA binding/differentiation 
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inhibitors (Ids) has also been shown to influence TGF-" mediated growth arrest, 
and appears to be a key difference in the ability of TGF-" and BMPs to carry out 
this function (Kowanetz et al., 2004). Pardali et al. established that TGF-"1 and 
BMP-7 were both able to induce p21cip1 activity, but while cell growth inhibition 
was observed in TGF-"1 signalling, it was only weakly so during BMP-7 signalling. 
Concomitant studies of Id2 activity revealed that TGF-"1 clearly down-regulated 
Id2 expression whereas BMP-7 increased it; Id2 was thus found to antagonise the 
anti-proliferative affects of p21cip1 (Pardali et al., 2005). Furthermore, inhibitory 
SMADs generated as part of a feedback loop that target SMADs for proteolytic 
destruction in non-stimulated cells (Zhang et al., 2001), were shown to block 
SMAD-mediated induction of p21cip1 expression (Pardali et al., 2005). TGF-" and 
BMP therefore affect cell cycle regulation in some cell types by modulating 
factors involved in growth arrest e.g. activity of Myc, DNA binding inhibitors and 
cdk inhibitors. 
 
In addition to the canonical SMAD signalling cascade, TGF-" and BMP activation 
have been implicated in the transduction of signals through non-SMAD pathways, 
particularly the MAPK pathway and Rho GTPases (Zhang, 2008). Thus TGF-"/BMP 
signalling may be able to affect cell growth etc via mechanisms associated with 
these other pathways. The MAPK cascade for instance has been shown to be both 
activated by TGF-"/BMP signalling, and to modulate it. TGF-" activated-kinase 1 
(TAK1) is a MAP3K that regulates TGF-"/BMP signal transduction through JNK and 
p38 in a SMAD-independent manner (Wang et al., 1997). In two separate studies 
Kretzschmar et al. were able to show that the activation of Ras (through growth 
factor mediated ERK signalling) induced the phosphorylation of MAPK binding 
sites in the linker regions of TGF-" and BMP specific SMADs, resulting in the 
inhibition of SMAD nuclear accumulation (Kretzschmar et al., 1999; Kretzschmar 
et al., 1997). MAPK can therefore inhibit the activation of TGF-"/BMP target 
genes in this manner.  
 
Another example briefly mentioned is the cross-talk between TGF-" and Hippo. 
YAP and TAZ have been shown to bind to SMAD complexes in the cytoplasm and 
facilitate their accumulation in the nucleus (Varelas et al., 2008). Active Hippo 
signalling drives the cytoplasmic retention of YAP and TAZ and thus inhibits the 
activation of SMAD target genes by inhibiting SMAD nuclear translocation. Since 
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Hippo signalling functions to switch off cell growth there is some indication that 
TGF-"-induced growth arrest might also participate in this function (Varelas and 
Wrana, 2012; Varelas et al., 2010b). In a reversal of this role however, TGF-" 
can also function to stimulate cell growth through cross-talk with Wnt. Jian et 
al. found that stimulation of MSCs with TGF-"1 promoted nuclear accumulation 
of "-catenin, which acted to both induce proliferation and suppress osteogenic 
differentiation via the SMAD cascade (Jian et al., 2006). 
 
BMPs are potent inducers of osteogenic and chondrogenic commitment (Biver et 
al., 2013) and it seems that any one member of the subfamily has the ability to 
elicit both responses. For instance, Majumdar et al. found that BMP-2 and BMP-9 
were able to promote chondrogenic commitment in MSCs cultured on alginate as 
evidenced by the expression of COL type II, cartilage oligomeric matrix protein 
and aggrecan, as well as the chondrogenic transcription factor Sox-9 (Majumdar 
et al., 2001). Knippenberg et al. found that while BMP-7 induced chondrogenesis 
in adipose-derived MSCs, BMP-2 induced osteogenesis (Knippenberg et al., 2006), 
and Cheng et al. demonstrated that BMP-2 and BMP-9 promoted osteogenesis in 
MSC progenitors, preosteoblasts and osteoblasts (Cheng et al., 2003).  
 
In a study by Shen et al. the authors found that MSCs supplemented with BMP-7 
enhanced expression of chondrogenic and osteogenic genes depending on the 
media conditions e.g. chondrogenic induction media induced chondrogenesis and 
osteogenic induction media gave rise to osteoblasts. The authors concluded that, 
while BMP-7 enhanced both phenotypes once committed, it was insufficient to 
direct commitment and likely worked in combination with other lineage specific 
regulators (Shen et al., 2010). A similar conclusion was drawn in Kemmis et al. 
regarding BMP-6, which induce both phenotypes in mouse adipose-derived MSCs 
depending on the culture conditions. In this study a single BMP-6 supplemented 
medium was used on cells cultured in a pellet or as a monolayer. MSCs that were 
seeded in pellet form exhibited increased expression of chondrogenic genes COL 
type II, aggrecan and sox-9 while cells cultured in a monolayer exhibit enhanced 
expression of CBFA1, OPN and OCN in a dose-dependent manner (Kemmis et al., 
2010). The conclusion is that although BMPs can enhance a particular phenotype, 
this enhancement appears to be defined by other factors that predispose cells to 
one phenotype over another e.g. induction media or a phenotypic environment 
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e.g. pellet versus monolayer. This may explain the often contradictory effects of 
BMP signalling observed in vitro.  
 
 
Figure A-3: TGF-"  and BMP signalling. Canonical TGF-" and BMP signalling operates through SMAD proteins 
which are activated into response to receptor-mediated phosphorylation. Both pathways propagate external 
signals to the nucleus using TGF-" and BMP-specific SMADs that are shuttled into the nucleus as a complex 
containing multiple proteins. In the nucleus SMADs bind to target genes using DNA binding co-factors along 
with transcription co-activators/co-repressors. Non-canonical TGF-"/BMP pathways may involve the MAPK 
cascade and RhoA activation (image courtesy of Cell Signaling Technology®). 
 
 
The effects of TGF-" on stem cell differentiation can be similarly contradictory. 
In vivo, TGF-" is actively involved in bone repair (Cho et al., 2002) but in vitro it 
has been shown to have both pro and inhibitory effects on osteogenic induction 
(de Gorter et al., 2011; Maeda et al., 2004; Alliston et al., 2001; Spinella-Jaegle 
et al., 2001). Alliston et al. showed that TGF-" represses CBFA1 transcription in 
several osteoblast and osteoblast-like cells and is also able to inhibit the activity 
of downstream targets of CBFA1 such as ALP, OPN and OCN (Alliston et al., 
2001). Despite this, de Gorter et al. found that siRNA knockdown of TGF-" type I 
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and II receptors reduced ALP expression in C2C12 mouse myoblasts inducted with 
BMP-6 suggesting a key role for TGF-" in the early stages of osteogenesis. In the 
same work, de Gorter also reported that TGF-" enhanced BMP-2/6 induced ALP, 
and also mineralisation in both human MSCs and mouse preostoblast KS483 cells 
upon co-stimulation. However, this stimulatory effect was temporally-dependent 
as TGF-" stimulation was found to inhibit BMP induced osteogenesis at later time 
points (de Gorter et al., 2011). The results of de Gorter’s work suggests that the 
inhibitory versus stimulatory effects of TGF-" on osteogenesis is time-dependent 
with early TGF-" expression acting to enhance osteogenesis, and late expression 
inhibiting it. This is consistent with Cho’s observation of the different expression 
of various BMP/TGF-" family members during fracture repair (Cho et al., 2002).  
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Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
PLAIN (SSM) vs. PLAIN (SFM).........................  65.2 *** 
PLAIN (LSM) vs. PLAIN (SFM) ........................  54.8 *** 
PEG (SSM) vs. PEG (SFM) .............................  51.6 *** 
PEG (LSM) vs. PEG (SFM) .............................  43.4 *** 
ARGE (SSM) vs. ARGE (SFM)..........................  57.4 *** 
ARGE (LSM) vs. ARGE (SFM)..........................  62.0 *** 
ARGD (SSM) vs. ARGD (SFM) .........................  64.6 *** 
ARGD (LSM) vs. ARGD (SFM) .........................  55.4 *** 
FMOC-E (SSM) vs. FMOC-E (SFM) ....................  62.8 *** 
FMOC-E (LSM) vs. FMOC-E (SFM) ....................  57.1 *** 
FMOC-D (SSM) vs. FMOC-D (SFM)....................  62.8 *** 
FMOC-D (LSM) vs. FMOC-D (SFM) ...................  57.1 *** 
DIGE-E (SSM) vs. DIGE-E (LSM) ......................  21.4 * 
DIGE-E (SSM) vs. DIGE-E (SFM) ......................  70.7 *** 
DIGE-E (LSM) vs. DIGE-E (SFM) ......................  49.3 *** 
DIGE-D (SSM) vs. DIGE-D (LSM)......................  21.8 * 
DIGE-D (SSM) vs. DIGE-D (SFM)......................  70.4 *** 
DIGE-D (LSM) vs. DIGE-D (SFM)......................  48.5 *** 
 
Table A-1: A complete list of significant differences for PromoCell® MSC size. Values refer to differences 
in MSC size on equivalent substrates using different culture media where identifiers SSM, LSM and SFM refer 
to standard serum media (SSM), low serum media (LSM) and serum free media (SFM). Difference in rank 
values were determined by one-way ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values denote 
the degree of significance where stars are *P<0.5 **P<0.1 and ***P<0.01. Data corresponds to Table 3-2 and 
Figure 3-9. 
 
 
 
Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
(SSM) PLAIN vs. PEG ..................................  -79.8 ** 
(SSM) PLAIN vs. ARGE.................................  -65.8 * 
(SSM) PEG vs. FMOC-E ................................  -79.2 ** 
(SSM) ARGE vs. FMOC-E ..............................  -65.2 * 
   
(LSM) PLAIN vs PEG ...................................  -78.9 *** 
(LSM) PLAIN vs DIGE-D................................  -66.4 ** 
(LSM) PEG vs ARGD ...................................  -65.0 ** 
(LSM) PEG vs ARGE....................................  -59.5 * 
(LSM) PEG vs FMOC-D.................................  -66.2 ** 
(LSM) PEG vs FMOC-E .................................  -96.1 *** 
(LSM) FMOC-E vs DIGE-D .............................  83.7 *** 
   
(SFM) PLAIN vs. ARGD ................................  -111. *** 
(SFM) PLAIN vs. FMOC-E..............................  -61.6 * 
(SFM) PLAIN vs. DIGE-D...............................  -123. *** 
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(SFM) PEG vs. ARGD ..................................  -157. *** 
(SFM) PEG vs. DIGE-D.................................  -169. *** 
(SFM) PEG vs. DIGE-E .................................  -96.2 ** 
(SFM) ARGD vs. ARGE.................................  -134. *** 
(SFM) ARGD vs. FMOC-D..............................  90.8 *** 
(SFM) ARGD vs. FMOC-E ..............................  172. *** 
(SFM) ARGD vs. DIGE-E ...............................  -61.3 * 
(SFM) ARGE vs. DIGE-D ...............................  -146. *** 
(SFM) ARGE vs. DIGE-E ...............................  -72.8 ** 
(SFM) FMOC-D vs. FMOC-E ...........................  -81.6 *** 
(SFM) FMOC-D vs. DIGE-D ............................  -102. *** 
(SFM) FMOC-E vs. DIGE-D ............................  -184. *** 
(SFM) FMOC-E vs. DIGE-E ............................  -111. *** 
(SFM) DIGE-D vs. DIGE-E .............................  -72.9 ** 
 
Table A-2: A complete list of significant differences for PromoCell® MSC size. Values refer to differences 
in MSC size on equivalent substrates using different culture media where identifiers SSM, LSM and SFM refer 
to standard serum media (SSM), low serum media (LSM) and serum free media (SFM). Difference in rank 
values were determined by one-way ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values denote 
the degree of significance where stars are *P<0.5 **P<0.1 and ***P<0.01. Data corresponds to Table 3-2 and 
Figure 3-10. 
 
 
 
Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
(FX) PEG vs. FMOC-E..................................  -82.9 ** 
(FX) PEG vs. DIGE-D ..................................  -84.9 ** 
(FX) ARGE vs.ARGD ...................................  -69.0 * 
(FX) ARGD vs. FMOC-D ...............................  -89.1 *** 
(FX) ARGD vs. DIGE-E.................................  -112. *** 
(FX) FMOC-E vs. DIGE-E ..............................  -74.2 ** 
(FX) DIGE-E vs. DIGE-D ...............................  -76.2 ** 
   
(FA) PLAIN vs. ARGE ..................................  -116. *** 
(FA) PLAIN vs. FMOC-E ...............................  -107. *** 
(FA) PLAIN vs. FMOC-D ...............................  -104. *** 
(FA) PLAIN vs. DIGE-E ................................  -73.1 * 
(FA) ARGE vs. ARGD ..................................  -102. *** 
(FA) ARGE vs. DIGE-D.................................  -88.2 *** 
(FA) ARGD vs. FMOC-E................................  -93.0 *** 
(FA) ARGD vs. FMOC-D ...............................  -90.1 *** 
(FA) FMOC-E vs. DIGE-D ..............................  -78.8 ** 
(FA) FMOC-D vs. DIGE-D..............................  -75.9 ** 
   
(SMA) PLAIN vs. PEG ..................................  -110. *** 
(SMA) PLAIN vs. ARGE ................................  -124. *** 
(SMA) PLAIN vs. FMOC-E .............................  -104. *** 
(SMA) PLAIN vs. FMOC-D .............................  -118. *** 
(SMA) PLAIN vs. DIGE-E...............................  -102. *** 
(SMA) PEG vs. ARGD ..................................  -98.9 *** 
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(SMA) PEG vs. DIGE-D.................................  -76.4 ** 
(SMA) ARGE vs. ARGD.................................  -113. *** 
(SMA) ARGE vs. DIGE-D ...............................  -90.8 *** 
(SMA) ARGD vs. FMOC-E..............................  -93.4 *** 
(SMA) ARGD vs. FMOC-D..............................  -107. *** 
(SMA) ARGD vs. DIGE-E ...............................  -90.5 *** 
(SMA) FMOC-E vs. DIGE-D ............................  -70.8 * 
(SMA) FMOC-D vs. DIGE-D ............................  -84.8 ** 
(SMA) DIGE-E vs. DIGE-D .............................  -68.0 * 
 
Table A-3: A complete list of significant differences for PromoCell® adhesion analysis. Values refer to 
the difference in adhesion subtypes between all substrates cultured using SSM. Difference in rank values 
were determined by one-way ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values denote the 
degree of significance where stars are *P<0.5 **P<0.1 and ***P<0.01. Identifiers FX, FA and SMA refer to the 
individual adhesion subtype focal complex (FX), focal adhesion (FA) and supermature focal adhesion (SMA). 
Data corresponds to Table 3-3 and Figure 3-13. 
 
 
 
Significance 
 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
PLAIN (75) vs. PLAIN (39) ............................  -29.9 *** 
PLAIN (75) vs. PLAIN (7) .............................  -32.2 *** 
PEG (75) vs. PEG (39) ................................  -47.8 *** 
PEG (39) vs. PEG (7) ..................................  -36.4 *** 
ARGE (75) vs. ARGE (39) .............................  -49.8 *** 
ARGE (75) vs. ARGE (7)...............................  -34.4 *** 
ARGD (75) vs. ARGD (39).............................  -25.4 ** 
ARGD (39) vs. ARGD (7) ..............................  -33.1 *** 
FMOC-E (75) vs. FMOC-E (39) .......................  -39.3 *** 
FMOC-E (75) vs. FMOC-E (7) .........................  -61.9 *** 
FMOC-E (39) vs. FMOC-E (7) .........................  -22.6 * 
FMOC-D (75) vs. FMOC-D (39) .......................  -48.7 *** 
FMOC-D (75) vs. FMOC-D (7).........................  -54.6 *** 
DIGE-E (75) vs. DIGE-E (39)..........................  -23.2 ** 
DIGE-E (75) vs. DIGE-E (7) ...........................  -66.6 *** 
DIGE-E (39) vs. DIGE-E (7) ...........................  -43.4 *** 
 
Table A-4: A complete list of significant differences for Stro1 MSC size. Values refer to differences in 
MSC size on equivalent substrates seeded at different densities where identifiers 75, 39 and 7 refer to 
seeding densities of 75, 39 and 7 cells/mm2 respectively. Difference in rank values were determined by 
one-way ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values denote the degree of significance 
where stars are *P<0.5 **P<0.1 and ***P<0.01. Data corresponds to Table 3-4 and Figure 3-16. 
 
 
 
Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
(75) PLAIN vs. PEG ....................................  -209. *** 
(75) PLAIN vs. ARGE ..................................  -167. *** 
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(75) PLAIN vs. FMOC-D ...............................  -76.2 * 
(75) PLAIN vs. FMOC-E ...............................  -155. *** 
(75) PLAIN vs. DIGE-E.................................  -140. *** 
(75) PEG vs. ARGD ....................................  -228. *** 
(75) PEG vs. FMOC-D .................................  -133. *** 
(75) PEG vs. DIGE-D...................................  -187. *** 
(75) PEG vs. DIGE-E...................................  -68.7 * 
(75) ARGD vs. ARGE...................................  -185. *** 
(75) ARGD vs. FMOC-D................................  -94.7 *** 
(75) ARGD vs. FMOC-E................................  -174. *** 
(75) ARGD vs. DIGE-E .................................  -159. *** 
(75) ARGE vs. FMOC-D................................  -90.8 *** 
(75) ARGE vs. DIGE-D .................................  -145. *** 
(75) FMOC-D vs. FMOC-E .............................  -79.3 ** 
(75) FMOC-E vs. DIGE-D ..............................  -134. *** 
(75) DIGE-D vs. DIGE-E ...............................  -119. *** 
   
(39) PLAIN vs. PEG ....................................  -224. *** 
(39) PLAIN vs. ARGE ..................................  -178. *** 
(39) PLAIN vs. FMOC-D ...............................  -87.5 *** 
(39) PLAIN vs. FMOC-E ...............................  -145. *** 
(39) PLAIN vs. DIGE-E.................................  -121. *** 
(39) PEG vs. ARGD ....................................  -244. *** 
(39) PEG vs. FMOC-D .................................  -136. *** 
(39) PEG vs. FMOC-E..................................  -78.6 ** 
(39) PEG vs. DIGE-D...................................  -230. *** 
(39) PEG vs. DIGE-E...................................  -103. *** 
(39) ARGD vs. ARGE...................................  -198. *** 
(39) ARGD vs. FMOC-D................................  -108. *** 
(39) ARGD vs. FMOC-E................................  -166. *** 
(39) ARGD vs. DIGE-E .................................  -142. *** 
(39) ARGE vs. FMOC-D................................  -90.5 *** 
(39) ARGE vs. DIGE-D .................................  -184. *** 
(39) FMOC-D vs. DIGE-D ..............................  -93.4 *** 
(39) FMOC-E vs. DIGE-D ..............................  -151. *** 
(39) DIGE-D vs. DIGE-E ...............................  -127. *** 
   
(7) PLAIN vs. PEG .....................................  -145. *** 
(7) PLAIN vs. ARGE....................................  -126. *** 
(7) PLAIN vs. FMOC D .................................  -84.9 ** 
(7) PLAIN vs. FMOC E .................................  -162. *** 
(7) PLAIN vs. DIGE E ..................................  -180. *** 
(7) PEG vs. ARGD......................................  -188. *** 
(7) PEG vs. DIGE D ....................................  -159. *** 
(7) ARGD vs. ARGE ....................................  -170. *** 
(7) ARGD vs. FMOC D .................................  -128. *** 
(7) ARGD vs. FMOC E .................................  -205. *** 
(7) ARGD vs. DIGE E ..................................  -223. *** 
(7) ARGE vs. DIGE D ..................................  -140. *** 
(7) FMOC D vs. FMOC E...............................  -77.0 ** 
(7) FMOC D vs. DIGE D................................  -98.8 *** 
(7) FMOC D vs. DIGE E ................................  -95.0 *** 
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(7) FMOC E vs. DIGE D ................................  -176. *** 
(7) DIGE D vs. DIGE E .................................  -194. *** 
 
Table A-5: A complete list of significant differences for Stro1 MSC size. Values refer to difference in MSC 
size between all surfaces using the same seeding density where identifiers 75, 39 and 7 refer to seeding 
densities of 75, 39 and 7 cells/mm2 respectively. Difference in rank values were determined by one-way 
ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values show the degree of significance where stars 
are *P<0.5 **P<0.1 and ***P<0.01. Data corresponds to Table 3-4 and Figure 3-17. 
 
 
 
Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
(FX) PLAIN FX vs ARGD FX ...........................  -99.4 *** 
(FX) PLAIN FX vs FMOC-E ............................  -71.4 * 
(FX) PEG FX vs ARGD FX..............................  -77.9 ** 
(FX) ARGE FX vs ARGD FX ............................  -79.1 ** 
(FX) ARGD FX vs FMOC-D.............................  -103. *** 
(FX) ARGD FX vs DIGE-E ..............................  -111. *** 
(FX) FMOC-E vs. FMOC-D .............................  -75.1 ** 
(FX) FMOC-E vs. DIGE-E ..............................  -82.6 ** 
   
(FA) PLAIN FA vs PEG FA .............................  -110. *** 
(FX) PLAIN FA vs ARGE FA ...........................  -100. *** 
(FX) PLAIN FA vs FMOC-E.............................  -151. *** 
(FX) PLAIN FA vs FMOC-D ............................  -86.6 *** 
(FX) PLAIN FA vs DIGE-E..............................  -115. *** 
(FX) PEG FA vs ARGD FA .............................  -150. *** 
(FX) PEG vs. DIGE-D ..................................  -109. *** 
(FX) ARGE FA vs ARGD FA -141. *** 
(FX) ARGE vs. DIGE-D.................................  -98.9 *** 
(FX) ARGD vs. FMOC-E................................  -192. *** 
(FX) ARGD vs. FMOC-D ...............................  -127. *** 
(FX) ARGD vs. DIGE-E.................................  -155. *** 
(FX) FMOC-E vs. FMOC-D .............................  -64.7 * 
(FX) FMOC-E vs. DIGE-D ..............................  -150. *** 
(FX) FMOC-D vs. DIGE-D..............................  85.3 ** 
(FX) DIGE-E vs. DIGE-D ...............................  -113. *** 
   
(SMA) PLAIN SMA vs PEG SMA........................  -110. *** 
(SMA) PLAIN SMA vs ARGE SMA ......................  -115. *** 
(SMA) PLAIN SMA vs FMOC-E.........................  -122. *** 
(SMA) PLAIN SMA vs FMOC-D.........................  -104. *** 
(SMA) PLAIN SMA vs DIGE-E ..........................  -187. *** 
(SMA) PEG SMA vs ARGD SMA ........................  -168. *** 
(SMA) PEG SMA vs DIGE-E SMA ......................  -77.0 ** 
(SMA) PEG SMA vs DIGE-D SMA ......................  -134. *** 
(SMA) ARGE SMA vs ARGD SMA ......................  -174. *** 
(SMA) ARGE SMA vs DIGE-E ..........................  -71.5 * 
(SMA) ARGE SMA vs DIGE-D ..........................  -139. *** 
(SMA) ARGD SMA vs FMOC-E .........................  -181. *** 
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(SMA) ARGD SMA vs FMOC-D .........................  -163. *** 
(SMA) ARGD SMA vs DIGE-E ..........................  -245. *** 
(SMA) FMOC-E vs. DIGE-E ............................  -64.8 * 
(SMA) FMOC-E vs. DIGE-D ............................  -146. *** 
(SMA) FMOC-D vs. DIGE-E ............................  -82.5 ** 
(SMA) FMOC-D vs. DIGE-D............................  -128. *** 
(SMA) DIGE-E vs. DIGE-D .............................  -211. *** 
 
Table A-6: A complete list of significant differences for Stro1 MSC adhesion analysis. Values refer to the 
differences in adhesion subtypes between different substrates seeded at 7 cells/mm2. Difference in rank 
values were determined by one-way ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values denote 
the degree of significance where stars are *P<0.5 **P<0.1 and ***P<0.01. Identifiers FX, FA and SMA refer to 
individual adhesion subtype focal complex (FX), focal adhesion (FA) and supermature focal adhesion (SMA). 
Data corresponds to Table 3-5 and Figure 3-19. 
 
 
 
Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
PLAIN vs. PEG..........................................  -177. *** 
PLAIN vs. ARGE ........................................  -158. *** 
PLAIN vs. FMOC-E .....................................  -95.9 *** 
PLAIN vs. DIGE-E ......................................  -138. *** 
PEG vs. ARGD ..........................................  -226. *** 
PEG vs. FMOC-E .......................................  -81.3 ** 
PEG vs. FMOC-D .......................................  -123. *** 
PEG vs. DIGE ...........................................  -205. *** 
ARGE vs. ARGD ........................................  -207. *** 
ARGE vs. FMOC-D .....................................  -104. *** 
ARGE vs. DIGE .........................................  -186. *** 
ARGD vs. FMOC-E .....................................  -145. *** 
ARGD vs. FMOC-D .....................................  -103. *** 
ARGD vs. DIGE-E.......................................  -187. *** 
FMOC-E vs. DIGE-D....................................  -124. *** 
FMOC-D vs. DIGE-E....................................  -83.6 ** 
FMOC-D vs. DIGE-D....................................  -82.2 ** 
DIGE-E vs. DIGE-D.....................................  -166. *** 
 
Table A-9: A complete list of significant differences for phosphomyosin expression. Data values refer to 
the difference in phosphomyosin expression (represented by fluorescence intensity) for Stro1 MSCs seeded 
on surfaces at a density of 7 cells/mm2 using SSM conditions. Difference in rank values were determined by 
one-way ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values denote the degree of significance 
where stars are *P<0.5 **P<0.1 and ***P<0.01. Table data corresponds to Table 3-6 and Figure 3-20. 
 
 
 
Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
7D PLAIN vs. FMOC-D .................................  -15.8 * 
7D ARGD vs. FMOC-D .................................  -16.7 ** 
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7D FMOC-D vs. DIGE-D................................  -19.1 ** 
   
21D PLAIN vs. ARGD ..................................  -34.5 *** 
21D ARGD vs. FMOC-D ................................  -23.7 ** 
21D ARGD vs. DIGE-D .................................  -22.3 * 
   
28D PLAIN vs. ARGD ..................................  -44.2 *** 
28D PLAIN vs. FMOC-D................................  -32.2 *** 
28D PLAIN vs. DIGE-D.................................  -29.5 *** 
 
Table A-10: A complete list of significant differences for osteopontin expression. Data values refer to 
the difference in osteopontin expression (represented by fluorescence intensity) for Stro1 MSCs seeded on 
surfaces at a density of 7 cells/mm2 using SSM conditions. Difference in rank values were determined by 
one-way ANOVA (Kruskal-Wallis test) and Dunn’s post hoc test. P-values denote the degree of significance 
where stars are *P<0.5 **P<0.1 and ***P<0.01. Table data corresponds to Table 4-2 and Figure 4-7.  
 
 
 
Significance 
 
Substrate 
 
 
Difference 
in rank 
 
 
P value 
summary 
 
 
7D PLAIN vs. FMOC-D .................................  -16.6 ** 
7D ARGD vs. FMOC-D .................................  -28.0 *** 
7D ARGD vs. DIGE-D ..................................  -19.4 ** 
   
21D PLAIN vs. ARGD ..................................  -35.9 *** 
21D PLAIN vs. DIGE-D.................................  -31.8 *** 
21D ARGD vs. FMOC-D ................................  -36.2 *** 
21D FMOC-D vs. DIGE-D ..............................  -32.1 *** 
   
28D PLAIN vs. FMOC-D................................  -21.6 * 
28D ARGD vs. FMOC-D ................................  -27.8 *** 
28D FMOC vs. DIGE-D.................................  -21.1 * 
 
Table A-11: A complete list of significant differences for osteocalcin expression. Data values refer to the 
difference in osteocalcin expression for Stro1 MSCs seeded on surfaces at a density of 7 cells/mm2 using SSM 
conditions. Difference in rank values were determined by one-way ANOVA (Kruskal-Wallis test) and Dunn’s 
post hoc test. P-values denote the degree of significance where stars are *P<0.5 **P<0.1 and ***P<0.01. 
Table data corresponds to Table 4-3 and Figure 4-8.  
 
 
 
Significance 
 
Substrate 
 
 
Fold 
Change 
 
 
P value 
summary 
 
 
Mercaptoethanol ......................................  0.004 0.009 
Orthophosphate .......................................  1.42 0.012 
N-Methyl-2-pyrrolidinone ............................  2.47 0.022 
3-Cyano-L-alanine ....................................  0.376 0.011 
(S)-3-Methyl-2-oxopentanoic acid ..................  1.27 0.039 
(S)-2-Acetolactate ....................................  0.734 0.003 
4-Nitrophenol..........................................  2.56 0.008 
(S)-2-Aceto-2-hydroxybutanoate ...................  0.600 0.023 
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[FA (7:0/2:0)] Heptanedioic acid...................  0.597 0.049 
L-Glutamate methylester............................  1372 0.004 
3-Methoxyanthranilate ...............................  0.313 0.011 
[FA hydroxy(9:0)] 2-hydroxy-nonanoic acid.......  0.082 0.024 
L-Gulonate .............................................  4.14 0.003 
2-C-Methyl-D-erythritol 4-phosphate ..............  3.59 0.024 
[ST hydroxy(3:0)] 3-hydroxy-estra-1,3,5(10)-
trien-17-one 3-D-glucuronide .......................  
1453 
 
0.008 
 
Glutarylcarnitine......................................  2003 0.018 
9-Riburonosyladenine ................................  2.62 0.017 
[FA (18:1)] 9Z-octadecenoic acid ..................  0.601 0.015 
2-Oxooctadecanoic acid .............................  0.400 0.013 
[SP amino,dimethyl(18:0)] 2-amino-14,16-
dimethyloctadecan-3-ol .............................  
0.534 
 
0.023 
 
[Fv] Viscumneoside V.................................  0.484 0.049 
Glucocochlearin .......................................  4.77 0.048 
1,2-dioctanoyl-1,2,6-hexanetriol...................  0.217 0.030 
4-hydroxy-3-indolylmethyl-glucosinolate .........  1.34 0.044 
 
Table A-12: Complete list of metabolites for D2_PLAIN significantly different from controls. Data values 
refer putative metabolites for Stro1 MSCs seeded on surfaces at a density 7 cells/mm2 using SSM conditions. 
Fold change is the magnitude of difference between the sample and control. Significant differences were 
determined by one-tailed Fischer’s exact test. P-values denote the degree of significance and table data 
corresponds to Figure 4-10. 
 
 
 
Significance 
 
Substrate 
 
 
Fold 
Change 
 
 
P value 
summary 
 
 
(S)-2-Aceto-2-hydroxybutanoate ...................  0.539 0.013 
[FA (7:0/2:0)] Heptanedioic acid...................  0.446 0.012 
L-Glutamate methylester............................  15345 0.004 
Robustine...............................................  8.91 0.023 
3-Hydroxy-2-methylpyridine-4,5-dicarboxylate ..  18.3 3.75E-05 
 
Table A-13: Complete list of metabolites for D2_ARGD significantly different from controls. Data values 
refer putative metabolites for Stro1 MSCs seeded on surfaces at a density 7 cells/mm2 using SSM conditions. 
Fold change is the magnitude of difference between the sample and control. Significant differences were 
determined by one-tailed Fischer’s exact test. P-values denote the degree of significance and table data 
corresponds to Figure 4-10. 
 
 
 
Significance 
 
Substrate 
 
 
Fold 
Change 
 
 
P value 
summary 
 
 
Mercaptoethanol ......................................  0.004 0.009 
N-Methyl-2-pyrrolidinone ............................  2.24 0.005 
Tiglic acid ..............................................  0.724 0.043 
Gyromitrin .............................................  1.22 0.050 
Diethanolamine .......................................  0.222 0.047 
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D-Glycerate ............................................  1.82 0.034 
3-Methyl-2-oxobutanoic acid........................  1.54 0.029 
4-Nitrophenol..........................................  2.65 0.027 
(S)-2-Aceto-2-hydroxybutanoate ...................  0.667 0.033 
[FA (7:0/2:0)] Heptanedioic acid...................  0.547 0.031 
L-Glutamate methylester............................  1359 0.006 
L-2-amino-4-oxo-5-chloropentanoate..............  2.74 0.026 
3-Methoxyanthranilate ...............................  0.313 0.014 
Urate....................................................  0.665 0.042 
N5-Ethyl-L-glutamine.................................  0.656 0.041 
[FA hydroxy(9:0)] 2-hydroxy-nonanoic acid.......  0.093 0.024 
Robustine...............................................  5.62 0.030 
[FA (18:1)] 9Z-octadecenamide ....................  0.390 0.036 
Arborinine..............................................  1.587 0.043 
[SP (17:0)] heptadecasphinganine..................  0.120 0.020 
2-Oxooctadecanoic acid .............................  0.405 0.015 
[Fv] Viscumneoside V.................................  0.297 0.027 
1,2-dioctanoyl-1,2,6-hexanetriol...................  0.228 0.014 
Mercaptoethanol ......................................  0.004 0.009 
 
Table A-14: Complete list of metabolites for D4_ARGD significantly different from controls. Data values 
refer putative metabolites for Stro1 MSCs seeded on surfaces at a density 7 cells/mm2 using SSM conditions. 
Fold change is the magnitude of difference between the sample and control. Significant differences were 
determined by one-tailed Fischer’s exact test. P-values denote the degree of significance and table data 
corresponds to Figure 4-10. 
 
 
 
Significance 
 
Substrate 
 
 
Fold 
Change 
 
 
P value 
summary 
 
 
L-Erythrulose ..........................................  0.688 0.030 
(S)-2-Aceto-2-hydroxybutanoate ...................  0.534 0.011 
Formylanthranilate ...................................  1.66 0.010 
Robustine...............................................  7.04 0.045 
[SP methyl(10:0/8:0/8:0)] (9aS)-6S-(deca-1,3E-
dienyl)-4S-methyloctahydro-1H-quinolizin-3R-ol 
1.50 
 
0.048 
 
[Fv Methyl(9:1)] 3',4'-Methylenedioxy-
[2'',3'':7,8]furanoflavanone ..........................  
0.730 
 
0.025 
 
 
Table A-15: Complete list of metabolites for D2_FMOC significantly different from controls. Data values 
refer putative metabolites for Stro1 MSCs seeded on surfaces at a density 7 cells/mm2 using SSM conditions. 
Fold change is the magnitude of difference between the sample and control. Significant differences were 
determined by one-tailed Fischer’s exact test. P-values denote the degree of significance and table data 
corresponds to Figure 4-10. 
 
 
 
 
Significance 
 
Substrate 
 
 
Fold 
Change 
 
 
P value 
summary 
 
 
Mercaptoethanol ......................................  0.004 0.009 
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N-Methyl-2-pyrrolidinone ............................  2.53 0.023 
3-Ureidopropionate...................................  5.48 0.039 
4-Nitrophenol..........................................  2.18 0.037 
1-(3-aminopropyl)-4-aminobutanal ................  1.91 0.049 
(S)-2-Aceto-2-hydroxybutanoate ...................  0.63 0.033 
L-Glutamate methylester............................  1460 0.001 
Formylanthranilate ...................................  1.49 0.010 
3-Methoxyanthranilate ...............................  0.29 0.023 
N(pi)-Methyl-L-histidine .............................  2.76 0.034 
[FA hydroxy(9:0)] 2-hydroxy-nonanoic acid.......  0.081 0.022 
Oxalosuccinate ........................................  5.01 0.045 
Inosine ..................................................  2.04 0.043 
Arborinine..............................................  1.59 0.008 
2-Oxooctadecanoic acid .............................  0.410 0.045 
[Fv] Viscumneoside V.................................  0.376 0.035 
6alpha,9-Difluoro-11beta-hydroxypregn-4-ene-
3,20-dione .............................................  
1493 
 
0.017 
 
1,2-dioctanoyl-1,2,6-hexanetriol...................  0.290 0.024 
[PC (16:0)] 1-hexadecanoyl-sn-glycero-3-
phosphocholine........................................  
1.26 
 
0.034 
 
[PC (18:0)] 1-octadecanoyl-sn-glycero-3-
phosphocholine........................................  
1.21 
 
0.047 
 
Phosphonate ...........................................  3.76 0.032 
1-Oleoylglycerophosphocholine.....................  1.38 0.024 
L-Gulonate .............................................  2.55 0.026 
Creatinine..............................................  1.72 0.028 
 
Table A-16: Complete list of metabolites for D4_FMOC significantly different from controls. Data values 
refer putative metabolites for Stro1 MSCs seeded on surfaces at a density 7 cells/mm2 using SSM conditions. 
Fold change is the magnitude of difference between the sample and control. Significant differences were 
determined by one-tailed Fischer’s exact test. P-values denote the degree of significance and table data 
corresponds to Figure 4-10. 
 
 
 
Significance 
 
Substrate 
 
 
Fold 
Change 
 
 
P value 
summary 
 
 
Mercaptoethanol ......................................  0.004 0.009 
N-Methyl-2-pyrrolidinone ............................  2.11 0.042 
(S)-2-Acetolactate ....................................  0.608 0.003 
N-hydroxyvaline .......................................  1.50 0.016 
4-Hydroxybenzoate ...................................  0.728 0.030 
6-Hydroxynicotinate..................................  2.29 0.027 
(S)-2-Aceto-2-hydroxybutanoate ...................  0.668 0.050 
3,4-Dihydroxyphenylacetaldehyde .................  0.413 0.011 
[FA (7:0/2:0)] Heptanedioic acid...................  0.588 0.047 
3-Methoxyanthranilate ...............................  0.328 0.023 
N5-Ethyl-L-glutamine.................................  2.03 0.011 
[FA hydroxy(9:0)] 2-hydroxy-nonanoic acid.......  0.081 0.024 
3-Hydroxy-2-methylpyridine-4,5-dicarboxylate ..  14.8 0.048 
Robustine...............................................  5.23 0.020 
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Leu-Val .................................................  10.5 0.004 
9-Riburonosyladenine ................................  2.46 0.042 
9-Riburonosyladenine ................................  2.56 0.035 
[FA (18:1)] 9Z-octadecenoic acid ..................  0.700 0.012 
Arborinine..............................................  1.72 0.004 
2-Oxooctadecanoic acid .............................  0.419 0.011 
[Fv Methyl(9:1)] 3',4'-Methylenedioxy-
[2'',3'':7,8]furanoflavanone ..........................  
0.819 
 
0.047 
 
[FA hydroxy(18:0)] 9,10-dihydroxy-octadecanoic 
acid .....................................................  
0.677 
 
0.048 
 
[Fv] Viscumneoside V.................................  0.436 0.042 
1,2-dioctanoyl-1,2,6-hexanetriol...................  0.273 0.034 
4-hydroxy-3-indolylmethyl-glucosinolate .........  0.739 0.007 
[PC (16:0)] 1-hexadecanoyl-sn-glycero-3-
phosphocholine........................................  
1.48 
 
0.005 
 
[PC (18:0)] 1-octadecanoyl-sn-glycero-3-
phosphocholine........................................  
1.85 
 
0.001 
 
 
Table A-17: Complete list of metabolites for D4_F/DIGE significantly different from controls. Data values 
refer putative metabolites for Stro1 MSCs seeded on surfaces at a density 7 cells/mm2 using SSM conditions. 
Fold change is the magnitude of difference between the sample and control. Significant differences were 
determined by one-tailed Fischer’s exact test. P-values denote the degree of significance and table data 
corresponds to Figure 4-10. 
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